ACADIA Pharmaceuticals Inc.
Introduktion
Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Julian Baker. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.
Gennemsnitlig handelsrentabilitet
Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.
Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.
Opdateringsfrekvens: Dagligt
Virksomheder med rapporterede insider-stillinger
SEC-registreringen viser, at Julian Baker har rapporteret besiddelser eller handler i følgende virksomheder:
Sådan fortolkes diagrammerne
Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Julian Baker. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.
I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.
Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.
Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.
Insiderkøb ACAD / ACADIA Pharmaceuticals Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg ACAD / ACADIA Pharmaceuticals Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb BCRX / BioCryst Pharmaceuticals, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg BCRX / BioCryst Pharmaceuticals, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb CELC / Celcuity Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg CELC / Celcuity Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb HOOK / HOOKIPA Pharma Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg HOOK / HOOKIPA Pharma Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb KALA / KALA BIO, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg KALA / KALA BIO, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb KNSA / Kiniksa Pharmaceuticals, Ltd. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg KNSA / Kiniksa Pharmaceuticals, Ltd. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb KOD / Kodiak Sciences Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg KOD / Kodiak Sciences Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb KYMR / Kymera Therapeutics, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg KYMR / Kymera Therapeutics, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb MDGL / Madrigal Pharmaceuticals, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg MDGL / Madrigal Pharmaceuticals, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb NTLA / Intellia Therapeutics, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg NTLA / Intellia Therapeutics, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb PRLD / Prelude Therapeutics Incorporated – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg PRLD / Prelude Therapeutics Incorporated – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb REPL / Replimune Group, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg REPL / Replimune Group, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb RYTM / Rhythm Pharmaceuticals, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg RYTM / Rhythm Pharmaceuticals, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb SERA / Sera Prognostics, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg SERA / Sera Prognostics, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb SYRE / Spyre Therapeutics, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg SYRE / Spyre Therapeutics, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb TCRX / TScan Therapeutics, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg TCRX / TScan Therapeutics, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb TLIS / Talis Biomedical Corporation – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg TLIS / Talis Biomedical Corporation – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb TRDA / Entrada Therapeutics, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg TRDA / Entrada Therapeutics, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb VTVT / vTv Therapeutics Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg VTVT / vTv Therapeutics Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb XOMAO / XOMA Royalty Corporation - Preferred Stock – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg XOMAO / XOMA Royalty Corporation - Preferred Stock – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb ZYME / Zymeworks Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ACAD / ACADIA Pharmaceuticals Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg ZYME / Zymeworks Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ACAD / ACADIA Pharmaceuticals Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
| Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
|---|---|---|---|---|---|---|---|
| Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderhandelshistorie
Denne tabel viser den komplette liste over insiderhandler foretaget af Julian Baker som oplyst til Securities Exchange Commission (SEC).
| Fil dato | Transdato | Form | Ticker | Sikkerhed | Kode | Aktier | Resterende aktier | Procent Lave om |
Del Pris |
Tran Værdi |
Tilbage Værdi |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 4.212 | 7.211.484 | 0,06 | 58,02 | 244.395 | 418.436.263 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 388 | 704.308 | 0,06 | 58,02 | 22.513 | 40.866.486 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 151.524 | 7.207.272 | 2,15 | 56,22 | 8.518.679 | 405.192.832 | |
| 2025-09-10 |
|
4 | CELC |
Celcuity Inc.
Common Stock |
P - Purchase | 13.976 | 703.920 | 2,03 | 56,22 | 785.731 | 39.574.382 | |
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 46.692 | 135.946 | 52,31 | ||||
| 2025-09-05 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
A - Award | 4.308 | 12.368 | 53,45 | ||||
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.128 | 1.859.091 | 0,55 | 372,16 | 3.769.209 | 691.874.287 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 933 | 194.625 | 0,48 | 372,16 | 347.223 | 72.431.115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.494 | 1.848.963 | 0,30 | 371,00 | 2.038.301 | 685.974.518 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 506 | 193.692 | 0,26 | 371,00 | 187.729 | 71.860.700 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.747 | 1.843.469 | 0,15 | 369,34 | 1.014.563 | 680.857.623 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 253 | 193.186 | 0,13 | 369,34 | 93.442 | 71.350.351 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.419 | 1.840.722 | 0,08 | 368,84 | 523.384 | 678.931.902 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 131 | 192.933 | 0,07 | 368,84 | 48.318 | 71.161.408 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.798 | 1.839.303 | 0,26 | 367,77 | 1.764.565 | 676.442.304 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 442 | 192.802 | 0,23 | 367,77 | 162.555 | 70.906.984 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.289 | 1.834.505 | 0,12 | 366,30 | 838.459 | 671.977.714 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 211 | 192.360 | 0,11 | 366,30 | 77.289 | 70.461.314 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.772 | 1.832.216 | 0,15 | 363,75 | 1.008.308 | 666.463.806 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 255 | 192.149 | 0,13 | 363,75 | 92.756 | 69.893.699 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.587 | 1.829.444 | 0,31 | 362,39 | 2.024.662 | 662.968.735 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 191.894 | 0,27 | 362,39 | 186.630 | 69.540.102 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.443 | 1.823.857 | 0,30 | 361,37 | 1.966.957 | 659.093.770 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 502 | 191.379 | 0,26 | 361,37 | 181.410 | 69.159.318 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.514 | 1.818.414 | 0,47 | 359,39 | 3.059.873 | 653.525.445 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 784 | 190.877 | 0,41 | 359,39 | 281.764 | 68.599.877 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.472 | 1.809.900 | 0,14 | 358,21 | 885.495 | 648.324.279 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 228 | 190.093 | 0,12 | 358,21 | 81.672 | 68.093.214 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.328 | 1.807.428 | 0,46 | 357,02 | 2.973.289 | 645.293.728 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 767 | 189.865 | 0,41 | 357,02 | 273.837 | 67.786.210 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 916 | 1.799.100 | 0,05 | 355,00 | 325.180 | 638.680.500 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 84 | 189.098 | 0,04 | 355,00 | 29.820 | 67.129.790 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.923 | 1.798.184 | 0,11 | 353,88 | 680.503 | 636.333.262 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 177 | 189.014 | 0,09 | 353,88 | 62.636 | 66.887.424 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9.362 | 1.947.968 | 0,48 | 392,24 | 3.672.178 | 764.076.617 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 862 | 202.813 | 0,43 | 392,24 | 338.113 | 79.551.959 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.506 | 1.938.606 | 0,13 | 389,89 | 977.059 | 755.838.828 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 231 | 201.951 | 0,11 | 389,89 | 90.064 | 78.738.231 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 366 | 1.936.100 | 0,02 | 389,00 | 142.374 | 753.142.900 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 34 | 201.720 | 0,02 | 389,00 | 13.226 | 78.469.080 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.441 | 1.935.734 | 0,23 | 387,07 | 1.718.969 | 749.260.688 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 409 | 201.686 | 0,20 | 387,07 | 158.311 | 78.066.197 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.545 | 1.931.293 | 0,71 | 385,06 | 5.215.601 | 743.658.468 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.248 | 201.277 | 0,62 | 385,06 | 480.552 | 77.503.178 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.049 | 1.917.748 | 0,21 | 383,79 | 1.553.954 | 736.007.135 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 373 | 200.029 | 0,19 | 383,79 | 143.153 | 76.768.570 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.838 | 1.913.699 | 0,15 | 382,82 | 1.086.447 | 732.604.739 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 262 | 199.656 | 0,13 | 382,82 | 100.299 | 76.432.569 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.136 | 1.910.861 | 0,06 | 382,29 | 434.280 | 730.501.332 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 105 | 199.394 | 0,05 | 382,29 | 40.140 | 76.226.153 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9.477 | 1.909.725 | 0,50 | 381,12 | 3.611.889 | 727.837.448 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 873 | 199.289 | 0,44 | 381,12 | 332.719 | 75.953.343 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.919 | 1.900.248 | 0,10 | 380,78 | 730.717 | 723.576.433 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 198.416 | 0,09 | 380,78 | 67.017 | 75.552.844 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.209 | 1.898.329 | 0,28 | 380,44 | 1.981.694 | 722.193.641 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 480 | 198.240 | 0,24 | 380,44 | 182.610 | 75.417.732 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.325 | 1.893.120 | 0,39 | 374,43 | 2.742.728 | 708.848.115 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 675 | 197.760 | 0,34 | 374,43 | 252.743 | 74.048.028 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26.704 | 1.885.795 | 1,44 | 372,87 | 9.957.102 | 703.155.062 | |
| 2025-08-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.460 | 197.085 | 1,26 | 372,87 | 917.258 | 73.486.946 | |
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -3.763.362 | 0 | -100,00 | ||||
| 2025-08-18 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
U - Other | -357.048 | 0 | -100,00 | ||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
689.944 | ||||||||
| 2025-08-01 | 3 | CELC |
Celcuity Inc.
Common Stock |
7.055.748 | ||||||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28.187.581 | 0,00 | ||||
| 2025-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 492 | 28.187.581 | 0,00 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3.763.362 | 0,03 | ||||
| 2025-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3.763.362 | 0,03 | ||||
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 600.309 | 6.117.295 | 10,88 | 44,00 | 26.413.596 | 269.160.980 | |
| 2025-06-30 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 55.191 | 534.134 | 11,52 | 44,00 | 2.428.404 | 23.501.896 | |
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.430 | 1.796.261 | 0,08 | ||||
| 2025-06-24 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.430 | 1.796.261 | 0,08 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.518 | 28.187.089 | 0,01 | ||||
| 2025-06-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.518 | 28.187.089 | 0,01 | ||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
326.302 | ||||||||
| 2025-06-05 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
3.405.393 | ||||||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10.565 | 3.415.958 | 0,31 | ||||
| 2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 10.565 | 3.415.958 | 0,31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8.397 | 2.738.816 | 0,31 | ||||
| 2025-06-05 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 8.397 | 2.738.816 | 0,31 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16.214 | 39.365.965 | 0,04 | ||||
| 2025-06-02 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 16.214 | 39.365.965 | 0,04 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21.970 | 148.069 | 17,42 | ||||
| 2025-05-22 |
|
4 | ONC |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 21.970 | 148.065 | 17,42 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 28.184.571 | 0,00 | ||||
| 2025-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 487 | 2.813.892 | 0,02 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 3.762.409 | 0,03 | ||||
| 2025-04-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 953 | 356.095 | 0,27 | ||||
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 92.349 | 2.144.060 | 4,50 | 29,56 | 2.729.864 | 63.379.057 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 8.589 | 178.596 | 5,05 | 29,56 | 253.893 | 5.279.351 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 646.290 | 2.051.711 | 45,99 | 29,74 | 19.221.699 | 61.021.168 | |
| 2025-03-19 |
|
4 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
P - Purchase | 60.110 | 170.007 | 54,70 | 29,74 | 1.787.768 | 5.056.280 | |
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
929.241 | ||||||||
| 2025-03-07 | 3 | REPL |
Replimune Group, Inc.
Common Stock |
10.116.095 | ||||||||
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -671.976 | 8.068.411 | -7,69 | 260,00 | -174.713.760 | 2.097.786.860 | |
| 2025-02-28 |
|
4 | ONC |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -60.851 | 730.642 | -7,69 | 260,00 | -15.821.260 | 189.966.920 | |
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
432.434 | ||||||||
| 2025-02-14 | 3 | SERA |
SERA PROGNOSTICS, INC.
Common Stock |
5.065.736 | ||||||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4.400 | 9.999.674 | 0,04 | ||||
| 2025-01-06 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
A - Award | 4.400 | 918.483 | 0,48 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28.184.084 | 0,00 | ||||
| 2025-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 446 | 28.184.084 | 0,00 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.761.456 | 0,05 | ||||
| 2025-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 355.142 | 0,56 | ||||
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 279.939 | 1.083.398 | 34,84 | 6,44 | 1.802.807 | 6.977.083 | |
| 2024-12-31 |
|
4 | KALA |
KALA BIO, Inc.
Common Stock |
P - Purchase | 30.620 | 118.496 | 34,84 | 6,44 | 197.193 | 763.114 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 457.631 | 9.995.274 | 4,80 | 15,34 | 7.020.883 | 153.345.495 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 42.369 | 914.083 | 4,86 | 15,34 | 650.017 | 14.023.679 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 566.814 | 9.537.643 | 6,32 | 13,80 | 7.824.300 | 131.657.624 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 52.656 | 871.714 | 6,43 | 13,80 | 726.863 | 12.033.140 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 244.587 | 8.970.829 | 2,80 | 13,72 | 3.356.761 | 123.117.451 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 22.722 | 819.058 | 2,85 | 13,72 | 311.841 | 11.240.916 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 59.995 | 8.726.242 | 0,69 | 13,63 | 817.660 | 118.928.207 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 5.573 | 796.336 | 0,70 | 13,63 | 75.953 | 10.853.104 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 30.241 | 8.666.247 | 0,35 | 13,50 | 408.190 | 116.976.135 | |
| 2024-12-17 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
P - Purchase | 2.809 | 790.763 | 0,36 | 13,50 | 37.916 | 10.673.640 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -916.964 | 8.740.387 | -9,49 | 186,50 | -171.013.786 | 1.630.082.176 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -83.036 | 791.493 | -9,49 | 186,50 | -15.486.214 | 147.613.444 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -33.943 | 9.657.351 | -0,35 | 208,01 | -7.060.609 | 2.008.861.314 | |
| 2024-12-10 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -3.074 | 874.529 | -0,35 | 208,01 | -639.434 | 181.914.013 | |
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4.730 | 2.730.419 | 0,17 | ||||
| 2024-10-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals International, plc
Class A Ordinary Shares |
A - Award | 4.730 | 2.730.419 | 0,17 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 28.183.638 | 0,00 | ||||
| 2024-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 496 | 2.812.959 | 0,02 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.759.462 | 0,05 | ||||
| 2024-10-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 353.148 | 0,57 | ||||
| 2024-08-22 |
|
4 | KYMR |
Kymera Therapeutics, Inc.
Common Stock |
P - Purchase | 1 | 5.516.986 | 0,00 | 46,41 | 46 | 256.043.320 | |
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28.183.142 | 0,00 | ||||
| 2024-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 537 | 28.183.142 | 0,00 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.757.468 | 0,05 | ||||
| 2024-07-02 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.757.468 | 0,05 | ||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
87.876 | ||||||||
| 2024-06-28 | 3 | KALA |
KALA BIO, Inc.
Common Stock |
803.459 | ||||||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.428 | 1.794.831 | 0,08 | ||||
| 2024-06-27 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.428 | 1.794.831 | 0,08 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 2.186.686 | 8.636.006 | 33,91 | ||||
| 2024-06-20 |
|
4 | BCYC |
BICYCLE THERAPEUTICS PLC
American Depositary Shares |
C - Conversion | 196.098 | 787.954 | 33,13 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -5.283.206 | 28.182.605 | -15,79 | 60,00 | -316.992.360 | 1.690.956.300 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
D - Sale to Issuer | -175.977 | 2.811.926 | -5,89 | 60,00 | -10.558.620 | 168.715.560 | |
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.830 | 33.465.811 | 0,01 | ||||
| 2024-06-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.830 | 33.465.811 | 0,01 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32.682 | 126.099 | 34,99 | ||||
| 2024-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 32.682 | 126.099 | 34,99 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6.346 | 2.725.689 | 0,23 | ||||
| 2024-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 6.346 | 2.725.689 | 0,23 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18.774 | 39.349.751 | 0,05 | ||||
| 2024-05-31 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 18.774 | 39.349.751 | 0,05 | ||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
109.897 | ||||||||
| 2024-05-29 | 3 | IMCR |
Immunocore Holdings plc
American Depositary Shares |
1.405.421 | ||||||||
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15.000 | 33.462.981 | 0,04 | 49,01 | 735.150 | 1.640.020.699 | |
| 2024-05-09 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 15.000 | 2.985.073 | 0,51 | 49,01 | 735.150 | 146.298.428 | |
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12.000 | 6.449.320 | 0,19 | ||||
| 2024-04-22 |
|
4 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
A - Award | 12.000 | 6.449.320 | 0,19 | ||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
579.856 | ||||||||
| 2024-04-18 | 3 | BCYC |
BICYCLE THERAPEUTICS plc
American Depositary Shares |
6.437.320 | ||||||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.755.474 | 0,05 | ||||
| 2024-04-01 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 1.994 | 3.755.474 | 0,05 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 33.447.981 | 0,00 | ||||
| 2024-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 543 | 2.970.073 | 0,02 | ||||
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 89.407 | 3.753.480 | 2,44 | 9,62 | 860.042 | 36.106.226 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8.066 | 347.166 | 2,38 | 9,62 | 77.590 | 3.339.529 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 8.439 | 3.664.073 | 0,23 | 9,27 | 78.207 | 33.956.064 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 761 | 339.100 | 0,22 | 9,27 | 7.052 | 3.142.541 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17.101 | 3.655.634 | 0,47 | 9,22 | 157.683 | 33.707.504 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 1.543 | 338.339 | 0,46 | 9,22 | 14.228 | 3.119.722 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 247.656 | 3.638.533 | 7,30 | 8,26 | 2.046.159 | 30.061.923 | |
| 2024-03-28 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 22.344 | 336.796 | 7,11 | 8,26 | 184.608 | 2.782.642 | |
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
12.836 | ||||||||
| 2024-03-07 | 3 | VTVT |
vTv Therapeutics Inc.
Common Stock |
142.135 | ||||||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -52.881 | 89.254 | -37,20 | ||||
| 2024-03-07 |
|
4 | VTVT |
vTv Therapeutics Inc.
Common Stock |
D - Sale to Issuer | -4.776 | 8.060 | -37,21 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33.447.438 | 0,00 | ||||
| 2024-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 556 | 33.447.438 | 0,00 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3.390.877 | 0,02 | ||||
| 2024-01-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 3.390.877 | 0,02 | ||||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -42.977.301 | 0 | -100,00 | 229,00 | -9.841.801.929 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -1.731.202 | 0 | -100,00 | 229,00 | -396.445.258 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23.277 | 0 | -100,00 | 229,00 | -5.330.433 | ||
| 2023-12-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
D - Sale to Issuer | -23.280 | 0 | -100,00 | 229,00 | -5.331.120 | ||
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 214.025 | 3.390.323 | 6,74 | 6,60 | 1.412.565 | 22.376.132 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 17.066 | 313.898 | 5,75 | 6,60 | 112.636 | 2.071.727 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 52.528 | 3.176.298 | 1,68 | 6,37 | 334.399 | 20.220.631 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 4.188 | 296.832 | 1,43 | 6,37 | 26.661 | 1.889.662 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 185 | 3.123.770 | 0,01 | 6,36 | 1.176 | 19.851.558 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 15 | 292.644 | 0,01 | 6,36 | 95 | 1.859.753 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 145.749 | 3.123.585 | 4,89 | 6,50 | 947.602 | 20.308.300 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 11.621 | 292.629 | 4,14 | 6,50 | 75.555 | 1.902.557 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 71.219 | 2.977.836 | 2,45 | 5,99 | 426.751 | 17.843.491 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 5.679 | 281.008 | 2,06 | 5,99 | 34.029 | 1.683.828 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 9.649 | 2.906.617 | 0,33 | 5,76 | 55.567 | 16.738.626 | |
| 2023-12-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 769 | 275.329 | 0,28 | 5,76 | 4.429 | 1.585.565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.857 | 1.699.129 | 0,23 | 221,24 | 853.330 | 375.918.358 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 308 | 178.461 | 0,17 | 221,24 | 68.142 | 39.483.033 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.408 | 1.695.272 | 0,26 | 220,65 | 972.645 | 374.069.565 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 352 | 178.153 | 0,20 | 220,65 | 77.670 | 39.310.279 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15.005 | 1.690.864 | 0,90 | 219,24 | 3.289.711 | 370.706.714 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.195 | 177.801 | 0,68 | 219,24 | 261.993 | 38.981.269 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.873 | 1.675.859 | 0,17 | 217,91 | 626.049 | 365.182.748 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 229 | 176.606 | 0,13 | 217,91 | 49.901 | 38.483.825 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1.672.986 | 0,01 | 217,90 | 40.312 | 364.543.649 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176.377 | 0,01 | 217,90 | 3.268 | 38.432.548 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.769 | 1.672.801 | 0,11 | 216,67 | 383.286 | 362.442.949 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 141 | 176.362 | 0,08 | 216,67 | 30.550 | 38.212.055 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 668 | 1.671.032 | 0,04 | 214,72 | 143.434 | 358.807.834 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 176.221 | 0,03 | 214,72 | 11.380 | 37.838.578 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 515 | 1.670.364 | 0,03 | 213,80 | 110.107 | 357.122.821 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 41 | 176.168 | 0,02 | 213,80 | 8.766 | 37.664.613 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 185 | 1.669.849 | 0,01 | 213,62 | 39.521 | 356.721.493 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15 | 176.127 | 0,01 | 213,62 | 3.204 | 37.625.130 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1.669.664 | 0,04 | 212,04 | 137.403 | 354.037.892 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176.112 | 0,03 | 212,04 | 11.026 | 37.343.035 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1.669.016 | 0,01 | 209,76 | 19.508 | 350.101.141 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 176.060 | 0,00 | 209,76 | 1.468 | 36.931.226 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 370 | 1.668.923 | 0,02 | 208,69 | 77.216 | 348.289.710 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 30 | 176.053 | 0,02 | 208,69 | 6.261 | 36.740.729 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 648 | 1.668.553 | 0,04 | 206,93 | 134.092 | 345.277.176 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 52 | 176.023 | 0,03 | 206,93 | 10.760 | 36.424.809 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 708 | 1.667.905 | 0,04 | 205,60 | 145.565 | 342.921.268 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 56 | 175.971 | 0,03 | 205,60 | 11.514 | 36.179.638 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 1.667.197 | 0,01 | 205,32 | 19.095 | 342.308.888 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7 | 175.915 | 0,00 | 205,32 | 1.437 | 36.118.868 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.960 | 1.793.403 | 0,22 | 229,86 | 910.264 | 412.240.043 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 316 | 185.979 | 0,17 | 229,86 | 72.637 | 42.750.007 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.204 | 1.789.443 | 0,12 | 228,79 | 504.252 | 409.405.411 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 185.663 | 0,09 | 228,79 | 40.267 | 42.477.708 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 11.602 | 1.787.239 | 0,65 | 227,86 | 2.643.597 | 407.234.917 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 925 | 185.487 | 0,50 | 227,86 | 210.768 | 42.264.511 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.343 | 1.775.637 | 0,08 | 226,97 | 304.822 | 403.018.106 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 107 | 184.562 | 0,06 | 226,97 | 24.286 | 41.890.222 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.594 | 1.774.294 | 0,32 | 224,91 | 1.258.156 | 399.059.480 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 446 | 184.455 | 0,24 | 224,91 | 100.311 | 41.486.088 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 363 | 1.768.700 | 0,02 | 223,94 | 81.289 | 396.078.079 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29 | 184.009 | 0,02 | 223,94 | 6.494 | 41.206.497 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 9.262 | 1.768.337 | 0,53 | 222,68 | 2.062.425 | 393.766.210 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 738 | 183.980 | 0,40 | 222,68 | 164.335 | 40.967.930 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.532 | 1.759.075 | 0,26 | 221,78 | 1.005.101 | 390.125.367 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 361 | 183.242 | 0,20 | 221,78 | 80.062 | 40.639.173 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.518 | 1.754.543 | 0,26 | 219,87 | 993.351 | 385.762.948 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 360 | 182.881 | 0,20 | 219,87 | 79.151 | 40.209.168 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 29.738 | 1.750.025 | 1,73 | 218,46 | 6.496.513 | 382.307.486 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.373 | 182.521 | 1,32 | 218,46 | 518.402 | 39.873.227 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.894 | 1.720.287 | 0,64 | 217,52 | 2.369.611 | 374.188.571 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 869 | 180.148 | 0,48 | 217,52 | 189.021 | 39.184.928 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.264 | 1.709.393 | 0,60 | 216,70 | 2.224.203 | 370.424.437 | |
| 2023-12-14 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 818 | 179.279 | 0,46 | 216,70 | 177.260 | 38.849.652 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 1.941.607 | 2.168.818 | 854,54 | 0,00 | 194 | 217 | |
| 2023-11-24 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
X - Other | 174.742 | 196.654 | 797,47 | 0,00 | 17 | 20 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.917 | 1.667.104 | 0,48 | 190,14 | 1.505.308 | 316.976.653 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 655 | 175.908 | 0,37 | 190,14 | 124.539 | 33.446.461 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15.620 | 1.659.187 | 0,95 | 188,70 | 2.947.539 | 313.093.399 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.291 | 175.253 | 0,74 | 188,70 | 243.615 | 33.070.749 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.505 | 1.643.567 | 0,83 | 188,46 | 2.545.218 | 309.754.690 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.117 | 173.962 | 0,65 | 188,46 | 210.515 | 32.785.731 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.011 | 1.630.062 | 0,80 | 188,32 | 2.450.273 | 306.978.492 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.076 | 172.845 | 0,63 | 188,32 | 202.636 | 32.550.724 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.712 | 1.617.051 | 0,29 | 187,27 | 882.420 | 302.826.273 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 388 | 171.769 | 0,23 | 187,27 | 72.661 | 32.167.301 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.124 | 1.612.339 | 0,13 | 187,24 | 397.706 | 301.900.642 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 176 | 171.381 | 0,10 | 187,24 | 32.955 | 32.090.047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.385 | 1.610.215 | 0,09 | 186,59 | 258.431 | 300.454.847 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 115 | 171.205 | 0,07 | 186,59 | 21.458 | 31.945.655 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 647 | 1.608.830 | 0,04 | 186,32 | 120.547 | 299.752.540 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 53 | 171.090 | 0,03 | 186,32 | 9.875 | 31.876.993 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 369 | 1.608.183 | 0,02 | 183,16 | 67.586 | 294.554.798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31 | 171.037 | 0,02 | 183,16 | 5.678 | 31.327.137 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 146 | 1.607.814 | 0,01 | 185,94 | 27.148 | 298.963.688 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12 | 171.006 | 0,01 | 185,94 | 2.231 | 31.797.574 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.022 | 1.607.668 | 0,19 | 189,70 | 573.267 | 304.971.083 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 250 | 170.994 | 0,15 | 189,70 | 47.424 | 32.437.186 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.147 | 1.604.646 | 0,07 | 188,84 | 216.595 | 303.014.772 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 95 | 170.744 | 0,06 | 188,84 | 17.939 | 32.242.597 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.895 | 1.603.499 | 0,31 | 187,34 | 917.054 | 300.407.520 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 405 | 170.649 | 0,24 | 187,34 | 75.875 | 31.970.237 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.206 | 1.598.604 | 0,08 | 185,86 | 224.153 | 297.124.532 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 100 | 170.244 | 0,06 | 185,86 | 18.586 | 31.642.401 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.010 | 1.597.398 | 0,44 | 183,40 | 1.285.633 | 292.962.633 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 579 | 170.144 | 0,34 | 183,40 | 106.189 | 31.204.393 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.847 | 1.590.388 | 0,12 | 181,93 | 336.025 | 289.339.289 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 153 | 169.565 | 0,09 | 181,93 | 27.835 | 30.848.960 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.715 | 1.588.541 | 0,68 | 175,82 | 1.883.889 | 279.293.943 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 903 | 169.412 | 0,54 | 175,82 | 158.764 | 29.785.662 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.923 | 1.577.826 | 0,31 | 175,72 | 865.062 | 277.253.218 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 415 | 168.509 | 0,25 | 175,72 | 72.923 | 29.610.149 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 18.125 | 1.572.903 | 1,17 | 174,87 | 3.169.606 | 275.061.098 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.528 | 168.094 | 0,92 | 174,87 | 267.209 | 29.395.405 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 978 | 1.554.778 | 0,06 | 174,67 | 170.827 | 271.572.762 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 82 | 166.566 | 0,05 | 174,67 | 14.323 | 29.094.050 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.660 | 1.553.800 | 0,11 | 173,75 | 288.422 | 269.969.798 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 140 | 166.484 | 0,08 | 173,75 | 24.325 | 28.926.279 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.151 | 1.552.140 | 0,27 | 173,20 | 718.960 | 268.833.131 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 350 | 166.344 | 0,21 | 173,20 | 60.621 | 28.811.047 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 461 | 1.547.989 | 0,03 | 171,79 | 79.195 | 265.929.030 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 39 | 165.994 | 0,02 | 171,79 | 6.700 | 28.516.109 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.107 | 1.547.528 | 0,07 | 168,78 | 186.842 | 261.195.645 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 93 | 165.955 | 0,06 | 168,78 | 15.697 | 28.010.300 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1.546.421 | 0,04 | 167,63 | 108.289 | 259.226.552 | |
| 2023-11-21 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 165.862 | 0,03 | 167,63 | 9.052 | 27.803.447 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 13.548 | 1.500.227 | 0,91 | 154,78 | 2.096.961 | 232.205.285 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.142 | 161.969 | 0,71 | 154,78 | 176.759 | 25.069.578 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.098 | 1.486.679 | 0,55 | 153,97 | 1.246.878 | 228.909.318 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 683 | 160.827 | 0,43 | 153,97 | 105.164 | 24.763.112 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.877 | 1.478.581 | 0,19 | 153,25 | 440.907 | 226.595.939 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 242 | 160.144 | 0,15 | 153,25 | 37.087 | 24.542.436 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 646 | 1.475.704 | 0,04 | 152,21 | 98.330 | 224.621.185 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 54 | 159.902 | 0,03 | 152,21 | 8.219 | 24.339.147 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6.022 | 1.475.058 | 0,41 | 152,48 | 918.235 | 224.916.844 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 507 | 159.848 | 0,32 | 152,48 | 77.307 | 24.373.623 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.542 | 1.469.036 | 0,24 | 154,60 | 547.582 | 227.108.412 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 299 | 159.341 | 0,19 | 154,60 | 46.224 | 24.633.625 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26.426 | 1.465.494 | 1,84 | 146,21 | 3.863.756 | 214.270.464 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.228 | 159.042 | 1,42 | 146,21 | 325.757 | 23.253.594 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.994 | 1.439.068 | 0,21 | 145,98 | 437.057 | 210.071.549 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 252 | 156.814 | 0,16 | 145,98 | 36.786 | 22.891.316 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 6.369 | 1.436.074 | 0,45 | 145,46 | 926.430 | 208.890.175 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 537 | 156.562 | 0,34 | 145,46 | 78.112 | 22.773.383 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.291 | 1.429.705 | 0,09 | 142,86 | 184.429 | 204.244.082 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 109 | 156.025 | 0,07 | 142,86 | 15.571 | 22.289.341 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.790 | 1.428.414 | 0,76 | 141,44 | 1.526.192 | 202.042.018 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 910 | 155.916 | 0,59 | 141,44 | 128.715 | 22.053.539 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.072 | 1.417.624 | 0,36 | 140,90 | 714.657 | 199.746.624 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 427 | 155.006 | 0,28 | 140,90 | 60.165 | 21.840.717 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.631 | 1.412.552 | 0,33 | 137,69 | 637.622 | 194.487.928 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 390 | 154.579 | 0,25 | 137,69 | 53.697 | 21.283.287 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.693 | 1.407.921 | 0,26 | 136,91 | 505.605 | 192.756.915 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 311 | 154.189 | 0,20 | 136,91 | 42.579 | 21.109.846 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.144 | 1.404.228 | 0,22 | 136,18 | 428.151 | 191.228.471 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 265 | 153.878 | 0,17 | 136,18 | 36.088 | 20.955.183 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14.018 | 1.545.775 | 0,92 | 161,97 | 2.270.439 | 250.362.994 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.181 | 165.808 | 0,72 | 161,97 | 191.282 | 26.855.259 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 31.530 | 1.531.757 | 2,10 | 156,42 | 4.932.061 | 239.604.170 | |
| 2023-11-15 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.658 | 164.627 | 1,64 | 156,42 | 415.776 | 25.751.680 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1.008.660 | 9.691.294 | -9,43 | 180,50 | -182.063.130 | 1.749.278.567 | |
| 2023-11-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -91.340 | 877.603 | -9,43 | 180,50 | -16.486.870 | 158.407.342 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -251.902 | 2.971.128 | -7,82 | 0,40 | -101.391 | 1.195.879 | |
| 2023-10-23 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
S - Sale | -22.837 | 286.893 | -7,37 | 0,40 | -9.192 | 115.474 | |
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 535.601 | 1.658.190 | 47,71 | ||||
| 2023-10-10 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
X - Other | 57.049 | 155.874 | 57,73 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 33.446.882 | 0,00 | ||||
| 2023-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 510 | 2.968.974 | 0,02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.896.968 | 0,02 | ||||
| 2023-10-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 274.560 | 0,20 | ||||
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 61.134 | 5.612.949 | 1,10 | 0,69 | 42.354 | 3.888.651 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 5.041 | 494.133 | 1,03 | 0,69 | 3.492 | 342.335 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 93.091 | 5.551.815 | 1,71 | 0,69 | 64.456 | 3.844.077 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 7.676 | 489.092 | 1,59 | 0,69 | 5.315 | 338.647 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4.434 | 5.458.724 | 0,08 | 0,68 | 3.028 | 3.727.217 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 366 | 481.416 | 0,08 | 0,68 | 250 | 328.711 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 207.676 | 5.454.290 | 3,96 | 0,68 | 141.324 | 3.711.644 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 17.124 | 481.050 | 3,69 | 0,68 | 11.653 | 327.355 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 4.342 | 5.246.614 | 0,08 | 0,66 | 2.887 | 3.488.998 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 358 | 463.926 | 0,08 | 0,66 | 238 | 308.511 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 1.740.581 | 5.242.272 | 49,71 | 0,63 | 1.097.958 | 3.306.825 | |
| 2023-08-17 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 143.519 | 463.568 | 44,84 | 0,63 | 90.532 | 292.419 | |
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33.446.372 | 0,00 | ||||
| 2023-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 512 | 33.446.372 | 0,00 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.896.414 | 0,02 | ||||
| 2023-07-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.896.414 | 0,02 | ||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
148.821 | ||||||||
| 2023-06-20 | 3 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
1.396.292 | ||||||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.792 | 1.401.084 | 0,34 | ||||
| 2023-06-20 |
|
4 | MDGL |
MADRIGAL PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.792 | 1.401.084 | 0,34 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25.844 | 93.417 | 38,25 | ||||
| 2023-06-20 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 25.844 | 93.417 | 38,25 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.505 | 33.445.860 | 0,01 | ||||
| 2023-06-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.505 | 33.445.860 | 0,01 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8.746 | 2.719.343 | 0,32 | ||||
| 2023-06-08 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 8.746 | 2.719.343 | 0,32 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13.304 | 39.330.977 | 0,03 | ||||
| 2023-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 13.304 | 39.330.977 | 0,03 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2.044 | 42.977.301 | 0,00 | ||||
| 2023-06-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 2.044 | 42.977.301 | 0,00 | ||||
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 259.109 | 39.317.673 | 0,66 | 25,65 | 6.646.146 | 1.008.498.312 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.113 | 3.610.443 | 0,67 | 25,65 | 618.498 | 92.607.863 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28.878 | 39.058.564 | 0,07 | 25,51 | 736.788 | 996.532.390 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.688 | 3.586.330 | 0,08 | 25,51 | 68.581 | 91.500.906 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218.171 | 39.029.686 | 0,56 | 25,27 | 5.513.683 | 986.369.933 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 20.304 | 3.583.642 | 0,57 | 25,27 | 513.129 | 90.566.876 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 74.582 | 38.811.515 | 0,19 | 25,54 | 1.904.824 | 991.246.093 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6.941 | 3.563.338 | 0,20 | 25,54 | 177.273 | 91.007.653 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 116.672 | 38.736.933 | 0,30 | 25,33 | 2.955.325 | 981.214.260 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10.858 | 3.556.397 | 0,31 | 25,33 | 275.035 | 90.084.247 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12.500 | 38.620.261 | 0,03 | 17,01 | 212.625 | 656.930.640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12.500 | 38.620.261 | 0,03 | 17,01 | 212.625 | 656.930.640 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 40.632 | 38.607.761 | 0,11 | 24,80 | 1.007.674 | 957.472.473 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.781 | 3.533.039 | 0,11 | 24,80 | 93.769 | 87.619.367 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 82.148 | 38.567.129 | 0,21 | 24,46 | 2.009.373 | 943.367.402 | |
| 2023-05-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.645 | 3.529.258 | 0,22 | 24,46 | 187.000 | 86.327.062 | |
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
21.912 | ||||||||
| 2023-05-05 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
227.211 | ||||||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209.175 | 23.277 | -89,99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -209.175 | 23.277 | -89,99 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209.175 | 232.452 | 898,63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | 209.175 | 232.452 | 898,63 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
J - Other | -2.368.357 | 1.729.158 | -57,80 | ||||
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8.750 | 42.975.257 | 0,02 | 36,70 | 321.125 | 1.577.191.932 | |
| 2023-05-03 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 8.750 | 42.975.257 | 0,02 | 36,70 | 321.125 | 1.577.191.932 | |
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33.443.355 | 0,00 | ||||
| 2023-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 429 | 33.443.355 | 0,00 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.895.860 | 0,02 | ||||
| 2023-04-04 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 554 | 2.895.860 | 0,02 | ||||
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.442.926 | 0,06 | 22,74 | 454.800 | 760.492.137 | |
| 2023-03-15 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.442.926 | 0,06 | 22,74 | 454.800 | 760.492.137 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15.000 | 38.484.981 | 0,04 | 5,22 | 78.300 | 200.891.601 | |
| 2023-01-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15.000 | 38.484.981 | 0,04 | 5,22 | 78.300 | 200.891.601 | |
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33.422.926 | 0,00 | ||||
| 2023-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 397 | 33.422.926 | 0,00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33.422.529 | 0,00 | ||||
| 2022-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 457 | 33.422.529 | 0,00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33.422.072 | 0,00 | ||||
| 2022-07-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 433 | 33.422.072 | 0,00 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10.000 | 2.710.597 | 0,37 | ||||
| 2022-06-30 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
A - Award | 10.000 | 2.710.597 | 0,37 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33.384 | 67.573 | 97,65 | ||||
| 2022-06-24 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 33.384 | 67.569 | 97,66 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.144 | 33.421.639 | 0,01 | ||||
| 2022-06-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 2.144 | 33.421.639 | 0,01 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 10.622.568 | 14.575.984 | 268,69 | ||||
| 2022-06-13 |
|
4 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
A - Award | 1.252.432 | 1.585.054 | 376,53 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17.104 | 38.469.981 | 0,04 | ||||
| 2022-06-09 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 17.104 | 38.469.981 | 0,04 | ||||
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 26.450 | 4.501.658 | 0,59 | 6,42 | 169.849 | 28.907.397 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3.118 | 364.161 | 0,86 | 6,42 | 20.022 | 2.338.460 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7.815 | 4.475.208 | 0,17 | 6,35 | 49.654 | 28.434.129 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 921 | 361.043 | 0,26 | 6,35 | 5.852 | 2.293.959 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2.364 | 4.467.393 | 0,05 | 5,82 | 13.759 | 26.001.121 | |
| 2022-06-06 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 279 | 360.122 | 0,08 | 5,82 | 1.624 | 2.095.982 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 170.549 | 15.967.504 | 1,08 | 7,78 | 1.327.008 | 124.239.955 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 20.108 | 1.342.986 | 1,52 | 7,78 | 156.456 | 10.449.505 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 101.315 | 15.796.955 | 0,65 | 7,75 | 785.070 | 122.407.445 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.945 | 1.322.878 | 0,91 | 7,75 | 92.559 | 10.250.717 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 78.271 | 15.695.640 | 0,50 | 7,95 | 622.466 | 124.822.716 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.224 | 1.310.933 | 0,71 | 7,95 | 73.356 | 10.425.457 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13.155 | 15.617.369 | 0,08 | 7,93 | 104.363 | 123.897.273 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.550 | 1.301.709 | 0,12 | 7,93 | 12.297 | 10.326.848 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 138.122 | 15.604.214 | 0,89 | 7,68 | 1.060.680 | 119.829.441 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16.278 | 1.300.159 | 1,27 | 7,68 | 125.004 | 9.984.311 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.585 | 15.466.092 | 0,07 | 7,51 | 79.540 | 116.218.402 | |
| 2022-06-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.247 | 1.283.881 | 0,10 | 7,51 | 9.370 | 9.647.595 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 88.046 | 15.455.507 | 0,57 | 6,92 | 609.278 | 106.952.108 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.386 | 1.282.634 | 0,82 | 6,92 | 71.871 | 8.875.827 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 51.082 | 15.367.461 | 0,33 | 6,78 | 346.367 | 104.200.606 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.026 | 1.272.248 | 0,48 | 6,78 | 40.860 | 8.626.605 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 358 | 15.316.379 | 0,00 | 6,64 | 2.375 | 101.624.175 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42 | 1.266.222 | 0,00 | 6,64 | 279 | 8.401.383 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 984 | 15.316.021 | 0,01 | 6,76 | 6.647 | 103.459.722 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116 | 1.266.180 | 0,01 | 6,76 | 784 | 8.553.046 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 53.401 | 15.315.037 | 0,35 | 6,75 | 360.521 | 103.394.878 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.299 | 1.266.064 | 0,50 | 6,75 | 42.526 | 8.547.451 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29.090 | 15.261.636 | 0,19 | 6,71 | 195.089 | 102.350.636 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.432 | 1.259.765 | 0,27 | 6,71 | 23.016 | 8.448.488 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42.250 | 15.232.546 | 0,28 | 6,60 | 279.002 | 100.589.641 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.984 | 1.256.333 | 0,40 | 6,60 | 32.912 | 8.296.321 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 48.222 | 15.190.296 | 0,32 | 6,53 | 315.058 | 99.245.799 | |
| 2022-05-27 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.688 | 1.251.349 | 0,46 | 6,53 | 37.163 | 8.175.689 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 19.789 | 4.465.029 | 0,45 | 5,74 | 113.619 | 25.635.964 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2.334 | 359.843 | 0,65 | 5,74 | 13.401 | 2.066.039 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 1.521 | 4.445.240 | 0,03 | 5,93 | 9.020 | 26.360.273 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 179 | 357.509 | 0,05 | 5,93 | 1.061 | 2.120.028 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7.010 | 4.443.719 | 0,16 | 5,99 | 41.972 | 26.606.323 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 827 | 357.330 | 0,23 | 5,99 | 4.952 | 2.139.478 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7.772 | 4.436.709 | 0,18 | 5,84 | 45.405 | 25.919.698 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 946 | 356.503 | 0,27 | 5,84 | 5.527 | 2.082.726 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 7.248 | 4.428.937 | 0,16 | 5,84 | 42.335 | 25.868.978 | |
| 2022-05-24 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 883 | 355.557 | 0,25 | 5,84 | 5.158 | 2.076.773 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.489 | 15.142.074 | 0,05 | 5,97 | 44.701 | 90.381.525 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 1.245.661 | 0,07 | 5,97 | 5.444 | 7.435.226 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 182.827 | 15.134.585 | 1,22 | 5,97 | 1.091.221 | 90.332.284 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.266 | 1.244.749 | 1,82 | 5,97 | 132.897 | 7.429.409 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.157 | 14.951.758 | 0,06 | 5,95 | 54.518 | 89.018.282 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.115 | 1.222.483 | 0,09 | 5,95 | 6.638 | 7.278.297 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 90.674 | 14.942.601 | 0,61 | 5,99 | 542.929 | 89.471.812 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.043 | 1.221.368 | 0,91 | 5,99 | 66.122 | 7.313.185 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.118 | 14.851.927 | 0,05 | 5,99 | 48.599 | 88.912.546 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 989 | 1.210.325 | 0,08 | 5,99 | 5.921 | 7.245.732 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15.154 | 14.843.809 | 0,10 | 5,75 | 87.098 | 85.314.792 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.846 | 1.209.336 | 0,15 | 5,75 | 10.610 | 6.950.659 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 93.690 | 14.828.655 | 0,64 | 5,71 | 534.979 | 84.673.103 | |
| 2022-05-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.410 | 1.207.490 | 0,95 | 5,71 | 65.152 | 6.894.889 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 30.003 | 4.421.689 | 0,68 | 6,00 | 180.018 | 26.530.134 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 3.654 | 354.674 | 1,04 | 6,00 | 21.924 | 2.128.044 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 692 | 4.391.686 | 0,02 | 5,92 | 4.095 | 25.989.998 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 84 | 351.020 | 0,02 | 5,92 | 497 | 2.077.336 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16.501 | 4.390.994 | 0,38 | 6,13 | 101.153 | 26.917.232 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2.010 | 350.936 | 0,58 | 6,13 | 12.322 | 2.151.273 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 16.937 | 4.374.493 | 0,39 | 5,83 | 98.673 | 25.485.359 | |
| 2022-05-18 |
|
4 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
P - Purchase | 2.063 | 348.926 | 0,59 | 5,83 | 12.019 | 2.032.808 | |
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3.676 | 3.676 | |||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.503 | 42.966.507 | 0,00 | ||||
| 2022-05-17 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.503 | 42.966.507 | 0,00 | ||||
| 2022-05-16 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25.000 | 25.000 | |||||
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 22.983 | 2.528.583 | 0,92 | 1,99 | 45.628 | 5.019.996 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 2.882 | 256.209 | 1,14 | 1,99 | 5.722 | 508.652 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 758.094 | 2.505.600 | 43,38 | 1,95 | 1.478.283 | 4.885.920 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 95.060 | 253.327 | 60,06 | 1,95 | 185.367 | 493.988 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 101.831 | 1.747.506 | 6,19 | 1,93 | 196.962 | 3.380.026 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 12.769 | 158.267 | 8,78 | 1,93 | 24.698 | 306.120 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 325.373 | 1.645.675 | 24,64 | 1,70 | 553.134 | 2.797.648 | |
| 2022-05-12 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 40.800 | 145.498 | 38,97 | 1,70 | 69.360 | 247.347 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 2.592.497 | 4.674.392 | 124,53 | 23,00 | 59.627.431 | 107.511.016 | |
| 2022-04-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
P - Purchase | 233.590 | 421.532 | 124,29 | 23,00 | 5.372.570 | 9.695.236 | |
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33.419.495 | 0,00 | ||||
| 2022-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 440 | 33.419.495 | 0,00 | ||||
| 2022-03-15 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 29.497 | 29.497 | |||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 42.965.004 | 0,04 | 20,06 | 351.050 | 861.877.980 | |
| 2022-03-10 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 42.965.004 | 0,04 | 20,06 | 351.050 | 861.877.980 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 175.795 | 33.419.055 | 0,53 | 73,31 | 12.887.303 | 2.449.907.477 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 14.490 | 2.941.147 | 0,50 | 73,31 | 1.062.243 | 215.611.663 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.017 | 33.243.260 | 0,00 | 71,95 | 73.177 | 2.391.975.557 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 84 | 2.926.657 | 0,00 | 71,95 | 6.044 | 210.583.800 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25.107 | 33.242.243 | 0,08 | 71,90 | 1.805.126 | 2.390.027.518 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.070 | 2.926.573 | 0,07 | 71,90 | 148.827 | 210.412.697 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65.147 | 33.217.136 | 0,20 | 71,72 | 4.672.408 | 2.382.366.211 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5.370 | 2.924.503 | 0,18 | 71,72 | 385.142 | 209.748.280 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92.385 | 33.151.989 | 0,28 | 70,68 | 6.529.310 | 2.343.016.823 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.615 | 2.919.133 | 0,26 | 70,68 | 538.190 | 206.309.725 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.059.604 | 0,06 | 22,05 | 441.000 | 728.964.268 | |
| 2022-03-10 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 33.059.604 | 0,06 | 22,05 | 441.000 | 728.964.268 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 92.234 | 33.039.604 | 0,28 | 68,07 | 6.278.507 | 2.249.055.404 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.566 | 2.891.518 | 0,26 | 68,07 | 515.029 | 196.829.968 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 22.178 | 32.947.370 | 0,07 | 68,43 | 1.517.656 | 2.254.611.592 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.827 | 2.883.952 | 0,06 | 68,43 | 125.023 | 197.350.854 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 100.731 | 32.925.192 | 0,31 | 68,37 | 6.886.696 | 2.251.003.187 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8.296 | 2.882.125 | 0,29 | 68,37 | 567.174 | 197.042.816 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 285.672 | 32.824.461 | 0,88 | 67,74 | 19.352.821 | 2.223.689.828 | |
| 2022-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.300 | 32.538.789 | 0,02 | 67,40 | 491.984 | 2.192.951.685 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 271.997 | 14.734.965 | 1,88 | 54,57 | 14.843.883 | 804.141.559 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.403 | 1.196.080 | 1,91 | 54,57 | 1.222.615 | 65.274.511 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.174 | 14.462.968 | 0,04 | 53,82 | 278.457 | 778.376.690 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 426 | 1.173.677 | 0,04 | 53,82 | 22.927 | 63.165.653 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 64.119 | 14.457.794 | 0,45 | 54,26 | 3.479.200 | 784.503.035 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.281 | 1.173.251 | 0,45 | 54,26 | 286.556 | 63.662.476 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 23.804 | 14.393.675 | 0,17 | 53,73 | 1.279.048 | 773.408.142 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.961 | 1.167.970 | 0,17 | 53,73 | 105.369 | 62.757.948 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.359 | 14.369.871 | 0,04 | 54,16 | 290.217 | 778.200.364 | |
| 2022-02-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 441 | 1.166.009 | 0,04 | 54,16 | 23.882 | 63.145.217 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 182.326 | 32.531.489 | 0,56 | 66,04 | 12.040.390 | 2.148.304.711 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 320.526 | 32.349.163 | 1,00 | 66,02 | 21.159.973 | 2.135.575.284 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10.985 | 32.028.637 | 0,03 | 66,95 | 735.433 | 2.144.278.813 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 265.522 | 32.017.652 | 0,84 | 66,81 | 17.740.295 | 2.139.192.181 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 772.751 | 31.752.130 | 2,49 | 67,54 | 52.192.839 | 2.144.589.664 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.100 | 30.979.379 | 0,02 | 67,20 | 409.899 | 2.081.705.841 | |
| 2022-02-14 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 40.164 | 30.973.279 | 0,13 | 66,57 | 2.673.577 | 2.061.782.777 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 27.841 | 14.364.512 | 0,19 | 57,22 | 1.593.076 | 821.944.559 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.307 | 1.165.568 | 0,20 | 57,22 | 132.008 | 66.694.384 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.526 | 14.336.671 | 0,08 | 51,61 | 594.898 | 739.967.202 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 953 | 1.163.261 | 0,08 | 51,61 | 49.188 | 60.040.088 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17.119 | 14.325.145 | 0,12 | 50,56 | 865.460 | 724.214.868 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.414 | 1.162.308 | 0,12 | 50,56 | 71.485 | 58.761.062 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.395 | 14.308.026 | 0,16 | 49,70 | 1.113.056 | 711.124.631 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.851 | 1.160.894 | 0,16 | 49,70 | 91.997 | 57.697.709 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 54.024 | 14.285.631 | 0,38 | 51,67 | 2.791.490 | 738.157.125 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.465 | 1.159.043 | 0,39 | 51,67 | 230.712 | 59.889.259 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 117.291 | 14.231.607 | 0,83 | 51,59 | 6.050.820 | 734.181.565 | |
| 2022-01-31 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86.479 | 14.114.316 | 0,62 | 52,04 | 4.500.497 | 734.530.176 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.500 | 14.027.837 | 0,04 | 58,90 | 323.934 | 826.198.919 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 57.547 | 14.022.337 | 0,41 | 58,87 | 3.387.844 | 825.507.599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.350 | 13.964.790 | 0,07 | 58,76 | 549.368 | 820.513.805 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 132.367 | 13.955.440 | 0,96 | 58,13 | 7.693.938 | 811.171.114 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 25.900 | 13.823.073 | 0,19 | 57,59 | 1.491.519 | 796.037.599 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116.083 | 13.797.173 | 0,85 | 56,86 | 6.601.060 | 784.576.243 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.200 | 13.681.090 | 0,01 | 56,60 | 67.914 | 774.281.289 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19.750 | 13.679.890 | 0,14 | 56,39 | 1.113.649 | 771.372.061 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 31.207 | 13.660.140 | 0,23 | 57,53 | 1.795.292 | 785.847.364 | |
| 2022-01-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 102.207 | 13.628.933 | 0,76 | 56,57 | 5.782.279 | 771.045.981 | |
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30.933.115 | 0,00 | ||||
| 2022-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 419 | 30.933.115 | 0,00 | ||||
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 193.997 | 30.932.696 | 0,63 | 72,91 | 14.144.224 | 2.255.287.399 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 881.875 | 30.738.699 | 2,95 | 72,77 | 64.177.924 | 2.236.990.377 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 29.703 | 29.856.824 | 0,10 | 72,00 | 2.138.616 | 2.149.691.328 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 139.612 | 29.827.121 | 0,47 | 71,96 | 10.045.795 | 2.146.213.474 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 288.368 | 29.687.509 | 0,98 | 71,91 | 20.736.197 | 2.134.793.147 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5.382 | 29.399.141 | 0,02 | 71,03 | 382.302 | 2.088.323.882 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9.893 | 29.393.759 | 0,03 | 70,24 | 694.840 | 2.064.485.360 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 36.476 | 29.383.866 | 0,12 | 69,63 | 2.539.700 | 2.045.898.684 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9.352 | 29.347.390 | 0,03 | 68,52 | 640.841 | 2.011.015.226 | |
| 2021-12-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 861 | 29.338.038 | 0,00 | 67,90 | 58.460 | 1.991.999.972 | |
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
346.863 | ||||||||
| 2021-12-16 | 3 | TRDA |
Entrada Therapeutics, Inc.
Common Stock |
4.357.556 | ||||||||
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -51.399 | 42.947.504 | -0,12 | 161,39 | -8.295.146 | 6.931.181.712 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -4.738 | 4.069.762 | -0,12 | 161,39 | -764.653 | 656.807.901 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -8.332 | 42.998.903 | -0,02 | 161,34 | -1.344.327 | 6.937.658.005 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -768 | 4.074.500 | -0,02 | 161,34 | -123.913 | 657.400.202 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -25.833 | 43.007.235 | -0,06 | 160,80 | -4.154.029 | 6.915.701.011 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2.381 | 4.075.268 | -0,06 | 160,80 | -382.872 | 655.316.135 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1.007 | 43.033.068 | 0,00 | 165,68 | -166.844 | 7.129.895.142 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -93 | 4.077.649 | 0,00 | 165,68 | -15.409 | 675.601.605 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -9.618 | 43.034.075 | -0,02 | 164,82 | -1.585.266 | 7.092.996.737 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -886 | 4.077.742 | -0,02 | 164,82 | -146.033 | 672.104.854 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1.337 | 43.043.693 | 0,00 | 163,39 | -218.449 | 7.032.809.999 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -123 | 4.078.628 | 0,00 | 163,39 | -20.097 | 666.397.648 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -20.154 | 43.045.030 | -0,05 | 160,96 | -3.243.986 | 6.928.523.724 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -1.858 | 4.078.751 | -0,05 | 160,96 | -299.063 | 656.515.353 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -29.432 | 43.065.184 | -0,07 | 160,53 | -4.724.631 | 6.913.124.792 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -2.713 | 4.080.609 | -0,07 | 160,53 | -435.510 | 655.047.921 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -5.860 | 43.094.616 | -0,01 | 160,08 | -938.044 | 6.898.400.822 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -540 | 4.083.322 | -0,01 | 160,08 | -86.441 | 653.640.627 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -208.597 | 43.100.476 | -0,48 | 160,00 | -33.375.520 | 6.896.076.160 | |
| 2021-12-02 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
S - Sale | -19.226 | 4.083.862 | -0,47 | 160,00 | -3.076.160 | 653.417.920 | |
| 2021-11-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 50.000 | 7.053.176 | 0,71 | 4,36 | 218.250 | 30.787.113 | |
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29.337.177 | 0,00 | ||||
| 2021-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 393 | 29.337.177 | 0,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 86.932 | 13.526.726 | 0,65 | 95,83 | 8.330.572 | 1.296.247.215 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -138.815 | 0 | -100,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
M - Exercise | -11.184 | 0 | -100,00 | ||||
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -14 | 13.439.794 | 0,00 | 102,00 | -1.428 | 1.370.858.988 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 138.815 | 13.439.808 | 1,04 | 0,01 | 1.388 | 134.398 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
F - Taxes | -2 | 1.154.578 | 0,00 | 102,00 | -204 | 117.766.956 | |
| 2021-10-01 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
M - Exercise | 11.184 | 1.154.580 | 0,98 | 0,01 | 112 | 11.546 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.153 | 13.300.993 | 0,01 | 94,59 | 109.064 | 1.258.164.870 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.299.840 | 0,00 | 94,48 | 37.791 | 1.256.535.634 | |
| 2021-09-17 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30.285 | 13.299.440 | 0,23 | 94,38 | 2.858.425 | 1.255.257.005 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 52.201 | 13.269.155 | 0,39 | 93,35 | 4.872.948 | 1.238.671.639 | |
| 2021-09-09 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.300 | 13.216.954 | 0,04 | 92,88 | 492.279 | 1.227.629.017 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 73.635 | 13.211.654 | 0,56 | 87,61 | 6.451.464 | 1.157.527.175 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.396 | 13.138.019 | 0,02 | 87,48 | 209.607 | 1.149.341.492 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.649 | 13.135.623 | 0,04 | 87,07 | 404.793 | 1.143.731.830 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.968 | 13.130.974 | 0,02 | 86,94 | 258.033 | 1.141.587.183 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.128.006 | 0,00 | 89,66 | 35.863 | 1.177.008.444 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.100 | 13.127.606 | 0,01 | 88,16 | 96.982 | 1.157.395.383 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.186 | 13.126.506 | 0,06 | 87,91 | 719.659 | 1.153.995.773 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12.898 | 13.118.320 | 0,10 | 87,79 | 1.132.303 | 1.151.644.194 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.764 | 13.105.422 | 0,06 | 85,95 | 667.333 | 1.126.439.853 | |
| 2021-08-19 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.097.658 | 0,00 | 84,80 | 33.921 | 1.110.714.143 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 400 | 13.097.258 | 0,00 | 88,82 | 35.526 | 1.163.232.969 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 16.269 | 13.096.858 | 0,12 | 88,76 | 1.444.017 | 1.162.461.400 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21.595 | 13.080.589 | 0,17 | 88,59 | 1.913.036 | 1.158.770.138 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.086 | 13.058.994 | 0,05 | 88,01 | 535.634 | 1.149.333.815 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.600 | 13.052.908 | 0,04 | 86,44 | 397.646 | 1.128.354.716 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 300 | 13.048.308 | 0,00 | 85,58 | 25.674 | 1.116.674.199 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.500 | 13.048.008 | 0,03 | 88,00 | 395.990 | 1.148.195.998 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 44.700 | 13.043.508 | 0,34 | 86,07 | 3.847.481 | 1.122.699.081 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 600 | 12.998.808 | 0,00 | 85,72 | 51.434 | 1.114.295.518 | |
| 2021-08-13 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.723 | 12.998.208 | 0,03 | 84,39 | 314.185 | 1.096.922.673 | |
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 3.960.811 | 3.960.811 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -3.960.811 | 0 | -100,00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Non-Voting Common Stock |
C - Conversion | 315.777 | 315.777 | |||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Series C Convertible Preferred Stock |
C - Conversion | -315.777 | 0 | -100,00 | ||||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 1.320.302 | 1.320.302 | 15,00 | 19.804.530 | 19.804.530 | ||
| 2021-07-22 |
|
4 | TCRX |
TScan Therapeutics, Inc.
Common Stock |
P - Purchase | 104.698 | 104.698 | 15,00 | 1.570.470 | 1.570.470 | ||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29.336.784 | 0,00 | ||||
| 2021-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 345 | 29.336.784 | 0,00 | ||||
| 2021-07-01 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 66.474 | 66.474 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7.368 | 7.368 | |||||
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 121.612 | 12.994.485 | 0,94 | 92,75 | 11.279.014 | 1.205.185.206 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.009 | 12.872.873 | 0,05 | 91,64 | 642.276 | 1.179.617.303 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.353 | 12.865.864 | 0,17 | 90,20 | 2.016.332 | 1.160.553.683 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.603 | 12.843.511 | 0,04 | 89,74 | 413.070 | 1.152.566.402 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 30.221 | 12.838.908 | 0,24 | 90,70 | 2.741.157 | 1.164.536.460 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.200 | 12.808.687 | 0,01 | 90,40 | 108.474 | 1.157.841.261 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 11.731 | 12.807.487 | 0,09 | 90,39 | 1.060.378 | 1.157.682.838 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.847 | 12.795.756 | 0,03 | 89,90 | 345.828 | 1.150.282.163 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.079 | 12.791.909 | 0,06 | 89,87 | 636.196 | 1.149.620.375 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.459 | 12.784.830 | 0,08 | 91,87 | 960.845 | 1.174.514.205 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.445 | 12.774.371 | 0,18 | 91,80 | 2.060.393 | 1.172.654.044 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.170 | 12.751.926 | 0,08 | 90,76 | 923.046 | 1.157.386.482 | |
| 2021-06-30 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.200 | 12.741.756 | 0,04 | 90,27 | 469.420 | 1.150.237.814 | |
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 23.274 | 23.274 | |||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12.782 | 38.452.877 | 0,03 | ||||
| 2021-06-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 12.782 | 38.452.877 | 0,03 | ||||
| 2021-06-22 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
A - Award | 23.344 | 23.344 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34.996 | 34.996 | |||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15.600 | 34.189 | 83,92 | ||||
| 2021-06-21 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 15.600 | 34.189 | 83,92 | ||||
| 2021-06-10 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 40.000 | 40.000 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 8.010 | 8.010 | |||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.923 | 29.336.439 | 0,01 | ||||
| 2021-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.923 | 29.336.439 | 0,01 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 3.462 | 3.462 | |||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Non-Qualified Stock Option (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.402 | 43.309.073 | 0,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
A - Award | 1.402 | 43.309.073 | 0,00 | ||||
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 43.307.671 | 0,04 | 19,02 | 332.850 | 823.711.902 | |
| 2021-05-18 |
|
4 | SGEN |
Seagen Inc.
Common Stock |
M - Exercise | 17.500 | 43.307.671 | 0,04 | 19,02 | 332.850 | 823.711.902 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.334.516 | 0,07 | 18,97 | 379.400 | 556.475.769 | |
| 2021-05-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 2.870.749 | 0,70 | 18,97 | 379.400 | 54.458.109 | |
| 2021-05-13 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25.000 | 25.000 | |||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.314.516 | 0,00 | ||||
| 2021-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.314.516 | 0,00 | ||||
| 2021-02-25 |
|
4 | AGLE |
Aeglea BioTherapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 47.200 | 47.200 | |||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
315.516 | ||||||||
| 2021-02-25 | 3 | AGLE |
Aeglea BioTherapeutics, Inc.
Common Stock |
3.094.590 | ||||||||
| 2021-02-23 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 6.423 | 6.423 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6.427.576 | 27.511.741 | 30,49 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536.438 | 2.345.481 | 29,65 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7.286.794 | 21.084.165 | 52,81 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 536.414 | 1.809.043 | 42,15 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 1.941 | 5.420 | 55,79 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 6.654.603 | 13.797.371 | 93,17 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 598.860 | 1.272.629 | 88,88 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 7.142.768 | 7.142.768 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 673.769 | 673.769 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series 1 Convertible Preferred Stock |
M - Exercise | 3.479 | 3.479 | |||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -9.191.433 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
M - Exercise | -767.106 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -10.420.117 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-2 Convertible Preferred Stock |
M - Exercise | -767.072 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series E-1 Convertible Preferred Stock |
M - Exercise | -2.776 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -9.516.082 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series D-2 Convertible Preferred Stock |
M - Exercise | -856.370 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -10.214.159 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -963.490 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series C-1 Convertible Preferred Stock |
M - Exercise | -4.975 | 0 | -100,00 | ||||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 5.792.538 | 7.003.176 | 478,47 | 16,00 | 92.680.608 | 112.050.816 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Common Stock |
P - Purchase | 457.462 | 571.659 | 400,59 | 16,00 | 7.319.392 | 9.146.544 | |
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 9.191.433 | 9.191.433 | 8,55 | 78.586.752 | 78.586.752 | ||
| 2021-02-19 |
|
4 | TLIS |
Talis Biomedical Corp
Series F-2 Convertible Preferred Stock |
A - Award | 767.106 | 767.106 | 8,55 | 6.558.756 | 6.558.756 | ||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158.456 | 23.277 | -87,19 | ||||
| 2021-02-16 |
|
5 | SGEN |
Seagen Inc.
Common Stock |
G - Gift | -158.460 | 23.280 | -87,19 | ||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
590 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
114.197 | ||||||||
| 2021-02-11 | 3 | TLIS |
Talis Biomedical Corp
Common Stock |
1.210.638 | ||||||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.188 | 41.500 | -11,11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.188 | 41.500 | -11,11 | ||||
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5.188 | 9.252.951 | 0,06 | 12,85 | 66.666 | 118.900.420 | |
| 2021-01-29 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
M - Exercise | 5.188 | 9.252.951 | 0,06 | 12,85 | 66.666 | 118.900.420 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.833 | 2.527 | -69,77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.833 | 2.527 | -69,77 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.377 | 6.723 | -44,44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.377 | 6.723 | -44,44 | ||||
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.833 | 2.895.306 | 0,20 | 40,27 | 234.895 | 116.593.973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.833 | 2.895.306 | 0,20 | 40,27 | 234.895 | 116.593.973 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.377 | 2.889.473 | 0,19 | 16,00 | 86.032 | 46.231.568 | |
| 2021-01-29 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
M - Exercise | 5.377 | 2.889.473 | 0,19 | 16,00 | 86.032 | 46.231.568 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 154.222 | 5.212.371 | 3,05 | 60,00 | 9.253.320 | 312.742.260 | |
| 2021-01-13 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
P - Purchase | 12.444 | 509.480 | 2,50 | 60,00 | 746.640 | 30.568.800 | |
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
332.622 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
Ordinary Shares |
3.953.416 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
1.200.369 | ||||||||
| 2021-01-11 | 3 | DBVT |
DBV Technologies S.A.
American Depositary Shares |
13.413.895 | ||||||||
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -111.094 | 10.699.954 | -1,03 | 220,50 | -24.496.227 | 2.359.339.857 | |
| 2021-01-06 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -10.060 | 968.943 | -1,03 | 220,50 | -2.218.230 | 213.651.932 | |
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.884.096 | 0,01 | ||||
| 2021-01-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.884.096 | 0,01 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29.314.152 | 0,00 | ||||
| 2021-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 343 | 29.314.152 | 0,00 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 518.555 | 10.283.888 | 5,31 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-Funded Warrants |
P - Purchase | 38.974 | 1.199.122 | 3,36 | ||||
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 394.360 | 3.501.691 | 12,69 | 15,25 | 6.013.990 | 53.400.788 | |
| 2020-12-23 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 29.640 | 320.049 | 10,21 | 15,25 | 452.010 | 4.880.747 | |
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 616.846 | 616.846 | 89,99 | 55.509.972 | 55.509.972 | ||
| 2020-12-11 |
|
4 | IGMS |
IGM Biosciences, Inc.
Pre-funded Warrants |
P - Purchase | 49.820 | 49.820 | 89,99 | 4.483.302 | 4.483.302 | ||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -1.386.033 | 10.811.048 | -11,36 | 220,50 | -305.620.276 | 2.383.836.084 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
S - Sale | -125.513 | 979.003 | -11,36 | 220,50 | -27.675.616 | 215.870.162 | |
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13.516 | 10.418 | -56,47 | ||||
| 2020-12-04 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
G - Gift | -13.516 | 10.418 | -56,47 | ||||
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.411.619 | 12.736.556 | 12,46 | 108,00 | 152.454.852 | 1.375.548.048 | |
| 2020-11-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 116.158 | 1.143.396 | 11,31 | 108,00 | 12.545.064 | 123.486.768 | |
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.873 | 0,01 | ||||
| 2020-10-05 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.873 | 0,01 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29.313.809 | 0,00 | ||||
| 2020-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 317 | 29.313.809 | 0,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 382.884 | 5.058.149 | 8,19 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -382.884 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 30.349 | 497.036 | 6,50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -30.349 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -574.327 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Convertible Preferred Stock |
C - Conversion | -45.524 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 2.698.424 | 4.675.265 | 136,50 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -2.698.424 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 247.034 | 466.687 | 112,47 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -247.034 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -4.047.634 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Convertible Preferred Stock |
C - Conversion | -370.552 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 1.976.841 | 1.976.841 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -1.976.841 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Voting Common Stock |
C - Conversion | 219.653 | 219.653 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -219.653 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -2.965.263 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series A Convertible Preferred Stock |
C - Conversion | -329.478 | 0 | -100,00 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 1.474.319 | 9.247.763 | 18,97 | 19,00 | 28.012.061 | 175.707.497 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
P - Purchase | 104.628 | 870.873 | 13,65 | 19,00 | 1.987.932 | 16.546.587 | |
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 574.327 | 7.773.444 | 7,98 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 45.524 | 766.245 | 6,32 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 4.047.634 | 7.199.117 | 128,44 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 370.552 | 720.721 | 105,82 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 2.965.263 | 3.151.483 | 1.592,34 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Common Stock |
C - Conversion | 329.478 | 350.169 | 1.592,37 | ||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Non-Qualified Stock Option (right to buy) |
A - Award | 46.688 | 46.688 | |||||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 957.211 | 957.211 | 14,52 | 13.898.321 | 13.898.321 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series C Preferred Stock |
P - Purchase | 75.873 | 75.873 | 14,52 | 1.101.646 | 1.101.646 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 3.373.029 | 3.373.029 | 3,93 | 13.264.099 | 13.264.099 | ||
| 2020-09-30 |
|
4 | PRLD |
Prelude Therapeutics Inc
Series B Preferred Stock |
P - Purchase | 308.793 | 308.793 | 3,93 | 1.214.298 | 1.214.298 | ||
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.843 | 11.324.937 | 0,07 | 58,09 | 455.565 | 657.814.628 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 557 | 1.027.238 | 0,05 | 58,09 | 32.354 | 59.667.633 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 19.235 | 11.317.094 | 0,17 | 56,92 | 1.094.854 | 644.167.859 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.365 | 1.026.681 | 0,13 | 56,92 | 77.696 | 58.438.580 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.705 | 11.297.859 | 0,04 | 56,76 | 267.055 | 641.265.347 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 334 | 1.025.316 | 0,03 | 56,76 | 18.958 | 58.196.834 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13.153 | 11.293.154 | 0,12 | 55,35 | 728.057 | 625.108.824 | |
| 2020-09-25 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 933 | 1.024.982 | 0,09 | 55,35 | 51.644 | 56.735.726 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29.327 | 11.280.001 | 0,26 | 52,11 | 1.528.374 | 587.856.124 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.081 | 1.024.049 | 0,20 | 52,11 | 108.451 | 53.368.211 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 4.306 | 11.250.674 | 0,04 | 51,41 | 221.368 | 578.388.150 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 306 | 1.021.968 | 0,03 | 51,41 | 15.731 | 52.538.557 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 74.381 | 11.246.368 | 0,67 | 52,44 | 3.900.235 | 589.713.428 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.278 | 1.021.662 | 0,52 | 52,44 | 276.757 | 53.571.766 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.467 | 11.171.987 | 0,09 | 52,40 | 548.468 | 585.408.767 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 743 | 1.016.384 | 0,07 | 52,40 | 38.933 | 53.258.217 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.120 | 11.161.520 | 0,01 | 51,97 | 58.206 | 580.064.194 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 80 | 1.015.641 | 0,01 | 51,97 | 4.158 | 52.782.863 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 22.361 | 11.160.400 | 0,20 | 51,98 | 1.162.235 | 580.072.950 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.587 | 1.015.561 | 0,16 | 51,98 | 82.486 | 52.784.799 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 36.647 | 11.138.039 | 0,33 | 50,15 | 1.837.909 | 558.591.591 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.601 | 1.013.974 | 0,26 | 50,15 | 130.445 | 50.852.520 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.983 | 11.101.392 | 0,10 | 49,72 | 546.102 | 551.988.964 | |
| 2020-09-24 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 779 | 1.011.373 | 0,08 | 49,72 | 38.734 | 50.287.994 | |
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
20.691 | ||||||||
| 2020-09-24 | 3 | PRLD |
Prelude Therapeutics Inc
Common Stock |
186.220 | ||||||||
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15.172 | 11.090.409 | 0,14 | 47,47 | 720.200 | 526.450.625 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.220 | 1.010.594 | 0,12 | 47,47 | 57.912 | 47.971.887 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 76.473 | 11.075.237 | 0,70 | 47,39 | 3.623.857 | 524.826.686 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.151 | 1.009.374 | 0,61 | 47,39 | 291.480 | 47.831.609 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15.807 | 10.998.764 | 0,14 | 47,04 | 743.482 | 517.326.865 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.272 | 1.003.223 | 0,13 | 47,04 | 59.829 | 47.186.594 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 10.982.957 | 0,00 | 45,88 | 8.487 | 503.843.152 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 15 | 1.001.951 | 0,00 | 45,88 | 688 | 45.964.502 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.101 | 10.982.772 | 0,08 | 47,50 | 432.281 | 521.661.901 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 712 | 1.001.936 | 0,07 | 47,50 | 33.819 | 47.590.157 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 26.238 | 10.973.671 | 0,24 | 47,26 | 1.239.984 | 518.605.815 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.054 | 1.001.224 | 0,21 | 47,26 | 97.070 | 47.316.945 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 29.319 | 10.947.433 | 0,27 | 46,62 | 1.366.767 | 510.337.579 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.295 | 999.170 | 0,23 | 46,62 | 106.986 | 46.578.408 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 12.132 | 10.918.114 | 0,11 | 45,30 | 549.535 | 494.550.167 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 950 | 996.875 | 0,10 | 45,30 | 43.031 | 45.154.749 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 32.088 | 10.905.982 | 0,30 | 49,00 | 1.572.312 | 534.393.118 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.512 | 995.925 | 0,25 | 49,00 | 123.088 | 48.800.325 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 77.456 | 10.873.894 | 0,72 | 47,60 | 3.686.658 | 517.562.558 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.062 | 993.413 | 0,61 | 47,60 | 288.532 | 47.283.280 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.987 | 10.796.438 | 0,03 | 47,45 | 141.725 | 512.260.753 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 234 | 987.351 | 0,02 | 47,45 | 11.103 | 46.847.040 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.359 | 10.793.451 | 0,02 | 46,97 | 110.798 | 506.947.886 | |
| 2020-09-08 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 185 | 987.117 | 0,02 | 46,97 | 8.689 | 46.363.010 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 83.832 | 10.791.092 | 0,78 | 49,08 | 4.114.734 | 529.660.248 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.645 | 986.932 | 0,68 | 49,08 | 326.157 | 48.441.682 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.286 | 10.707.260 | 0,02 | 48,74 | 111.430 | 521.922.177 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 181 | 980.287 | 0,02 | 48,74 | 8.823 | 47.783.796 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 42.714 | 10.704.974 | 0,40 | 47,74 | 2.039.256 | 511.077.939 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.386 | 980.106 | 0,35 | 47,74 | 161.655 | 46.792.319 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 754 | 10.662.260 | 0,01 | 47,82 | 36.058 | 509.896.995 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 60 | 976.720 | 0,01 | 47,82 | 2.869 | 46.709.290 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 41.155 | 10.661.506 | 0,39 | 47,72 | 1.963.970 | 508.780.926 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.262 | 976.660 | 0,34 | 47,72 | 155.667 | 46.607.485 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.640 | 10.620.351 | 0,10 | 46,50 | 494.716 | 493.802.778 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 843 | 973.398 | 0,09 | 46,50 | 39.196 | 45.259.016 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.576 | 10.609.711 | 0,03 | 46,30 | 165.575 | 491.248.717 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 283 | 972.555 | 0,03 | 46,30 | 13.103 | 45.031.047 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.585 | 10.606.135 | 0,03 | 46,99 | 168.447 | 498.345.162 | |
| 2020-08-21 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 284 | 972.272 | 0,03 | 46,99 | 13.344 | 45.683.658 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1.335.362 | 11.638.314 | 12,96 | 21,00 | 28.042.602 | 244.404.594 | |
| 2020-07-28 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 93.210 | 1.143.650 | 8,87 | 21,00 | 1.957.410 | 24.016.650 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728.370 | 6.173.327 | 13,38 | 16,00 | 11.653.920 | 98.773.232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52.880 | 542.114 | 10,81 | 16,00 | 846.080 | 8.673.824 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 728.370 | 6.173.327 | 13,38 | 16,00 | 11.653.920 | 98.773.232 | |
| 2020-07-20 |
|
4 | BCEL |
Atreca, Inc.
Class B Common Stock |
P - Purchase | 52.880 | 542.114 | 10,81 | 16,00 | 846.080 | 8.673.824 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 13.589.904 | 18.840.379 | 258,83 | 14,23 | 193.395.206 | 268.113.665 | |
| 2020-07-17 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary Shares |
A - Award | 994.276 | 1.021.851 | 3.605,72 | 14,23 | 14.149.343 | 14.541.757 | |
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.650 | 0,01 | ||||
| 2020-07-06 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.650 | 0,01 | ||||
| 2020-07-02 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 7.106 | 7.106 | |||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29.313.492 | 0,00 | ||||
| 2020-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 294 | 29.313.492 | 0,00 | ||||
| 2020-07-02 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37.520 | 37.520 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Options (right to buy) |
A - Award | 11.158 | 11.158 | |||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6.118 | 38.440.095 | 0,02 | ||||
| 2020-06-25 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
A - Award | 6.118 | 38.440.095 | 0,02 | ||||
| 2020-06-19 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 90.766 | 90.766 | |||||
| 2020-06-10 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Options (right to buy) |
A - Award | 4.135 | 4.135 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29.313.198 | 0,00 | 102,55 | 103 | 3.006.068.455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1 | 29.313.198 | 0,00 | 102,55 | 103 | 3.006.068.455 | |
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 10.514 | 10.514 | |||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.282 | 29.313.197 | 0,00 | ||||
| 2020-05-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.282 | 29.313.197 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 3.171 | 3.171 | |||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1.335 | 43.290.171 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 1.335 | 43.290.171 | 0,00 | ||||
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1.602.312 | 43.288.836 | -3,57 | 160,00 | -256.369.920 | 6.926.213.760 | |
| 2020-05-19 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -147.688 | 4.082.851 | -3,49 | 160,00 | -23.630.080 | 653.256.160 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1.465.603 | 10.302.952 | 16,58 | 18,25 | 26.747.255 | 188.028.874 | |
| 2020-05-18 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 134.397 | 1.050.440 | 14,67 | 18,25 | 2.452.745 | 19.170.530 | |
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.189 | 7.846.213 | 0,02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 1.189 | 7.846.213 | 0,02 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.468 | 7.845.024 | 0,04 | ||||
| 2020-05-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.468 | 7.845.024 | 0,04 | ||||
| 2020-05-12 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 9.000 | 9.000 | |||||
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -457.803 | 44.891.148 | -1,01 | 158,50 | -72.561.776 | 7.115.246.958 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -42.197 | 4.230.539 | -0,99 | 158,50 | -6.688.224 | 670.540.432 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4.343 | 45.348.951 | -0,01 | 166,15 | -721.610 | 7.534.941.349 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -400 | 4.272.736 | -0,01 | 166,15 | -66.462 | 709.935.168 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -48.880 | 45.353.294 | -0,11 | 164,96 | -8.063.118 | 7.481.361.460 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4.505 | 4.273.136 | -0,11 | 164,96 | -743.133 | 704.885.404 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -84.663 | 45.402.174 | -0,19 | 164,19 | -13.901.157 | 7.454.764.558 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -7.805 | 4.277.641 | -0,18 | 164,19 | -1.281.534 | 702.362.986 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16.159 | 45.486.837 | -0,04 | 163,41 | -2.640.610 | 7.433.195.079 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -1.489 | 4.285.446 | -0,03 | 163,41 | -243.324 | 700.302.730 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -41.072 | 45.502.996 | -0,09 | 166,62 | -6.843.564 | 7.581.873.004 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -3.786 | 4.286.935 | -0,09 | 166,62 | -630.837 | 714.304.543 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -91.613 | 45.544.068 | -0,20 | 165,70 | -15.180.641 | 7.546.834.244 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -8.444 | 4.290.721 | -0,20 | 165,70 | -1.399.205 | 710.989.633 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -178.862 | 45.635.681 | -0,39 | 164,60 | -29.440.041 | 7.511.468.804 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -16.485 | 4.299.165 | -0,38 | 164,60 | -2.713.372 | 707.627.082 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -45.606 | 45.814.543 | -0,10 | 164,06 | -7.482.107 | 7.516.320.180 | |
| 2020-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
S - Sale | -4.204 | 4.315.650 | -0,10 | 164,06 | -689.707 | 708.024.244 | |
| 2020-05-07 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 25.000 | 25.000 | |||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.311.915 | 0,07 | 13,34 | 266.800 | 391.020.946 | |
| 2020-04-29 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.311.915 | 0,07 | 13,34 | 266.800 | 391.020.946 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -17.500 | 0 | -100,00 | ||||
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17.500 | 45.860.149 | 0,04 | 12,76 | 223.300 | 585.175.501 | |
| 2020-04-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 17.500 | 45.860.149 | 0,04 | 12,76 | 223.300 | 585.175.501 | |
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.427 | 0,01 | ||||
| 2020-04-03 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
A - Award | 223 | 2.883.427 | 0,01 | ||||
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29.291.915 | 0,00 | 73,23 | 28.706 | 2.145.046.935 | |
| 2020-04-01 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 392 | 29.291.915 | 0,00 | 73,23 | 28.706 | 2.145.046.935 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 42.473 | 38.433.977 | 0,11 | 34,47 | 1.463.896 | 1.324.684.668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.837 | 3.470.609 | 0,11 | 34,47 | 132.248 | 119.619.745 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 33.464 | 38.391.504 | 0,09 | 33,63 | 1.125.465 | 1.291.186.902 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.023 | 3.466.772 | 0,09 | 33,63 | 101.670 | 116.594.823 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.201 | 38.358.040 | 0,01 | 32,85 | 72.302 | 1.260.053.942 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 199 | 3.463.749 | 0,01 | 32,85 | 6.537 | 113.783.462 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 46.225 | 38.355.839 | 0,12 | 32,61 | 1.507.268 | 1.250.676.513 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.175 | 3.463.550 | 0,12 | 32,61 | 136.135 | 112.936.668 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 275 | 38.309.614 | 0,00 | 31,94 | 8.782 | 1.223.417.523 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25 | 3.459.375 | 0,00 | 31,94 | 798 | 110.475.141 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 93.006 | 38.309.339 | 0,24 | 33,86 | 3.149.406 | 1.297.246.161 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8.402 | 3.459.350 | 0,24 | 33,86 | 284.512 | 117.141.893 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.223 | 38.216.333 | 0,06 | 32,32 | 782.873 | 1.235.128.953 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.188 | 3.450.948 | 0,06 | 32,32 | 70.715 | 111.532.569 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 29.624 | 38.192.110 | 0,08 | 32,19 | 953.620 | 1.229.434.575 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.676 | 3.448.760 | 0,08 | 32,19 | 86.143 | 111.018.343 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.612 | 38.162.486 | 0,02 | 31,83 | 242.290 | 1.214.711.929 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 688 | 3.446.084 | 0,02 | 31,83 | 21.899 | 109.688.854 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43.212 | 38.154.874 | 0,11 | 31,74 | 1.371.359 | 1.210.867.819 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.903 | 3.445.396 | 0,11 | 31,74 | 123.864 | 109.341.709 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.913 | 38.111.662 | 0,01 | 31,00 | 121.285 | 1.181.290.020 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 353 | 3.441.493 | 0,01 | 31,00 | 10.941 | 106.670.796 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 631.281 | 38.107.749 | 1,68 | 31,51 | 19.893.937 | 1.200.912.359 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 57.022 | 3.441.140 | 1,68 | 31,51 | 1.796.968 | 108.442.710 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.503 | 37.476.468 | 0,01 | 31,19 | 171.613 | 1.168.714.898 | |
| 2020-03-18 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 497 | 3.384.118 | 0,01 | 31,19 | 15.499 | 105.534.735 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.172 | 10.602.550 | 0,09 | 38,38 | 352.019 | 406.922.688 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 971.988 | 0,09 | 38,38 | 31.778 | 37.304.608 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.237 | 10.593.378 | 0,06 | 37,75 | 235.433 | 399.876.714 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 563 | 971.160 | 0,06 | 37,75 | 21.252 | 36.659.153 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 17.058 | 10.587.141 | 0,16 | 36,69 | 625.914 | 388.477.141 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.542 | 970.597 | 0,16 | 36,69 | 56.581 | 35.614.407 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 9.172 | 10.570.083 | 0,09 | 38,98 | 357.570 | 412.074.686 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 828 | 969.055 | 0,09 | 38,98 | 32.280 | 37.778.609 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 95.934 | 10.560.911 | 0,92 | 39,97 | 3.834.588 | 422.131.230 | |
| 2020-03-18 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.666 | 968.227 | 0,90 | 39,97 | 346.390 | 38.701.098 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 14.731 | 7.841.556 | 0,19 | 83,14 | 1.224.797 | 651.979.900 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.331 | 994.296 | 0,13 | 83,14 | 110.665 | 82.669.945 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.321 | 7.826.825 | 0,02 | 82,92 | 109.537 | 648.995.633 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 119 | 992.965 | 0,01 | 82,92 | 9.867 | 82.336.062 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 15.928 | 7.825.504 | 0,20 | 82,13 | 1.308.149 | 642.700.035 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.439 | 992.846 | 0,15 | 82,13 | 118.183 | 81.541.350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 25.640 | 7.809.576 | 0,33 | 81,79 | 2.097.003 | 638.717.107 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.314 | 991.407 | 0,23 | 81,79 | 189.254 | 81.083.609 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.203 | 7.783.936 | 0,05 | 81,47 | 342.438 | 634.193.850 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 380 | 989.093 | 0,04 | 81,47 | 30.960 | 80.586.055 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12.815 | 7.779.733 | 0,16 | 81,09 | 1.039.177 | 630.863.995 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 1.158 | 988.713 | 0,12 | 81,09 | 93.903 | 80.175.429 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 3.298 | 7.766.918 | 0,04 | 80,91 | 266.845 | 628.431.432 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 298 | 987.555 | 0,03 | 80,91 | 24.112 | 79.904.359 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 10.285 | 7.763.620 | 0,13 | 79,87 | 821.429 | 620.054.709 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 929 | 987.257 | 0,09 | 79,87 | 74.196 | 78.848.959 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 26.022 | 7.753.335 | 0,34 | 79,72 | 2.074.362 | 618.062.527 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.351 | 986.328 | 0,24 | 79,72 | 187.412 | 78.625.827 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.888 | 7.727.313 | 0,04 | 79,29 | 228.980 | 612.673.148 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 261 | 983.977 | 0,03 | 79,29 | 20.694 | 78.016.289 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.191 | 7.724.425 | 0,05 | 79,16 | 331.760 | 611.467.028 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 379 | 983.716 | 0,04 | 79,16 | 30.002 | 77.871.155 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 565 | 7.720.234 | 0,01 | 78,66 | 44.443 | 607.273.606 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 51 | 983.337 | 0,01 | 78,66 | 4.012 | 77.349.288 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 65.505 | 7.719.669 | 0,86 | 76,67 | 5.022.445 | 591.887.865 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.917 | 983.286 | 0,61 | 76,67 | 453.672 | 75.391.192 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 27.866 | 7.654.164 | 0,37 | 76,10 | 2.120.480 | 582.448.202 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.517 | 977.369 | 0,26 | 76,10 | 191.533 | 74.373.480 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 62.129 | 7.626.298 | 0,82 | 79,76 | 4.955.720 | 608.311.660 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 5.612 | 974.852 | 0,58 | 79,76 | 447.641 | 77.759.070 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 133.042 | 7.564.169 | 1,79 | 79,14 | 10.529.170 | 598.641.194 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 12.017 | 969.240 | 1,26 | 79,14 | 951.046 | 76.707.301 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.612 | 7.431.127 | 0,10 | 77,94 | 593.260 | 579.163.461 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 688 | 957.223 | 0,07 | 77,94 | 53.621 | 74.603.568 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 8.309 | 7.423.515 | 0,11 | 77,89 | 647.203 | 578.230.946 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 750 | 956.535 | 0,08 | 77,89 | 58.419 | 74.506.233 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 32.228 | 7.415.206 | 0,44 | 75,66 | 2.438.422 | 561.046.350 | |
| 2020-03-18 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.911 | 955.785 | 0,31 | 75,66 | 220.251 | 72.316.222 | |
| 2020-03-16 |
|
4 | ZYME |
Zymeworks Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 18.000 | 18.000 | |||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
1.876.724 | ||||||||
| 2020-03-16 | 3 | ZYME |
Zymeworks Inc.
Common Stock |
3.248.692 | ||||||||
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 82.740 | 10.464.977 | 0,80 | 57,82 | 4.783.944 | 605.074.505 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.460 | 959.561 | 0,78 | 57,82 | 431.330 | 55.480.857 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.989 | 10.382.237 | 0,09 | 59,61 | 535.824 | 618.873.727 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 811 | 952.101 | 0,09 | 59,61 | 48.343 | 56.753.693 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14.631 | 10.373.248 | 0,14 | 59,99 | 877.642 | 622.240.319 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.319 | 951.290 | 0,14 | 59,99 | 79.120 | 57.063.226 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 145.994 | 10.358.617 | 1,43 | 57,68 | 8.421.518 | 597.526.463 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 13.164 | 949.971 | 1,41 | 57,68 | 759.352 | 54.798.127 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14.051 | 10.212.623 | 0,14 | 57,22 | 803.980 | 584.353.012 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.267 | 936.807 | 0,14 | 57,22 | 72.496 | 53.602.879 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 14.402 | 10.198.572 | 0,14 | 58,80 | 846.819 | 599.662.775 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.298 | 935.540 | 0,14 | 58,80 | 76.321 | 55.008.536 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8.623 | 10.184.170 | 0,08 | 60,77 | 524.043 | 618.919.508 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 777 | 934.242 | 0,08 | 60,77 | 47.220 | 56.776.409 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 6.788 | 10.175.547 | 0,07 | 58,54 | 397.393 | 595.711.118 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 612 | 933.465 | 0,07 | 58,54 | 35.829 | 54.648.215 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 7.122 | 10.168.759 | 0,07 | 58,39 | 415.826 | 593.714.180 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 642 | 932.853 | 0,07 | 58,39 | 37.484 | 54.465.649 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 3.577 | 10.161.637 | 0,04 | 57,62 | 206.108 | 585.517.589 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 323 | 932.211 | 0,03 | 57,62 | 18.611 | 53.714.371 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 21.301 | 10.158.060 | 0,21 | 56,69 | 1.207.513 | 575.841.121 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.921 | 931.888 | 0,21 | 56,69 | 108.898 | 52.826.960 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 5.804 | 10.136.759 | 0,06 | 56,62 | 328.631 | 573.958.500 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 523 | 929.967 | 0,06 | 56,62 | 29.613 | 52.656.126 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 10.121 | 10.130.955 | 0,10 | 56,25 | 569.277 | 569.836.839 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 912 | 929.444 | 0,10 | 56,25 | 51.297 | 52.278.530 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 92 | 10.120.834 | 0,00 | 55,45 | 5.102 | 561.225.547 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 8 | 928.532 | 0,00 | 55,45 | 444 | 51.489.421 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.813 | 10.120.742 | 0,02 | 55,77 | 101.117 | 564.468.192 | |
| 2020-02-26 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 164 | 928.524 | 0,02 | 55,77 | 9.147 | 51.786.940 | |
| 2020-02-07 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 10.000 | 10.000 | |||||
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29.291.523 | 0,00 | 87,32 | 27.593 | 2.557.735.788 | |
| 2020-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 316 | 29.291.523 | 0,00 | 87,32 | 27.593 | 2.557.735.788 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 9.765.333 | 9.765.333 | |||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Pre-funded Warrants |
A - Award | 1.160.148 | 1.161.048 | 128.905,33 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -9.765.333 | 3.107.331 | -75,86 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -1.160.148 | 290.409 | -79,98 | ||||
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 2.767.505 | 12.872.664 | 27,39 | 8,40 | 23.247.042 | 108.130.378 | |
| 2019-12-20 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Common Stock |
P - Purchase | 250.037 | 1.450.557 | 20,83 | 8,40 | 2.100.311 | 12.184.679 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 1.743.993 | 10.118.929 | 20,82 | 46,00 | 80.223.678 | 465.470.734 | |
| 2019-12-06 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 158.180 | 928.360 | 20,54 | 46,00 | 7.276.280 | 42.704.560 | |
| 2019-10-15 |
|
4 | NLTX |
Neoleukin Therapeutics, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 22.000 | 22.000 | |||||
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7.642.042 | 0,00 | 67,28 | 24.894 | 514.156.586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 7.642.042 | 0,00 | 67,28 | 24.894 | 514.156.586 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 1.217.279 | 0,03 | 67,28 | 24.894 | 81.898.531 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 244.595 | 0,15 | 67,28 | 24.894 | 16.456.352 | |
| 2019-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 370 | 160.223 | 0,23 | 67,28 | 24.894 | 10.779.803 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.291.207 | 0,00 | 74,23 | 27.020 | 2.174.286.296 | |
| 2019-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 364 | 29.291.207 | 0,00 | 74,23 | 27.020 | 2.174.286.296 | |
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 2.081.895 | 2.081.895 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -2.081.895 | 0 | -100,00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Voting Common Stock |
C - Conversion | 187.942 | 187.942 | |||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Series C Convertible Preferred |
C - Conversion | -187.942 | 0 | -100,00 | ||||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 2.883.204 | 2.883.204 | 16,00 | 46.131.264 | 46.131.264 | ||
| 2019-09-20 |
|
4 | IGMS |
IGM Biosciences, Inc.
Common Stock |
P - Purchase | 260.796 | 260.796 | 16,00 | 4.172.736 | 4.172.736 | ||
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.494.025 | 37.470.965 | 4,15 | 40,00 | 59.761.000 | 1.498.838.600 | |
| 2019-09-20 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 68.475 | 3.383.621 | 2,07 | 40,00 | 2.739.000 | 135.344.840 | |
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock Warrant (right to buy) |
X - Other | -1 | 138.815 | 0,00 | ||||
| 2019-09-20 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
X - Other | 1 | 8.374.936 | 0,00 | 0,01 | 0 | 83.749 | |
| 2019-09-19 |
|
4 | IGMS |
IGM Biosciences, Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 12.100 | 12.100 | |||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95.289 | 0 | -100,00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
G - Gift | -95.289 | 0 | -100,00 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8.341 | 95.289 | 9,59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | 8.340 | 95.289 | 9,59 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -8.866 | 43.361 | -16,98 | ||||
| 2019-08-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
J - Other | -7.815 | 165.610 | -4,51 | ||||
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 50.436 | 10.105.159 | 0,50 | 3,15 | 159.020 | 31.860.556 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4.564 | 1.200.520 | 0,38 | 3,15 | 14.390 | 3.785.120 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 209.382 | 10.054.723 | 2,13 | 3,02 | 633.255 | 30.409.504 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 18.943 | 1.195.956 | 1,61 | 3,02 | 57.291 | 3.617.049 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.869 | 9.845.341 | 0,06 | 2,96 | 17.358 | 29.118.581 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 531 | 1.177.013 | 0,05 | 2,96 | 1.570 | 3.481.134 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 65.568 | 9.839.472 | 0,67 | 2,85 | 186.666 | 28.011.993 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.932 | 1.176.482 | 0,51 | 2,85 | 16.888 | 3.349.327 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9.445 | 9.773.904 | 0,10 | 2,83 | 26.756 | 27.687.515 | |
| 2019-08-08 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 855 | 1.170.550 | 0,07 | 2,83 | 2.422 | 3.315.934 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7.641.672 | 0,01 | 58,86 | 24.957 | 449.788.814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 7.641.672 | 0,01 | 58,86 | 24.957 | 449.788.814 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 1.390.806 | 0,03 | 58,86 | 24.957 | 81.862.841 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 418.122 | 0,10 | 58,86 | 24.957 | 24.610.661 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 333.750 | 0,13 | 58,86 | 24.957 | 19.644.525 | |
| 2019-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 424 | 226.124 | 0,19 | 58,86 | 24.957 | 13.309.659 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.964 | 4.290.995 | 0,07 | 2,61 | 7.736 | 11.199.497 | |
| 2019-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.964 | 4.290.995 | 0,07 | 2,61 | 7.736 | 11.199.497 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29.290.843 | 0,00 | 84,96 | 26.338 | 2.488.550.021 | |
| 2019-07-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 310 | 29.290.843 | 0,00 | 84,96 | 26.338 | 2.488.550.021 | |
| 2019-06-28 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 1.904.850 | 5.444.957 | 53,81 | 17,00 | 32.382.450 | 92.564.269 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
P - Purchase | 95.150 | 489.234 | 24,14 | 17,00 | 1.617.550 | 8.316.978 | |
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 3.540.107 | 3.540.107 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -3.540.107 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class B common stock |
C - Conversion | 394.084 | 394.084 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series C2 Preferred Stock |
C - Conversion | -394.084 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -920.361 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series B Preferred Stock |
C - Conversion | -89.878 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -2.302.669 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Series A Preferred Stock |
C - Conversion | -219.852 | 0 | -100,00 | ||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 3.223.030 | 3.223.030 | |||||
| 2019-06-26 |
|
4 | BCEL |
Atreca, Inc.
Class A common stock |
C - Conversion | 309.730 | 309.730 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 13.166 | 13.166 | |||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 7.641.248 | 0,03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 7.641.248 | 0,03 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 1.390.382 | 0,14 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 417.698 | 0,46 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 333.326 | 0,58 | ||||
| 2019-06-18 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 1.910 | 225.700 | 0,85 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74.229 | 181.733 | 69,05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 74.229 | 181.733 | 69,05 | ||||
| 2019-06-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -1.002.483 | 4.302.354 | -18,90 | ||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14.840 | 14.840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | 14.840 | 14.840 | |||||
| 2019-06-07 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
J - Other | -200.423 | 98.980 | -66,94 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31.229 | 102.876 | 43,59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 31.229 | 102.876 | 43,59 | ||||
| 2019-06-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -421.756 | 3.315.146 | -11,29 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 880 | 880 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1.660 | 1.660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 1.660 | 1.660 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6.256 | 6.256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | 6.256 | 6.256 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -6.009 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -11.337 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Warrants to purchase Common Stock |
J - Other | -42.724 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21.929 | 21.929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | 21.929 | 21.929 | |||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -59.267 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
J - Other | -178.967 | 347.757 | -33,98 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43.109 | 43.109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | 43.109 | 43.109 | |||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
J - Other | -582.200 | 18.591 | -96,91 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13.516 | 20.618 | 190,31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 13.516 | 20.618 | 190,31 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -182.539 | 1.028.034 | -15,08 | ||||
| 2019-06-07 |
|
4 | BGNE |
BeiGene, Ltd.
Shares Option (Right to Buy) |
A - Award | 129.220 | 129.220 | |||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220.141 | 281.190 | 360,60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 220.141 | 281.190 | 360,60 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -692.706 | 0 | -100,00 | ||||
| 2019-06-07 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -1.603.238 | 2.826.766 | -36,19 | ||||
| 2019-06-05 |
|
4 | KOD |
Kodiak Sciences Inc.
Non-Qualified Stock Option (right to buy) |
A - Award | 24.747 | 24.747 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37.520 | 37.520 | |||||
| 2019-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Non-Qualified Share Option (right to buy) |
A - Award | 37.520 | 37.520 | |||||
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22.720 | 7.382.978 | -0,31 | 120,77 | -2.743.928 | 891.653.328 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2.729 | 952.874 | -0,29 | 120,77 | -329.585 | 115.080.022 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -13.213 | 7.405.698 | -0,18 | 122,31 | -1.616.054 | 905.775.370 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1.587 | 955.603 | -0,17 | 122,31 | -194.103 | 116.877.796 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15.355 | 7.418.911 | -0,21 | 120,12 | -1.844.459 | 891.167.750 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1.845 | 957.190 | -0,19 | 120,12 | -221.623 | 114.978.716 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -35.796 | 7.434.266 | -0,48 | 122,37 | -4.380.432 | 909.746.742 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4.300 | 959.035 | -0,45 | 122,37 | -526.200 | 117.359.127 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -30.766 | 7.470.062 | -0,41 | 123,06 | -3.786.036 | 919.259.107 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -3.696 | 963.335 | -0,38 | 123,06 | -454.826 | 118.547.138 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -39.732 | 7.500.828 | -0,53 | 121,37 | -4.822.189 | 910.359.743 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -4.772 | 967.031 | -0,49 | 121,37 | -579.168 | 117.366.522 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -71.819 | 7.540.560 | -0,94 | 127,06 | -9.125.258 | 958.096.767 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -8.627 | 971.803 | -0,88 | 127,06 | -1.096.139 | 123.476.415 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -22.886 | 7.612.379 | -0,30 | 125,05 | -2.861.901 | 951.930.278 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -2.749 | 980.430 | -0,28 | 125,05 | -343.763 | 122.603.066 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -15.541 | 7.635.265 | -0,20 | 126,25 | -1.962.085 | 963.969.004 | |
| 2019-05-30 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
S - Sale | -1.867 | 983.179 | -0,19 | 126,25 | -235.713 | 124.128.512 | |
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7.038 | 7.038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 7.038 | 7.038 | |||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2.963 | 45.842.649 | 0,01 | ||||
| 2019-05-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 2.963 | 45.842.649 | 0,01 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.726 | 7.650.806 | 0,04 | ||||
| 2019-05-17 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.726 | 7.650.806 | 0,04 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 45.839.686 | 0,02 | 8,38 | 83.800 | 384.136.569 | |
| 2019-05-01 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 45.839.686 | 0,02 | 8,38 | 83.800 | 384.136.569 | |
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12.472 | 12.472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12.472 | 12.472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 12.472 | 12.472 | |||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.520 | 812.602 | 0,19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.520 | 812.602 | 0,19 | ||||
| 2019-04-30 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 1.520 | 812.602 | 0,19 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 529.758 | 529.758 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -529.758 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 60.194 | 60.194 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series D Preferred Stock |
C - Conversion | -60.194 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 2.905.359 | 2.905.359 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -2.905.359 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Class A Common Stock |
C - Conversion | 324.421 | 324.421 | |||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Series C Preferred Stock |
C - Conversion | -324.421 | 0 | -100,00 | ||||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 820.729 | 820.729 | 14,00 | 11.490.206 | 11.490.206 | ||
| 2019-04-23 |
|
4 | HOOK |
HOOKIPA Pharma Inc.
Common Stock |
P - Purchase | 72.128 | 72.128 | 14,00 | 1.009.792 | 1.009.792 | ||
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.232 | 7.639.338 | -0,12 | 65,32 | -603.070 | 499.031.352 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.417 | 1.214.575 | -0,12 | 65,32 | -92.564 | 79.340.776 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -244 | 241.891 | -0,10 | 65,32 | -15.939 | 15.801.263 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -142 | 157.519 | -0,09 | 65,32 | -9.276 | 10.289.755 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 49.893 | -0,02 | 65,32 | -719 | 3.259.205 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -158 | 171.091 | -0,09 | 65,32 | -10.321 | 11.176.331 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63.775 | 7.648.570 | -0,83 | 67,13 | -4.281.177 | 513.443.915 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.791 | 1.215.992 | -0,80 | 67,13 | -657.264 | 81.628.813 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.688 | 242.135 | -0,69 | 67,13 | -113.314 | 16.254.377 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -979 | 157.661 | -0,62 | 67,13 | -65.720 | 10.583.688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 49.904 | -0,15 | 67,13 | -4.968 | 3.350.026 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.093 | 171.249 | -0,63 | 67,13 | -73.372 | 11.495.843 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -173.085 | 7.712.345 | -2,19 | 64,62 | -11.184.701 | 498.369.420 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -26.575 | 1.225.783 | -2,12 | 64,62 | -1.717.269 | 79.209.730 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.581 | 243.823 | -1,84 | 64,62 | -296.023 | 15.755.769 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.656 | 158.640 | -1,65 | 64,62 | -171.630 | 10.251.269 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -202 | 49.978 | -0,40 | 64,62 | -13.053 | 3.229.563 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.966 | 172.342 | -1,69 | 64,62 | -191.662 | 11.136.688 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106.054 | 7.885.430 | -1,33 | 66,61 | -7.063.981 | 525.227.990 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16.282 | 1.252.358 | -1,28 | 66,61 | -1.084.502 | 83.416.310 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.807 | 248.404 | -1,12 | 66,61 | -186.967 | 16.545.545 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.628 | 161.296 | -1,00 | 66,61 | -108.437 | 10.743.507 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -124 | 50.180 | -0,25 | 66,61 | -8.259 | 3.342.359 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.817 | 175.308 | -1,03 | 66,61 | -121.026 | 11.676.810 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -60.618 | 7.991.484 | -0,75 | 67,42 | -4.086.914 | 538.792.244 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.307 | 1.268.640 | -0,73 | 67,42 | -627.485 | 85.532.724 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.604 | 251.211 | -0,63 | 67,42 | -108.143 | 16.936.847 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -930 | 162.924 | -0,57 | 67,42 | -62.701 | 10.984.466 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 50.304 | -0,14 | 67,42 | -4.787 | 3.391.536 | |
| 2019-04-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.039 | 177.125 | -0,58 | 67,42 | -70.050 | 11.941.909 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.832 | 8.052.102 | -0,13 | 69,12 | -748.735 | 556.581.420 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.663 | 1.277.947 | -0,13 | 69,12 | -114.951 | 88.334.892 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 252.815 | -0,11 | 69,12 | -19.838 | 17.475.205 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -166 | 163.854 | -0,10 | 69,12 | -11.474 | 11.325.998 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 50.375 | -0,03 | 69,12 | -899 | 3.482.046 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -185 | 178.164 | -0,10 | 69,12 | -12.788 | 12.315.141 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -102.618 | 8.062.934 | -1,26 | 68,70 | -7.049.918 | 553.928.404 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.755 | 1.279.610 | -1,22 | 68,70 | -1.082.378 | 87.909.975 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.716 | 253.102 | -1,06 | 68,70 | -186.591 | 17.388.259 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.575 | 164.020 | -0,95 | 68,70 | -108.203 | 11.268.272 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -120 | 50.388 | -0,24 | 68,70 | -8.244 | 3.461.686 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.758 | 178.349 | -0,98 | 68,70 | -120.776 | 12.252.683 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.543 | 8.165.552 | -0,19 | 67,68 | -1.051.888 | 552.611.897 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.386 | 1.295.365 | -0,18 | 67,68 | -161.475 | 87.665.122 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -411 | 255.818 | -0,16 | 67,68 | -27.815 | 17.312.739 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -239 | 165.595 | -0,14 | 67,68 | -16.175 | 11.206.807 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 50.508 | -0,04 | 67,68 | -1.218 | 3.418.179 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -266 | 180.107 | -0,15 | 67,68 | -18.002 | 12.188.921 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.813 | 8.181.095 | -0,02 | 67,87 | -123.047 | 555.244.373 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -278 | 1.297.751 | -0,02 | 67,87 | -18.868 | 88.077.322 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 256.229 | -0,02 | 67,87 | -3.258 | 17.390.057 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 165.834 | -0,02 | 67,87 | -1.900 | 11.255.021 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50.526 | 0,00 | 67,87 | -136 | 3.429.159 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31 | 180.373 | -0,02 | 67,87 | -2.104 | 12.241.771 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18.661 | 8.182.908 | -0,23 | 67,90 | -1.267.017 | 555.590.813 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.865 | 1.298.029 | -0,22 | 67,90 | -194.523 | 88.131.626 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -494 | 256.277 | -0,19 | 67,90 | -33.541 | 17.400.311 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 165.862 | -0,17 | 67,90 | -19.418 | 11.261.449 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 50.528 | -0,04 | 67,90 | -1.494 | 3.430.674 | |
| 2019-04-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -320 | 180.404 | -0,18 | 67,90 | -21.727 | 12.248.800 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42.863 | 8.201.569 | -0,52 | 68,72 | -2.945.370 | 563.578.195 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.581 | 1.300.894 | -0,50 | 68,72 | -452.219 | 89.392.102 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.134 | 256.771 | -0,44 | 68,72 | -77.924 | 17.644.250 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -658 | 166.148 | -0,39 | 68,72 | -45.215 | 11.417.009 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 50.550 | -0,10 | 68,72 | -3.436 | 3.473.589 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -734 | 180.724 | -0,40 | 68,72 | -50.437 | 12.418.612 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21.116 | 8.244.432 | -0,26 | 68,63 | -1.449.147 | 565.798.055 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.242 | 1.307.475 | -0,25 | 68,63 | -222.492 | 89.729.264 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 257.905 | -0,22 | 68,63 | -38.363 | 17.699.479 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -324 | 166.806 | -0,19 | 68,63 | -22.235 | 11.447.545 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 50.600 | -0,05 | 68,63 | -1.716 | 3.472.572 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -362 | 181.458 | -0,20 | 68,63 | -24.843 | 12.453.081 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66.784 | 8.265.548 | -0,80 | 66,64 | -4.450.459 | 550.812.813 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.253 | 1.310.717 | -0,78 | 66,64 | -683.256 | 87.345.657 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.768 | 258.464 | -0,68 | 66,64 | -117.819 | 17.223.938 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.025 | 167.130 | -0,61 | 66,64 | -68.306 | 11.137.476 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -78 | 50.625 | -0,15 | 66,64 | -5.198 | 3.373.630 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.145 | 181.820 | -0,63 | 66,64 | -76.302 | 12.116.412 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -80.146 | 8.332.332 | -0,95 | 68,90 | -5.521.963 | 574.087.676 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12.305 | 1.320.970 | -0,92 | 68,90 | -847.800 | 91.013.248 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.121 | 260.232 | -0,81 | 68,90 | -146.134 | 17.929.673 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.230 | 168.155 | -0,73 | 68,90 | -84.746 | 11.585.678 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -93 | 50.703 | -0,18 | 68,90 | -6.408 | 3.493.376 | |
| 2019-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.374 | 182.965 | -0,75 | 68,90 | -94.667 | 12.606.069 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.161 | 89.233 | 4,89 | 2,59 | 10.777 | 231.113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.161 | 89.233 | 4,89 | 2,59 | 10.777 | 231.113 | |
| 2019-04-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 4.161 | 4.288.031 | 0,10 | 2,59 | 10.777 | 11.106.000 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8.412.478 | 0,00 | 66,84 | 19.918 | 562.290.030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 8.412.478 | 0,00 | 66,84 | 19.918 | 562.290.030 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 1.507.172 | 0,02 | 66,84 | 19.918 | 100.739.376 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 436.250 | 0,07 | 66,84 | 19.918 | 29.158.950 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 343.282 | 0,09 | 66,84 | 19.918 | 22.944.969 | |
| 2019-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 298 | 224.693 | 0,13 | 66,84 | 19.918 | 15.018.480 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811.082 | 0,03 | 86,01 | 18.922 | 69.761.163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811.082 | 0,03 | 86,01 | 18.922 | 69.761.163 | |
| 2019-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 220 | 811.082 | 0,03 | 86,01 | 18.922 | 69.761.163 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46.678 | 8.412.180 | -0,55 | 74,71 | -3.487.122 | 628.439.478 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.167 | 1.332.977 | -0,53 | 74,71 | -535.417 | 99.581.246 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.235 | 262.055 | -0,47 | 74,71 | -92.262 | 19.577.055 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -716 | 169.087 | -0,42 | 74,71 | -53.489 | 12.631.797 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55 | 50.498 | -0,11 | 74,71 | -4.109 | 3.772.499 | |
| 2019-03-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -800 | 184.041 | -0,43 | 74,71 | -59.765 | 13.748.949 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41.281 | 8.458.858 | -0,49 | 74,34 | -3.068.962 | 628.858.572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.338 | 1.340.144 | -0,47 | 74,34 | -471.187 | 99.630.593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.092 | 263.290 | -0,41 | 74,34 | -81.183 | 19.573.821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169.803 | -0,37 | 74,34 | -47.134 | 12.623.698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50.553 | -0,09 | 74,34 | -3.568 | 3.758.272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184.841 | -0,38 | 74,34 | -52.561 | 13.741.671 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -86.620 | 8.500.139 | -1,01 | 74,63 | -6.464.529 | 634.373.024 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.298 | 1.346.482 | -0,98 | 74,63 | -992.442 | 100.489.163 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.293 | 264.382 | -0,86 | 74,63 | -171.129 | 19.731.067 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.329 | 170.437 | -0,77 | 74,63 | -99.184 | 12.719.867 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -101 | 50.601 | -0,20 | 74,63 | -7.538 | 3.776.398 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.485 | 185.548 | -0,79 | 74,63 | -110.827 | 13.847.614 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -90.251 | 8.586.759 | -1,04 | 74,19 | -6.695.487 | 637.029.325 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.856 | 1.359.780 | -1,01 | 74,19 | -1.027.941 | 100.878.543 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.388 | 266.675 | -0,89 | 74,19 | -177.160 | 19.783.925 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.385 | 171.766 | -0,80 | 74,19 | -102.750 | 12.742.873 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -106 | 50.702 | -0,21 | 74,19 | -7.864 | 3.761.450 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.547 | 187.033 | -0,82 | 74,19 | -114.768 | 13.875.492 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -413 | 8.677.010 | 0,00 | 74,56 | -30.795 | 647.001.251 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 1.373.636 | 0,00 | 74,56 | -4.698 | 102.425.168 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 269.063 | 0,00 | 74,56 | -820 | 20.062.683 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 173.151 | 0,00 | 74,56 | -447 | 12.911.004 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 188.580 | 0,00 | 74,56 | -522 | 14.061.468 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42.124 | 8.677.423 | -0,48 | 74,50 | -3.138.238 | 646.468.014 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.467 | 1.373.699 | -0,47 | 74,50 | -481.792 | 102.340.576 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.115 | 269.074 | -0,41 | 74,50 | -83.068 | 20.046.013 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -647 | 173.157 | -0,37 | 74,50 | -48.202 | 12.900.196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 50.808 | -0,10 | 74,50 | -3.650 | 3.785.196 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -722 | 188.587 | -0,38 | 74,50 | -53.789 | 14.049.732 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.068 | 8.719.547 | -0,04 | 76,57 | -234.915 | 667.649.610 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -471 | 1.380.166 | -0,03 | 76,57 | -36.064 | 105.678.345 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -81 | 270.189 | -0,03 | 76,57 | -6.202 | 20.688.183 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -47 | 173.804 | -0,03 | 76,57 | -3.599 | 13.308.051 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 50.857 | -0,01 | 76,57 | -306 | 3.894.085 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 189.309 | -0,03 | 76,57 | -3.982 | 14.495.258 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41.281 | 8.458.858 | -0,49 | 74,34 | -3.068.962 | 628.858.572 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.338 | 1.340.144 | -0,47 | 74,34 | -471.187 | 99.630.593 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.092 | 263.290 | -0,41 | 74,34 | -81.183 | 19.573.821 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -634 | 169.803 | -0,37 | 74,34 | -47.134 | 12.623.698 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -48 | 50.553 | -0,09 | 74,34 | -3.568 | 3.758.272 | |
| 2019-03-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -707 | 184.841 | -0,38 | 74,34 | -52.561 | 13.741.671 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.648 | 8.722.615 | -0,02 | 76,03 | -125.301 | 663.197.864 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1.380.637 | -0,02 | 76,03 | -19.236 | 104.972.592 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 270.270 | -0,02 | 76,03 | -3.345 | 20.549.169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 173.851 | -0,01 | 76,03 | -1.901 | 13.218.239 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 50.861 | 0,00 | 76,03 | -152 | 3.867.064 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 189.361 | -0,01 | 76,03 | -2.129 | 14.397.496 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51.987 | 8.724.263 | -0,59 | 76,50 | -3.977.031 | 667.410.482 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.982 | 1.380.890 | -0,57 | 76,50 | -610.627 | 105.638.775 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.375 | 270.314 | -0,51 | 76,50 | -105.188 | 20.679.156 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -798 | 173.876 | -0,46 | 76,50 | -61.047 | 13.301.601 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61 | 50.863 | -0,12 | 76,50 | -4.667 | 3.891.045 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -891 | 189.389 | -0,47 | 76,50 | -68.162 | 14.488.353 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 8.776.250 | 0,00 | 75,40 | -18.624 | 661.729.250 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 1.388.872 | 0,00 | 75,40 | -2.941 | 104.720.949 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7 | 271.689 | 0,00 | 75,40 | -528 | 20.485.351 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174.674 | 0,00 | 75,40 | -302 | 13.170.420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 174.674 | 0,00 | 75,40 | -302 | 13.170.420 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 50.924 | 0,00 | 75,40 | -75 | 3.839.670 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63.047 | 8.776.497 | -0,71 | 75,92 | -4.786.390 | 666.292.344 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.679 | 1.388.911 | -0,69 | 75,92 | -734.808 | 105.443.068 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.668 | 271.696 | -0,61 | 75,92 | -126.631 | 20.626.563 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -967 | 174.678 | -0,55 | 75,92 | -73.413 | 13.261.169 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -73 | 50.925 | -0,14 | 75,92 | -5.542 | 3.866.114 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.080 | 190.284 | -0,56 | 75,92 | -81.991 | 14.445.943 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.832 | 8.839.544 | -0,03 | 76,05 | -215.369 | 672.232.294 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -435 | 1.398.590 | -0,03 | 76,05 | -33.081 | 106.360.392 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75 | 273.364 | -0,03 | 76,05 | -5.704 | 20.788.867 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 175.645 | -0,02 | 76,05 | -3.270 | 13.357.504 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 50.998 | -0,01 | 76,05 | -228 | 3.878.311 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -49 | 191.364 | -0,03 | 76,05 | -3.726 | 14.552.907 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -61.122 | 8.842.376 | -0,69 | 75,63 | -4.622.669 | 668.750.665 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.384 | 1.399.025 | -0,67 | 75,63 | -709.714 | 105.808.541 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.618 | 273.439 | -0,59 | 75,63 | -122.370 | 20.680.246 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -938 | 175.688 | -0,53 | 75,63 | -70.941 | 13.287.319 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 51.001 | -0,14 | 75,63 | -5.370 | 3.857.216 | |
| 2019-03-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.047 | 191.413 | -0,54 | 75,63 | -79.185 | 14.476.603 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.296 | 8.903.498 | -0,04 | 74,03 | -244.007 | 659.137.531 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1.408.409 | -0,04 | 74,03 | -37.460 | 104.266.349 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 275.057 | -0,03 | 74,03 | -6.441 | 20.362.827 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 176.626 | -0,03 | 74,03 | -3.776 | 13.075.852 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 51.072 | -0,01 | 74,03 | -296 | 3.780.927 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 192.460 | -0,03 | 74,03 | -4.146 | 14.248.064 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37.107 | 8.906.794 | -0,41 | 75,08 | -2.786.101 | 668.747.923 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.697 | 1.408.915 | -0,40 | 75,08 | -427.747 | 105.785.424 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -982 | 275.144 | -0,36 | 75,08 | -73.731 | 20.658.609 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -569 | 176.677 | -0,32 | 75,08 | -42.722 | 13.265.422 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 51.076 | -0,08 | 75,08 | -3.229 | 3.834.934 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -637 | 192.516 | -0,33 | 75,08 | -47.828 | 14.454.660 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18.703 | 8.943.901 | -0,21 | 73,55 | -1.375.551 | 657.797.981 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.872 | 1.414.612 | -0,20 | 73,55 | -211.227 | 104.040.610 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -495 | 276.126 | -0,18 | 73,55 | -36.406 | 20.308.267 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -287 | 177.246 | -0,16 | 73,55 | -21.108 | 13.035.929 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22 | 51.119 | -0,04 | 73,55 | -1.618 | 3.759.654 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -321 | 193.153 | -0,17 | 73,55 | -23.609 | 14.205.843 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.647 | 8.962.604 | -0,02 | 73,72 | -121.421 | 660.745.573 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1.417.484 | -0,02 | 73,72 | -18.652 | 104.500.464 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 276.621 | -0,02 | 73,72 | -3.244 | 20.393.192 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 177.533 | -0,01 | 73,72 | -1.843 | 13.088.177 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51.141 | 0,00 | 73,72 | -147 | 3.770.242 | |
| 2019-03-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 193.474 | -0,01 | 73,72 | -2.138 | 14.263.387 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.486 | 8.964.251 | -0,09 | 77,04 | -653.755 | 690.598.726 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.303 | 1.417.737 | -0,09 | 77,04 | -100.382 | 109.221.324 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -225 | 276.665 | -0,08 | 77,04 | -17.334 | 21.314.050 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -130 | 177.558 | -0,07 | 77,04 | -10.015 | 13.678.926 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51.143 | -0,02 | 77,04 | -770 | 3.940.016 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 193.503 | -0,08 | 77,04 | -11.248 | 14.907.316 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22.914 | 8.972.737 | -0,25 | 76,49 | -1.752.680 | 686.320.167 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.518 | 1.419.040 | -0,25 | 76,49 | -269.090 | 108.541.660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -607 | 276.890 | -0,22 | 76,49 | -46.429 | 21.179.178 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -352 | 177.688 | -0,20 | 76,49 | -26.924 | 13.591.266 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51.153 | -0,05 | 76,49 | -2.065 | 3.912.667 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -393 | 193.649 | -0,20 | 76,49 | -30.060 | 14.812.115 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -58.412 | 8.995.651 | -0,65 | 77,15 | -4.506.626 | 694.036.064 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.968 | 1.422.558 | -0,63 | 77,15 | -691.903 | 109.753.764 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.546 | 277.497 | -0,55 | 77,15 | -119.278 | 21.409.560 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -896 | 178.040 | -0,50 | 77,15 | -69.129 | 13.736.213 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 51.180 | -0,13 | 77,15 | -5.246 | 3.948.660 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.001 | 194.042 | -0,51 | 77,15 | -77.230 | 14.970.806 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.909 | 9.054.063 | -0,08 | 77,64 | -536.386 | 702.919.424 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.060 | 1.431.526 | -0,07 | 77,64 | -82.294 | 111.137.666 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -183 | 279.043 | -0,07 | 77,64 | -14.207 | 21.663.727 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -107 | 178.936 | -0,06 | 77,64 | -8.307 | 13.891.840 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51.248 | -0,02 | 77,64 | -621 | 3.978.679 | |
| 2019-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 195.043 | -0,06 | 77,64 | -9.161 | 15.142.319 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9.060.972 | -0,01 | 76,20 | -37.565 | 690.423.414 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1.432.586 | -0,01 | 76,20 | -5.791 | 109.159.472 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 279.226 | 0,00 | 76,20 | -991 | 21.276.323 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 179.043 | 0,00 | 76,20 | -610 | 13.642.629 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.256 | 0,00 | 76,20 | -76 | 3.905.579 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 195.161 | 0,00 | 76,20 | -686 | 14.870.780 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -742 | 9.061.465 | -0,01 | 76,20 | -56.540 | 690.483.633 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 1.432.662 | -0,01 | 76,20 | -8.687 | 109.168.844 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20 | 279.239 | -0,01 | 76,20 | -1.524 | 21.278.012 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 179.051 | -0,01 | 76,20 | -838 | 13.643.686 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.257 | 0,00 | 76,20 | -76 | 3.905.783 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 195.170 | -0,01 | 76,20 | -991 | 14.871.954 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -31.482 | 9.062.207 | -0,35 | 76,66 | -2.413.501 | 694.735.069 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.833 | 1.432.776 | -0,34 | 76,66 | -370.512 | 109.840.763 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -833 | 279.259 | -0,30 | 76,66 | -63.860 | 21.408.805 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -484 | 179.062 | -0,27 | 76,66 | -37.105 | 13.727.412 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 51.258 | -0,07 | 76,66 | -2.837 | 3.929.587 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -539 | 195.183 | -0,28 | 76,66 | -41.321 | 14.963.295 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 9.093.689 | -0,01 | 77,81 | -48.239 | 707.539.019 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 1.437.609 | -0,01 | 77,81 | -7.392 | 111.853.887 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 280.092 | -0,01 | 77,81 | -1.245 | 21.792.698 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 179.546 | -0,01 | 77,81 | -778 | 13.969.666 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.295 | 0,00 | 77,81 | -78 | 3.991.033 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 195.722 | -0,01 | 77,81 | -856 | 15.228.248 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.506 | 9.094.309 | -0,07 | 78,13 | -508.342 | 710.577.468 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -999 | 1.437.704 | -0,07 | 78,13 | -78.056 | 112.333.996 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -172 | 280.108 | -0,06 | 78,13 | -13.439 | 21.886.043 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -100 | 179.556 | -0,06 | 78,13 | -7.813 | 14.029.482 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 51.296 | -0,02 | 78,13 | -625 | 4.007.977 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112 | 195.733 | -0,06 | 78,13 | -8.751 | 15.293.461 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 9.100.815 | 0,09 | 17,59 | 145.118 | 160.083.336 | |
| 2019-02-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 9.100.815 | 0,09 | 17,59 | 145.118 | 160.083.336 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.288.793 | 0,07 | 2,80 | 56.000 | 82.008.620 | |
| 2019-02-27 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 29.288.793 | 0,07 | 2,80 | 56.000 | 82.008.620 | |
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 1.818.475 | 8.837.349 | 25,91 | ||||
| 2019-02-06 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
A - Award | 181.525 | 916.043 | 24,71 | ||||
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.634 | 9.092.565 | -0,15 | 70,55 | -961.887 | 641.485.916 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.093 | 1.430.453 | -0,15 | 70,55 | -147.662 | 100.919.317 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -361 | 280.280 | -0,13 | 70,55 | -25.469 | 19.773.922 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -210 | 179.656 | -0,12 | 70,55 | -14.816 | 12.674.839 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51.304 | -0,03 | 70,55 | -1.129 | 3.619.528 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 195.845 | -0,12 | 70,55 | -16.509 | 13.816.982 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24.660 | 9.106.199 | -0,27 | 71,35 | -1.759.553 | 649.750.064 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.786 | 1.432.546 | -0,26 | 71,35 | -270.141 | 102.215.738 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -653 | 280.641 | -0,23 | 71,35 | -46.593 | 20.024.437 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -378 | 179.866 | -0,21 | 71,35 | -26.971 | 12.833.889 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29 | 51.320 | -0,06 | 71,35 | -2.069 | 3.661.810 | |
| 2019-01-30 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -423 | 196.079 | -0,22 | 71,35 | -30.182 | 13.990.727 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -75.736 | 9.130.859 | -0,82 | 72,20 | -5.468.397 | 659.279.065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.627 | 1.436.332 | -0,80 | 72,20 | -839.509 | 103.708.054 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.004 | 281.294 | -0,71 | 72,20 | -144.696 | 20.310.383 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.162 | 180.244 | -0,64 | 72,20 | -83.900 | 13.014.230 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51.349 | -0,17 | 72,20 | -6.426 | 3.707.572 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.298 | 196.502 | -0,66 | 72,20 | -93.720 | 14.188.113 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65.426 | 9.206.595 | -0,71 | 72,02 | -4.711.967 | 663.057.131 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.044 | 1.447.959 | -0,69 | 72,02 | -723.367 | 104.281.718 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.732 | 283.298 | -0,61 | 72,02 | -124.738 | 20.403.065 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.004 | 181.406 | -0,55 | 72,02 | -72.308 | 13.064.824 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 51.438 | -0,15 | 72,02 | -5.474 | 3.704.554 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.121 | 197.800 | -0,56 | 72,02 | -80.734 | 14.245.516 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.648 | 9.272.021 | -0,02 | 73,46 | -121.054 | 681.076.303 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -253 | 1.458.003 | -0,02 | 73,46 | -18.584 | 107.097.610 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44 | 285.030 | -0,02 | 73,46 | -3.232 | 20.936.879 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 182.410 | -0,01 | 73,46 | -1.836 | 13.398.927 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 51.514 | 0,00 | 73,46 | -147 | 3.783.961 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 198.921 | -0,01 | 73,46 | -2.057 | 14.611.742 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -29.260 | 9.273.669 | -0,31 | 70,52 | -2.063.313 | 653.946.680 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.492 | 1.458.256 | -0,31 | 70,52 | -316.760 | 102.831.109 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -774 | 285.074 | -0,27 | 70,52 | -54.580 | 20.102.421 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -450 | 182.435 | -0,25 | 70,52 | -31.732 | 12.864.678 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34 | 51.516 | -0,07 | 70,52 | -2.398 | 3.632.728 | |
| 2019-01-25 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -502 | 198.949 | -0,25 | 70,52 | -35.399 | 14.029.187 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42.521 | 9.302.929 | -0,45 | 71,00 | -3.018.995 | 660.508.889 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.529 | 1.462.748 | -0,44 | 71,00 | -463.560 | 103.855.254 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.125 | 285.848 | -0,39 | 71,00 | -79.875 | 20.295.237 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -652 | 182.885 | -0,36 | 71,00 | -46.292 | 12.984.853 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -50 | 51.550 | -0,10 | 71,00 | -3.550 | 3.660.055 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -729 | 199.451 | -0,36 | 71,00 | -51.759 | 14.161.041 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10.547 | 9.345.450 | -0,11 | 71,61 | -755.298 | 669.251.973 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.619 | 1.469.277 | -0,11 | 71,61 | -115.941 | 105.218.746 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -279 | 286.973 | -0,10 | 71,61 | -19.980 | 20.550.883 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -162 | 183.537 | -0,09 | 71,61 | -11.601 | 13.143.562 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12 | 51.600 | -0,02 | 71,61 | -859 | 3.695.210 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -181 | 200.180 | -0,09 | 71,61 | -12.962 | 14.335.410 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.595 | 9.355.997 | -0,15 | 72,23 | -981.964 | 675.781.792 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.087 | 1.470.896 | -0,14 | 72,23 | -150.744 | 106.242.524 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 287.252 | -0,13 | 72,23 | -26.003 | 20.748.155 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 183.699 | -0,11 | 72,23 | -15.096 | 13.268.542 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 51.612 | -0,03 | 72,23 | -1.156 | 3.727.924 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 200.361 | -0,12 | 72,23 | -16.830 | 14.472.035 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132.363 | 9.369.592 | -1,39 | 72,79 | -9.634.226 | 681.978.871 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -20.322 | 1.472.983 | -1,36 | 72,79 | -1.479.165 | 107.213.130 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.503 | 287.612 | -1,20 | 72,79 | -254.971 | 20.934.242 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.031 | 183.908 | -1,09 | 72,79 | -147.829 | 13.386.001 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -155 | 51.628 | -0,30 | 72,79 | -11.282 | 3.757.816 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.268 | 200.594 | -1,12 | 72,79 | -165.080 | 14.600.515 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -149.754 | 9.501.955 | -1,55 | 70,79 | -10.601.295 | 672.656.697 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -22.991 | 1.493.305 | -1,52 | 70,79 | -1.627.565 | 105.713.152 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.963 | 291.115 | -1,34 | 70,79 | -280.546 | 20.608.438 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.298 | 185.939 | -1,22 | 70,79 | -162.679 | 13.162.882 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -175 | 51.783 | -0,34 | 70,79 | -12.388 | 3.665.791 | |
| 2019-01-22 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.566 | 202.862 | -1,25 | 70,79 | -181.651 | 14.360.885 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -493 | 9.651.709 | -0,01 | 70,07 | -34.545 | 676.311.658 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76 | 1.516.296 | -0,01 | 70,07 | -5.325 | 106.249.438 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13 | 295.078 | 0,00 | 70,07 | -911 | 20.676.617 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8 | 188.237 | 0,00 | 70,07 | -561 | 13.190.087 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.958 | 0,00 | 70,07 | -70 | 3.640.785 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 205.428 | 0,00 | 70,07 | -631 | 14.394.689 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23.462 | 9.652.202 | -0,24 | 70,22 | -1.647.574 | 677.807.546 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.602 | 1.516.372 | -0,24 | 70,22 | -252.944 | 106.484.343 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -621 | 295.091 | -0,21 | 70,22 | -43.609 | 20.722.205 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 188.245 | -0,19 | 70,22 | -25.280 | 13.219.147 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 51.959 | -0,05 | 70,22 | -1.896 | 3.648.722 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -402 | 205.437 | -0,20 | 70,22 | -28.230 | 14.426.423 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.392 | 9.675.664 | -0,09 | 70,28 | -589.772 | 679.985.347 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.288 | 1.519.974 | -0,08 | 70,28 | -90.518 | 106.820.581 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -222 | 295.712 | -0,08 | 70,28 | -15.602 | 20.782.018 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 188.605 | -0,07 | 70,28 | -9.066 | 13.254.763 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 51.986 | -0,02 | 70,28 | -703 | 3.653.467 | |
| 2019-01-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -144 | 205.839 | -0,07 | 70,28 | -10.120 | 14.465.933 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.658 | 85.072 | 4,49 | 3,52 | 12.876 | 299.453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.658 | 85.072 | 4,49 | 3,52 | 12.876 | 299.453 | |
| 2019-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.658 | 85.072 | 4,49 | 3,52 | 12.876 | 299.453 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295.934 | 0,10 | 64,41 | 19.967 | 19.061.109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295.934 | 0,10 | 64,41 | 19.967 | 19.061.109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 295.934 | 0,10 | 64,41 | 19.967 | 19.061.109 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 1.695.159 | 0,02 | 64,41 | 19.967 | 109.185.191 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 225.893 | 0,14 | 64,41 | 19.967 | 14.549.768 | |
| 2019-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 310 | 362.631 | 0,09 | 64,41 | 19.967 | 23.357.063 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810.862 | 0,04 | 63,59 | 18.950 | 51.562.715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 810.862 | 0,04 | 63,59 | 18.950 | 51.562.715 | |
| 2019-01-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 298 | 29.421.884 | 0,00 | 63,59 | 18.950 | 1.870.937.604 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.243 | 9.683.746 | -0,16 | 73,09 | -1.114.047 | 707.744.323 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.340 | 1.520.952 | -0,15 | 73,09 | -171.021 | 111.159.994 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -403 | 295.624 | -0,14 | 73,09 | -29.454 | 21.605.917 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -234 | 188.424 | -0,12 | 73,09 | -17.102 | 13.771.119 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 51.686 | -0,03 | 73,09 | -1.316 | 3.777.513 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -262 | 205.673 | -0,13 | 73,09 | -19.148 | 15.031.776 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12.627 | 9.698.989 | -0,13 | 71,81 | -906.797 | 696.524.166 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.939 | 1.523.292 | -0,13 | 71,81 | -139.248 | 109.393.844 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -334 | 296.027 | -0,11 | 71,81 | -23.986 | 21.258.913 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -194 | 188.658 | -0,10 | 71,81 | -13.932 | 13.548.304 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15 | 51.704 | -0,03 | 71,81 | -1.077 | 3.713.076 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 205.935 | -0,10 | 71,81 | -15.512 | 14.789.037 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -34.794 | 9.711.616 | -0,36 | 74,88 | -2.605.510 | 727.243.681 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.342 | 1.525.231 | -0,35 | 74,88 | -400.030 | 114.215.246 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -921 | 296.361 | -0,31 | 74,88 | -68.968 | 22.192.667 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -534 | 188.852 | -0,28 | 74,88 | -39.988 | 14.141.974 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -41 | 51.719 | -0,08 | 74,88 | -3.070 | 3.872.920 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -597 | 206.151 | -0,29 | 74,88 | -44.706 | 15.437.391 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.718 | 9.746.410 | -0,08 | 73,83 | -569.813 | 719.568.679 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.185 | 1.530.573 | -0,08 | 73,83 | -87.487 | 113.000.827 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 297.282 | -0,07 | 73,83 | -15.061 | 21.948.063 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -118 | 189.386 | -0,06 | 73,83 | -8.712 | 13.982.198 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 51.760 | -0,02 | 73,83 | -664 | 3.821.394 | |
| 2018-12-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -132 | 206.748 | -0,06 | 73,83 | -9.745 | 15.264.019 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84.418 | 9.754.128 | -0,86 | 76,15 | -6.428.768 | 742.815.864 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -12.961 | 1.531.758 | -0,84 | 76,15 | -987.032 | 116.649.499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.234 | 297.486 | -0,75 | 76,15 | -170.128 | 22.654.749 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.296 | 189.504 | -0,68 | 76,15 | -98.696 | 14.431.488 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99 | 51.769 | -0,19 | 76,15 | -7.539 | 3.942.416 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.447 | 206.880 | -0,69 | 76,15 | -110.195 | 15.754.740 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -76.364 | 9.838.546 | -0,77 | 75,46 | -5.762.481 | 742.423.568 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.724 | 1.544.719 | -0,75 | 75,46 | -884.701 | 116.565.577 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.021 | 299.720 | -0,67 | 75,46 | -152.506 | 22.617.081 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.172 | 190.800 | -0,61 | 75,46 | -88.440 | 14.397.902 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89 | 51.868 | -0,17 | 75,46 | -6.716 | 3.913.996 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.309 | 208.327 | -0,62 | 75,46 | -98.778 | 15.720.501 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.538 | 9.914.910 | -0,03 | 77,75 | -197.318 | 770.839.635 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -390 | 1.556.443 | -0,03 | 77,75 | -30.321 | 121.006.439 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -67 | 301.741 | -0,02 | 77,75 | -5.209 | 23.459.005 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39 | 191.972 | -0,02 | 77,75 | -3.032 | 14.924.959 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3 | 51.957 | -0,01 | 77,75 | -233 | 4.039.423 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 209.636 | -0,02 | 77,75 | -3.343 | 16.298.256 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.493 | 9.917.448 | -0,06 | 73,81 | -405.449 | 732.025.680 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -843 | 1.556.833 | -0,05 | 73,81 | -62.223 | 114.912.802 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -146 | 301.808 | -0,05 | 73,81 | -10.777 | 22.277.022 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -84 | 192.011 | -0,04 | 73,81 | -6.200 | 14.172.697 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 51.960 | -0,01 | 73,81 | -443 | 3.835.266 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -95 | 209.679 | -0,05 | 73,81 | -7.012 | 15.476.805 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18.604 | 9.922.941 | -0,19 | 75,83 | -1.410.758 | 752.465.547 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.856 | 1.557.676 | -0,18 | 75,83 | -216.573 | 118.119.973 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -492 | 301.954 | -0,16 | 75,83 | -37.309 | 22.897.444 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -286 | 192.095 | -0,15 | 75,83 | -21.688 | 14.566.737 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 51.966 | -0,04 | 75,83 | -1.592 | 3.940.629 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -319 | 209.774 | -0,15 | 75,83 | -24.190 | 15.907.351 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -371 | 9.941.545 | 0,00 | 77,11 | -28.608 | 766.592.535 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57 | 1.560.532 | 0,00 | 77,11 | -4.395 | 120.332.623 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 302.446 | 0,00 | 77,11 | -771 | 23.321.611 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192.381 | 0,00 | 77,11 | -463 | 14.834.499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 192.381 | 0,00 | 77,11 | -463 | 14.834.499 | |
| 2018-12-07 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.987 | 0,00 | 77,11 | -77 | 4.008.718 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1.569 | 1.569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | 1.569 | 1.569 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
J - Other | -10.731 | 0 | -100,00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71.647 | 71.647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | 71.647 | 71.647 | |||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
J - Other | -489.977 | 0 | -100,00 | ||||
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.178.823 | 35.976.940 | 45,08 | 17,00 | 190.039.991 | 611.607.980 | |
| 2018-12-04 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 585.882 | 3.736.902 | 18,59 | 17,00 | 9.959.994 | 63.527.334 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -247 | 9.941.916 | 0,00 | 76,62 | -18.925 | 761.724.749 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 1.560.589 | 0,00 | 76,62 | -2.911 | 119.568.428 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6 | 302.456 | 0,00 | 76,62 | -460 | 23.173.423 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192.387 | 0,00 | 76,62 | -306 | 14.740.211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 192.387 | 0,00 | 76,62 | -306 | 14.740.211 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1 | 51.988 | 0,00 | 76,62 | -77 | 3.983.191 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -32.598 | 9.942.163 | -0,33 | 77,52 | -2.527.147 | 770.762.210 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.005 | 1.560.627 | -0,32 | 77,52 | -388.011 | 120.986.984 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -863 | 302.462 | -0,28 | 77,52 | -66.904 | 23.448.246 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -500 | 192.391 | -0,26 | 77,52 | -38.762 | 14.915.035 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38 | 51.989 | -0,07 | 77,52 | -2.946 | 4.030.426 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -559 | 210.103 | -0,27 | 77,52 | -43.336 | 16.288.151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -89.047 | 9.974.761 | -0,88 | 78,05 | -6.950.074 | 778.525.109 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.671 | 1.565.632 | -0,87 | 78,05 | -1.067.015 | 122.196.795 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.357 | 303.325 | -0,77 | 78,05 | -183.963 | 23.674.365 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.367 | 192.891 | -0,70 | 78,05 | -106.694 | 15.055.046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -104 | 52.027 | -0,20 | 78,05 | -8.117 | 4.060.681 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.526 | 210.662 | -0,72 | 78,05 | -119.104 | 16.442.064 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -44.659 | 10.063.808 | -0,44 | 80,09 | -3.576.721 | 806.006.357 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.856 | 1.579.303 | -0,43 | 80,09 | -549.094 | 126.485.746 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.182 | 305.682 | -0,39 | 80,09 | -94.666 | 24.481.949 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -685 | 194.258 | -0,35 | 80,09 | -54.861 | 15.558.046 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -52 | 52.131 | -0,10 | 80,09 | -4.165 | 4.175.151 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -765 | 212.188 | -0,36 | 80,09 | -61.269 | 16.994.052 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129.121 | 10.108.467 | -1,26 | 79,07 | -10.209.675 | 799.282.551 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19.824 | 1.586.159 | -1,23 | 79,07 | -1.567.496 | 125.418.544 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.417 | 306.864 | -1,10 | 79,07 | -270.184 | 24.263.921 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.981 | 194.943 | -1,01 | 79,07 | -156.639 | 15.414.260 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -151 | 52.183 | -0,29 | 79,07 | -11.940 | 4.126.141 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.214 | 212.953 | -1,03 | 79,07 | -175.062 | 16.838.321 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -39.591 | 10.237.588 | -0,39 | 79,63 | -3.152.536 | 815.194.562 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -6.078 | 1.605.983 | -0,38 | 79,63 | -483.977 | 127.880.572 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.048 | 310.281 | -0,34 | 79,63 | -83.450 | 24.706.931 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -608 | 196.924 | -0,31 | 79,63 | -48.414 | 15.680.586 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46 | 52.334 | -0,09 | 79,63 | -3.663 | 4.167.231 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -678 | 215.167 | -0,31 | 79,63 | -53.988 | 17.133.232 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30.257 | 10.277.179 | -0,29 | 77,61 | -2.348.376 | 797.656.054 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.646 | 1.612.061 | -0,29 | 77,61 | -360.596 | 125.118.986 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -801 | 311.329 | -0,26 | 77,61 | -62.169 | 24.163.582 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -465 | 197.532 | -0,23 | 77,61 | -36.091 | 15.331.308 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -35 | 52.380 | -0,07 | 77,61 | -2.717 | 4.065.437 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -518 | 215.845 | -0,24 | 77,61 | -40.204 | 16.752.659 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.994 | 10.307.436 | -0,12 | 78,80 | -945.149 | 812.244.510 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.841 | 1.616.707 | -0,11 | 78,80 | -145.074 | 127.399.422 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -317 | 312.130 | -0,10 | 78,80 | -24.980 | 24.596.406 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -184 | 197.997 | -0,09 | 78,80 | -14.500 | 15.602.520 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 52.415 | -0,03 | 78,80 | -1.103 | 4.130.396 | |
| 2018-12-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -206 | 216.363 | -0,10 | 78,80 | -16.233 | 17.049.794 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77.976 | 10.319.430 | -0,75 | 76,81 | -5.989.017 | 792.593.109 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.972 | 1.618.548 | -0,73 | 76,81 | -919.520 | 124.314.036 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.064 | 312.447 | -0,66 | 76,81 | -158.527 | 23.997.773 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.197 | 198.181 | -0,60 | 76,81 | -91.937 | 15.221.470 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52.429 | -0,17 | 76,81 | -6.989 | 4.026.857 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.335 | 216.569 | -0,61 | 76,81 | -102.536 | 16.633.777 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -13.595 | 10.397.406 | -0,13 | 74,01 | -1.006.150 | 769.499.541 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.087 | 1.630.520 | -0,13 | 74,01 | -154.456 | 120.672.829 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -360 | 314.511 | -0,11 | 74,01 | -26.643 | 23.276.582 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -209 | 199.378 | -0,10 | 74,01 | -15.468 | 14.755.727 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16 | 52.520 | -0,03 | 74,01 | -1.184 | 3.886.942 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -233 | 217.904 | -0,11 | 74,01 | -17.244 | 16.126.814 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -57.979 | 10.411.001 | -0,55 | 74,71 | -4.331.524 | 777.790.268 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.901 | 1.632.607 | -0,54 | 74,71 | -664.980 | 121.969.620 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.534 | 314.871 | -0,48 | 74,71 | -114.603 | 23.523.540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -890 | 199.587 | -0,44 | 74,71 | -66.491 | 14.910.845 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -68 | 52.536 | -0,13 | 74,71 | -5.080 | 3.924.886 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -994 | 218.137 | -0,45 | 74,71 | -74.260 | 16.296.688 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56.764 | 10.468.980 | -0,54 | 75,27 | -4.272.831 | 788.037.813 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.715 | 1.641.508 | -0,53 | 75,27 | -656.009 | 123.562.217 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.502 | 316.405 | -0,47 | 75,27 | -113.061 | 23.816.943 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -871 | 200.477 | -0,43 | 75,27 | -65.563 | 15.090.626 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 52.604 | -0,13 | 75,27 | -4.968 | 3.959.692 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -973 | 219.131 | -0,44 | 75,27 | -73.241 | 16.494.779 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36.652 | 10.525.744 | -0,35 | 73,76 | -2.703.294 | 776.333.617 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.627 | 1.650.223 | -0,34 | 73,76 | -415.023 | 121.713.353 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -970 | 317.907 | -0,30 | 73,76 | -71.543 | 23.447.453 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -563 | 201.348 | -0,28 | 73,76 | -41.524 | 14.850.563 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -43 | 52.670 | -0,08 | 73,76 | -3.171 | 3.884.713 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -628 | 220.104 | -0,28 | 73,76 | -46.319 | 16.233.925 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -77.558 | 10.562.396 | -0,73 | 74,24 | -5.758.092 | 784.177.629 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.907 | 1.655.850 | -0,71 | 74,24 | -884.004 | 122.934.278 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.052 | 318.877 | -0,64 | 74,24 | -152.345 | 23.674.194 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.190 | 201.911 | -0,59 | 74,24 | -88.348 | 14.990.357 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -91 | 52.713 | -0,17 | 74,24 | -6.756 | 3.913.540 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.329 | 220.732 | -0,60 | 74,24 | -98.668 | 16.387.673 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.204 | 10.639.954 | -0,08 | 74,05 | -607.484 | 787.859.866 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.260 | 1.667.757 | -0,08 | 74,05 | -93.300 | 123.492.903 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -217 | 320.929 | -0,07 | 74,05 | -16.068 | 23.763.926 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -126 | 203.101 | -0,06 | 74,05 | -9.330 | 15.039.081 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -10 | 52.804 | -0,02 | 74,05 | -740 | 3.909.994 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -141 | 222.061 | -0,06 | 74,05 | -10.441 | 16.443.017 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24.487 | 10.648.158 | -0,23 | 74,36 | -1.820.848 | 791.794.899 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.759 | 1.669.017 | -0,22 | 74,36 | -279.518 | 124.107.770 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -648 | 321.146 | -0,20 | 74,36 | -48.185 | 23.880.352 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -376 | 203.227 | -0,18 | 74,36 | -27.959 | 15.111.919 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -28 | 52.814 | -0,05 | 74,36 | -2.082 | 3.927.238 | |
| 2018-11-28 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -419 | 222.202 | -0,19 | 74,36 | -31.157 | 16.522.896 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -55.365 | 10.672.645 | -0,52 | 76,35 | -4.227.024 | 814.838.302 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.499 | 1.672.776 | -0,51 | 76,35 | -648.884 | 127.713.604 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.466 | 321.794 | -0,45 | 76,35 | -111.927 | 24.568.425 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -850 | 203.603 | -0,42 | 76,35 | -64.896 | 15.544.743 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -65 | 52.842 | -0,12 | 76,35 | -4.963 | 4.034.397 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -949 | 222.621 | -0,42 | 76,35 | -72.455 | 16.996.735 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -16.646 | 10.728.010 | -0,15 | 77,66 | -1.292.763 | 833.159.785 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.556 | 1.681.275 | -0,15 | 77,66 | -198.504 | 130.571.347 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -440 | 323.260 | -0,14 | 77,66 | -34.171 | 25.105.050 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -255 | 204.453 | -0,12 | 77,66 | -19.804 | 15.878.249 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19 | 52.907 | -0,04 | 77,66 | -1.476 | 4.108.869 | |
| 2018-11-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -285 | 223.570 | -0,13 | 77,66 | -22.134 | 17.362.916 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -38.330 | 10.744.656 | -0,36 | 79,13 | -3.033.110 | 850.240.746 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.885 | 1.683.831 | -0,35 | 79,13 | -465.689 | 133.244.073 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.014 | 323.700 | -0,31 | 79,13 | -80.239 | 25.614.867 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -588 | 204.708 | -0,29 | 79,13 | -46.529 | 16.198.851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -45 | 52.926 | -0,08 | 79,13 | -3.561 | 4.188.114 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -657 | 223.855 | -0,29 | 79,13 | -51.989 | 17.713.982 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.296 | 10.782.986 | -0,03 | 80,09 | -263.978 | 863.613.662 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -506 | 1.689.716 | -0,03 | 80,09 | -40.526 | 135.330.030 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -87 | 324.714 | -0,03 | 80,09 | -6.968 | 26.006.474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -51 | 205.296 | -0,02 | 80,09 | -4.085 | 16.442.239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 52.971 | -0,01 | 80,09 | -320 | 4.242.469 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 224.512 | -0,02 | 80,09 | -4.485 | 17.981.256 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -53.013 | 10.786.282 | -0,49 | 80,07 | -4.244.714 | 863.650.049 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.139 | 1.690.222 | -0,48 | 80,07 | -651.684 | 135.334.892 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.403 | 324.801 | -0,43 | 80,07 | -112.337 | 26.006.589 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -814 | 205.347 | -0,39 | 80,07 | -65.176 | 16.441.991 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62 | 52.975 | -0,12 | 80,07 | -4.964 | 4.241.671 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -908 | 224.568 | -0,40 | 80,07 | -72.703 | 17.981.003 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -99.280 | 10.839.295 | -0,91 | 78,09 | -7.752.428 | 846.402.609 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.242 | 1.698.361 | -0,89 | 78,09 | -1.190.194 | 132.619.066 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.628 | 326.204 | -0,80 | 78,09 | -205.211 | 25.472.129 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.524 | 206.161 | -0,73 | 78,09 | -119.004 | 16.098.391 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -115 | 53.037 | -0,22 | 78,09 | -8.980 | 4.141.474 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.702 | 225.476 | -0,75 | 78,09 | -132.903 | 17.606.632 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.014 | 10.938.575 | -0,14 | 81,26 | -1.220.038 | 888.868.604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.305 | 1.713.603 | -0,13 | 81,26 | -187.304 | 139.247.380 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -397 | 328.832 | -0,12 | 81,26 | -32.260 | 26.720.888 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -230 | 207.685 | -0,11 | 81,26 | -18.690 | 16.876.483 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53.152 | -0,03 | 81,26 | -1.463 | 4.319.132 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -257 | 227.178 | -0,11 | 81,26 | -20.884 | 18.460.484 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -46.511 | 10.953.589 | -0,42 | 81,16 | -3.774.912 | 889.011.904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.140 | 1.715.908 | -0,41 | 81,16 | -579.495 | 139.266.010 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.231 | 329.229 | -0,37 | 81,16 | -99.910 | 26.720.785 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -714 | 207.915 | -0,34 | 81,16 | -57.949 | 16.874.735 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -54 | 53.170 | -0,10 | 81,16 | -4.383 | 4.315.368 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -796 | 227.435 | -0,35 | 81,16 | -64.605 | 18.459.011 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -7.533 | 11.000.100 | -0,07 | 80,51 | -606.473 | 885.604.851 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.156 | 1.723.048 | -0,07 | 80,51 | -93.068 | 138.720.527 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -199 | 330.460 | -0,06 | 80,51 | -16.021 | 26.604.938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -116 | 208.629 | -0,06 | 80,51 | -9.339 | 16.796.470 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53.224 | -0,02 | 80,51 | -725 | 4.285.000 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 228.231 | -0,06 | 80,51 | -10.386 | 18.374.604 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11.877 | 11.007.633 | -0,11 | 80,38 | -954.711 | 884.828.765 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.824 | 1.724.204 | -0,11 | 80,38 | -146.619 | 138.597.035 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -314 | 330.659 | -0,09 | 80,38 | -25.240 | 26.579.429 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -182 | 208.745 | -0,09 | 80,38 | -14.630 | 16.779.591 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -14 | 53.233 | -0,03 | 80,38 | -1.125 | 4.279.039 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -204 | 228.360 | -0,09 | 80,38 | -16.398 | 18.356.308 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -19.367 | 11.019.510 | -0,18 | 85,11 | -1.648.296 | 937.853.967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.973 | 1.726.028 | -0,17 | 85,11 | -253.028 | 146.899.654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -513 | 330.973 | -0,15 | 85,11 | -43.661 | 28.168.616 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -297 | 208.927 | -0,14 | 85,11 | -25.277 | 17.781.464 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -23 | 53.247 | -0,04 | 85,11 | -1.957 | 4.531.772 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -332 | 228.564 | -0,15 | 85,11 | -28.256 | 19.452.739 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -112.010 | 11.038.877 | -1,00 | 82,06 | -9.191.025 | 905.799.468 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17.198 | 1.729.001 | -0,98 | 82,06 | -1.411.189 | 141.873.869 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.964 | 331.486 | -0,89 | 82,06 | -243.212 | 27.200.216 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.720 | 209.224 | -0,82 | 82,06 | -141.135 | 17.167.959 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -129 | 53.270 | -0,24 | 82,06 | -10.585 | 4.371.091 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.919 | 228.896 | -0,83 | 82,06 | -157.464 | 18.782.153 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -8.157 | 11.150.887 | -0,07 | 82,55 | -673.321 | 920.452.198 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.252 | 1.746.199 | -0,07 | 82,55 | -103.347 | 144.140.346 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -216 | 334.450 | -0,06 | 82,55 | -17.830 | 27.607.242 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -125 | 210.944 | -0,06 | 82,55 | -10.318 | 17.412.415 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9 | 53.399 | -0,02 | 82,55 | -743 | 4.407.831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -140 | 230.815 | -0,06 | 82,55 | -11.556 | 19.052.670 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.120 | 11.159.044 | -0,04 | 83,90 | -345.678 | 936.271.689 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1.747.451 | -0,04 | 83,90 | -53.110 | 146.615.508 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 334.666 | -0,03 | 83,90 | -9.145 | 28.079.314 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 211.069 | -0,03 | 83,90 | -5.286 | 17.709.217 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53.408 | -0,01 | 83,90 | -420 | 4.481.065 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 230.955 | -0,03 | 83,90 | -5.957 | 19.377.702 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -62.929 | 11.163.164 | -0,56 | 83,20 | -5.235.598 | 928.758.500 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.661 | 1.748.084 | -0,55 | 83,20 | -803.781 | 145.437.967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.665 | 334.775 | -0,49 | 83,20 | -138.526 | 27.852.778 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -966 | 211.132 | -0,46 | 83,20 | -80.370 | 17.565.866 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 53.413 | -0,14 | 83,20 | -6.157 | 4.443.881 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.078 | 231.026 | -0,46 | 83,20 | -89.688 | 19.221.017 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -17.602 | 11.226.093 | -0,16 | 85,87 | -1.511.565 | 964.036.246 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.702 | 1.757.745 | -0,15 | 85,87 | -232.033 | 150.945.649 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -466 | 336.440 | -0,14 | 85,87 | -40.018 | 28.891.650 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -270 | 212.098 | -0,13 | 85,87 | -23.186 | 18.213.831 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21 | 53.487 | -0,04 | 85,87 | -1.803 | 4.593.175 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -302 | 232.104 | -0,13 | 85,87 | -25.934 | 19.931.838 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.120 | 11.243.695 | -0,04 | 82,00 | -337.840 | 921.982.990 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -633 | 1.760.447 | -0,04 | 82,00 | -51.906 | 144.356.654 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -109 | 336.906 | -0,03 | 82,00 | -8.938 | 27.626.292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 212.368 | -0,03 | 82,00 | -5.166 | 17.414.176 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53.508 | -0,01 | 82,00 | -410 | 4.387.656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -71 | 232.406 | -0,03 | 82,00 | -5.822 | 19.057.292 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.565 | 11.247.815 | -0,01 | 83,85 | -131.227 | 943.138.286 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -240 | 1.761.080 | -0,01 | 83,85 | -20.124 | 147.667.967 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 337.015 | -0,01 | 83,85 | -3.522 | 28.258.977 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -24 | 212.431 | -0,01 | 83,85 | -2.012 | 17.812.509 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2 | 53.513 | 0,00 | 83,85 | -168 | 4.487.108 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -27 | 232.477 | -0,01 | 83,85 | -2.264 | 19.493.382 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -9.301 | 11.249.380 | -0,08 | 84,84 | -789.121 | 954.426.648 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -1.428 | 1.761.320 | -0,08 | 84,84 | -121.155 | 149.434.968 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -246 | 337.057 | -0,07 | 84,84 | -20.871 | 28.596.792 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -143 | 212.455 | -0,07 | 84,84 | -12.132 | 18.025.235 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -11 | 53.515 | -0,02 | 84,84 | -933 | 4.540.352 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -159 | 232.504 | -0,07 | 84,84 | -13.490 | 19.726.244 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -21.423 | 11.258.681 | -0,19 | 89,34 | -1.913.901 | 1.005.834.798 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.289 | 1.762.748 | -0,19 | 89,34 | -293.835 | 157.481.438 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -567 | 337.303 | -0,17 | 89,34 | -50.655 | 30.134.178 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -329 | 212.598 | -0,15 | 89,34 | -29.392 | 18.993.208 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -25 | 53.526 | -0,05 | 89,34 | -2.233 | 4.781.938 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -367 | 232.663 | -0,16 | 89,34 | -32.787 | 20.785.787 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -30.555 | 11.280.104 | -0,27 | 85,15 | -2.601.670 | 960.468.143 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.692 | 1.766.037 | -0,26 | 85,15 | -399.510 | 150.372.929 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -809 | 337.870 | -0,24 | 85,15 | -68.884 | 28.768.651 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -470 | 212.927 | -0,22 | 85,15 | -40.019 | 18.130.117 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -37 | 53.551 | -0,07 | 85,15 | -3.150 | 4.559.712 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -522 | 233.030 | -0,22 | 85,15 | -44.447 | 19.841.829 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -36.174 | 11.310.659 | -0,32 | 85,78 | -3.102.970 | 970.217.018 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5.554 | 1.770.729 | -0,31 | 85,78 | -476.417 | 151.891.363 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -957 | 338.679 | -0,28 | 85,78 | -82.091 | 29.051.546 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -555 | 213.397 | -0,26 | 85,78 | -47.607 | 18.304.981 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -42 | 53.588 | -0,08 | 85,78 | -3.603 | 4.596.725 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -620 | 233.552 | -0,26 | 85,78 | -53.183 | 20.033.857 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -3.663 | 11.346.833 | -0,03 | 87,30 | -319.780 | 990.579.656 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -562 | 1.776.283 | -0,03 | 87,30 | -49.063 | 155.069.684 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -97 | 339.636 | -0,03 | 87,30 | -8.468 | 29.650.257 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -56 | 213.952 | -0,03 | 87,30 | -4.889 | 18.678.031 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4 | 53.630 | -0,01 | 87,30 | -349 | 4.681.904 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -63 | 234.172 | -0,03 | 87,30 | -5.500 | 20.443.239 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -4.306 | 11.350.496 | -0,04 | 88,38 | -380.544 | 1.003.104.624 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -661 | 1.776.845 | -0,04 | 88,38 | -58.416 | 157.029.388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -114 | 339.733 | -0,03 | 88,38 | -10.075 | 30.024.040 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -66 | 214.008 | -0,03 | 88,38 | -5.833 | 18.913.043 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -5 | 53.634 | -0,01 | 88,38 | -442 | 4.739.926 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -74 | 234.235 | -0,03 | 88,38 | -6.540 | 20.700.612 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -15.798 | 11.354.802 | -0,14 | 83,94 | -1.326.160 | 953.176.583 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -2.425 | 1.777.506 | -0,14 | 83,94 | -203.566 | 149.212.386 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -418 | 339.847 | -0,12 | 83,94 | -35.089 | 28.528.388 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -242 | 214.074 | -0,11 | 83,94 | -20.315 | 17.970.399 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -18 | 53.639 | -0,03 | 83,94 | -1.511 | 4.502.715 | |
| 2018-11-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
S - Sale | -271 | 234.309 | -0,12 | 83,94 | -22.749 | 19.669.022 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -3.660.993 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Secured Bridge Notes 30% 12/1/2020 |
C - Conversion | -294.948 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -4.627.208 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Series B Redeemable Convertible Preferred Shares |
C - Conversion | -372.792 | 0 | -100,00 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 2.248.102 | 8.374.935 | 36,69 | 10,00 | 22.481.020 | 83.749.350 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
P - Purchase | 251.898 | 770.180 | 48,60 | 10,00 | 2.518.980 | 7.701.800 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 767.427 | 6.126.833 | 14,32 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
J - Other | 86.501 | 518.282 | 20,03 | ||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 732.198 | 5.359.406 | 15,82 | 5,00 | 3.660.990 | 26.797.030 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 58.989 | 431.781 | 15,82 | 5,00 | 294.945 | 2.158.905 | |
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 4.627.208 | 4.627.208 | |||||
| 2018-10-11 |
|
4 | KOD |
Kodiak Sciences Inc.
Common Stock |
C - Conversion | 372.792 | 372.792 | |||||
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340.265 | 0,08 | 70,18 | 19.931 | 23.879.798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 340.265 | 0,08 | 70,18 | 19.931 | 23.879.798 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 11.544.497 | 0,00 | 70,18 | 19.931 | 810.192.799 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 1.953.828 | 0,01 | 70,18 | 19.931 | 137.119.649 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 227.554 | 0,12 | 70,18 | 19.931 | 15.969.740 | |
| 2018-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 284 | 388.213 | 0,07 | 70,18 | 19.931 | 27.244.788 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.340 | 81.414 | 2,96 | 8,71 | 20.381 | 709.116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.340 | 81.414 | 2,96 | 8,71 | 20.381 | 709.116 | |
| 2018-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 2.340 | 4.280.212 | 0,05 | 8,71 | 20.381 | 37.280.647 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810.564 | 0,03 | 69,08 | 18.997 | 55.993.761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 810.564 | 0,03 | 69,08 | 18.997 | 55.993.761 | |
| 2018-10-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 275 | 1.269.837 | 0,02 | 69,08 | 18.997 | 87.720.340 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 131.007 | 24.798.117 | 0,53 | 19,09 | 2.501.238 | 473.455.569 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14.555 | 3.151.020 | 0,46 | 19,09 | 277.890 | 60.160.534 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38.207 | 24.667.110 | 0,16 | 19,01 | 726.353 | 468.946.428 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.245 | 3.136.465 | 0,14 | 19,01 | 80.702 | 59.627.336 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 920.495 | 24.628.903 | 3,88 | 18,64 | 17.154.897 | 458.999.014 | |
| 2018-09-24 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102.267 | 3.132.220 | 3,38 | 18,64 | 1.905.909 | 58.373.931 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 5.231.900 | 5.250.491 | 28.142,11 | 108,00 | 565.045.200 | 567.053.028 | |
| 2018-08-06 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
P - Purchase | 582.200 | 600.791 | 3.131,62 | 108,00 | 62.877.600 | 64.885.428 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16.383 | 632.599 | 2,66 | 1,32 | 21.626 | 835.031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16.383 | 632.599 | 2,66 | 1,32 | 21.626 | 835.031 | |
| 2018-07-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 16.383 | 34.222.983 | 0,05 | 1,32 | 21.626 | 45.174.338 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810.289 | 0,03 | 67,00 | 18.961 | 54.289.363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810.289 | 0,03 | 67,00 | 18.961 | 54.289.363 | |
| 2018-07-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 283 | 810.289 | 0,03 | 67,00 | 18.961 | 54.289.363 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339.981 | 0,12 | 50,40 | 19.958 | 17.135.042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339.981 | 0,12 | 50,40 | 19.958 | 17.135.042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 339.981 | 0,12 | 50,40 | 19.958 | 17.135.042 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 1.953.544 | 0,02 | 50,40 | 19.958 | 98.458.618 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 227.270 | 0,17 | 50,40 | 19.958 | 11.454.408 | |
| 2018-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 396 | 387.929 | 0,10 | 50,40 | 19.958 | 19.551.622 | |
| 2018-06-21 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100.000 | 100.000 | |||||
| 2018-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2018-06-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (Right to Buy) |
A - Award | 34.884 | 34.884 | |||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18.580 | 73.180.602 | 0,03 | ||||
| 2018-06-08 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
A - Award | 18.580 | 73.180.602 | 0,03 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 14.658.102 | 14.658.102 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -14.658.102 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class B1 Common Shares |
C - Conversion | 1.399.516 | 1.399.516 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series A Preferred |
C - Conversion | -1.399.516 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3.284.771 | 7.018.874 | 87,97 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -3.284.771 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 313.621 | 734.518 | 74,51 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series B Preferred |
C - Conversion | -313.621 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 3.734.103 | 3.734.103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -3.734.103 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A1 Common Shares |
C - Conversion | 420.897 | 420.897 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
C - Conversion | -420.897 | 0 | -100,00 | ||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 2.700.597 | 2.700.597 | 18,00 | 48.610.746 | 48.610.746 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Class A Common Shares |
P - Purchase | 299.403 | 299.403 | 18,00 | 5.389.254 | 5.389.254 | ||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 3.734.103 | 3.734.103 | |||||
| 2018-05-31 |
|
4 | KNSA |
Kiniksa Pharmaceuticals, Ltd.
Series C Preferred |
P - Purchase | 420.897 | 420.897 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 45.829.686 | 0,01 | 56,77 | 210.049 | 2.601.751.274 | |
| 2018-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 45.829.686 | 0,01 | 56,77 | 210.049 | 2.601.751.274 | |
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.174 | 7.648.080 | 0,03 | ||||
| 2018-05-11 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.174 | 7.648.080 | 0,03 | ||||
| 2018-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 126.399 | 45.825.986 | 0,28 | 54,02 | 6.828.339 | 2.475.615.998 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129.715 | 45.699.587 | 0,28 | 53,70 | 6.966.305 | 2.454.282.610 | |
| 2018-05-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 204.537 | 45.569.872 | 0,45 | 52,68 | 10.775.582 | 2.400.748.453 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 810.006 | 2,53 | 9,92 | 198.400 | 8.035.260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 810.006 | 2,53 | 9,92 | 198.400 | 8.035.260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 810.006 | 2,53 | 9,92 | 198.400 | 8.035.260 | |
| 2018-05-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.105 | 45.365.335 | 0,02 | 54,42 | 495.488 | 2.468.749.775 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.442 | 45.356.230 | 0,05 | 52,26 | 1.120.576 | 2.370.352.865 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37.400 | 45.334.788 | 0,08 | 52,33 | 1.957.022 | 2.372.224.385 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.000 | 45.297.388 | 0,00 | 51,88 | 103.750 | 2.349.802.002 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.951 | 45.295.388 | 0,01 | 52,33 | 311.418 | 2.370.321.243 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37.963 | 45.289.437 | 0,08 | 52,06 | 1.976.213 | 2.357.600.519 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57.270 | 45.251.474 | 0,13 | 51,37 | 2.941.708 | 2.324.369.113 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.500 | 45.194.204 | 0,02 | 51,36 | 539.280 | 2.321.174.317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22.700 | 45.183.704 | 0,05 | 51,30 | 1.164.424 | 2.317.752.317 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.533 | 45.161.004 | 0,16 | 51,26 | 3.717.693 | 2.314.736.292 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100.000 | 45.088.471 | 0,22 | 51,14 | 5.114.000 | 2.305.824.407 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 44.988.471 | 0,02 | 10,08 | 100.800 | 453.483.788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 44.988.471 | 0,02 | 10,08 | 100.800 | 453.483.788 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 168.097 | 44.978.471 | 0,38 | 51,25 | 8.614.786 | 2.305.097.162 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 52.700 | 44.810.374 | 0,12 | 51,07 | 2.691.173 | 2.288.282.078 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 248.121 | 44.757.674 | 0,56 | 51,03 | 12.661.069 | 2.283.885.637 | |
| 2018-05-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 154.218 | 44.509.553 | 0,35 | 50,90 | 7.849.897 | 2.265.594.110 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.349 | 616.216 | 2,21 | 1,62 | 21.625 | 998.270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.349 | 616.216 | 2,21 | 1,62 | 21.625 | 998.270 | |
| 2018-04-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.349 | 616.216 | 2,21 | 1,62 | 21.625 | 998.270 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339.585 | 0,19 | 31,29 | 19.963 | 10.625.615 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 1.382.967 | 0,05 | 31,29 | 19.963 | 43.273.037 | |
| 2018-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 638 | 339.585 | 0,19 | 31,29 | 19.963 | 10.625.615 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790.006 | 0,03 | 83,33 | 18.999 | 65.831.200 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 1.249.279 | 0,02 | 83,33 | 18.999 | 104.102.419 | |
| 2018-04-02 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 228 | 790.006 | 0,03 | 83,33 | 18.999 | 65.831.200 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 999.514 | 7.480.182 | 15,42 | 4,50 | 4.497.813 | 33.660.819 | |
| 2018-03-29 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 111.597 | 845.858 | 15,20 | 4,50 | 502.186 | 3.806.361 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -439.036 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -17.626.445 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock Warrant (right to buy) |
M - Exercise | -2.250.846 | 0 | -100,00 | ||||
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 439.036 | 602.867 | 267,98 | 0,47 | 206.347 | 283.347 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 17.626.445 | 34.193.251 | 106,40 | 0,47 | 8.284.429 | 16.070.828 | |
| 2018-03-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 2.250.846 | 4.102.796 | 121,54 | 0,47 | 1.057.898 | 1.928.314 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 338.947 | 2,49 | 18,50 | 152.625 | 6.270.520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 338.947 | 2,49 | 18,50 | 152.625 | 6.270.520 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.382.329 | 0,60 | 18,50 | 152.625 | 25.573.086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.382.329 | 0,60 | 18,50 | 152.625 | 25.573.086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.382.329 | 0,60 | 18,50 | 152.625 | 25.573.086 | |
| 2018-03-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 338.947 | 2,49 | 18,50 | 152.625 | 6.270.520 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.456.543 | 44.355.335 | 8,45 | 52,00 | 179.740.236 | 2.306.477.420 | |
| 2018-02-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 389.610 | 5.278.174 | 7,97 | 52,00 | 20.259.720 | 274.465.048 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1.645.148 | 5.121.404 | 47,33 | 101,00 | 166.159.948 | 517.261.804 | |
| 2018-01-22 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 335.050 | 708.025 | 89,83 | 101,00 | 33.840.050 | 71.510.525 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4.136 | 58.131 | -6,64 | 7,91 | -32.715 | 459.799 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -265.708 | 3.734.776 | -6,64 | 7,91 | -2.101.671 | 29.540.958 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -25.517 | 358.671 | -6,64 | 7,91 | -201.832 | 2.836.980 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -4.548 | 62.267 | -6,81 | 8,12 | -36.910 | 505.340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -292.168 | 4.000.484 | -6,81 | 8,12 | -2.371.148 | 32.466.728 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -28.058 | 384.188 | -6,81 | 8,12 | -227.710 | 3.117.955 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -3.649 | 66.815 | -5,18 | 8,63 | -31.476 | 576.340 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -234.437 | 4.292.652 | -5,18 | 8,63 | -2.022.230 | 37.027.987 | |
| 2018-01-19 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
S - Sale | -22.514 | 412.246 | -5,18 | 8,63 | -194.204 | 3.555.993 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.333 | 163.831 | 6,04 | 2,21 | 20.626 | 362.067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.333 | 163.831 | 6,04 | 2,21 | 20.626 | 362.067 | |
| 2018-01-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.333 | 163.831 | 6,04 | 2,21 | 20.626 | 362.067 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330.697 | 0,18 | 34,20 | 19.973 | 11.309.837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330.697 | 0,18 | 34,20 | 19.973 | 11.309.837 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1.374.079 | 0,04 | 34,20 | 19.973 | 46.993.502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1.374.079 | 0,04 | 34,20 | 19.973 | 46.993.502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 1.374.079 | 0,04 | 34,20 | 19.973 | 46.993.502 | |
| 2018-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 584 | 330.697 | 0,18 | 34,20 | 19.973 | 11.309.837 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789.778 | 0,03 | 94,71 | 18.942 | 74.799.874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789.778 | 0,03 | 94,71 | 18.942 | 74.799.874 | |
| 2018-01-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 200 | 789.778 | 0,03 | 94,71 | 18.942 | 74.799.874 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -39.378 | 0 | -100,00 | ||||
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -1.941 | 489.977 | -0,39 | 28,00 | -54.348 | 13.719.356 | |
| 2017-11-29 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 39.378 | 491.918 | 8,70 | 1,38 | 54.342 | 678.847 | |
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 1.618.684 | 1.618.684 | 13,00 | 21.041.273 | 21.041.273 | ||
| 2017-11-20 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
P - Purchase | 304.392 | 304.392 | 13,00 | 3.956.792 | 3.956.792 | ||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -5.996 | 0 | -100,00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -249.801 | 0 | -100,00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -24.466 | 0 | -100,00 | ||||
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 5.996 | 35.999 | 19,98 | 7,86 | 47.129 | 282.952 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 249.801 | 2.372.218 | 11,77 | 7,86 | 1.963.436 | 18.645.633 | |
| 2017-11-13 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 24.466 | 141.244 | 20,95 | 7,86 | 192.303 | 1.110.178 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 7.204.652 | 16.557.473 | 77,03 | 1,50 | 10.806.978 | 24.836.210 | |
| 2017-10-30 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 795.348 | 1.842.617 | 75,94 | 1,50 | 1.193.022 | 2.763.926 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock Warrant (right to buy) |
M - Exercise | -1.426.590 | 0 | -100,00 | ||||
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
F - Taxes | -55.457 | 23.708.408 | -0,23 | 35,40 | -1.963.178 | 839.277.643 | |
| 2017-10-16 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1.426.590 | 23.763.865 | 6,39 | 1,38 | 1.968.694 | 32.794.134 | |
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7.102 | 7.102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | 7.102 | 7.102 | |||||
| 2017-10-16 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
J - Other | -49.200 | 0 | -100,00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -9.913.242 | 0 | -100,00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Series A Convertible Prefered |
C - Conversion | -760.829 | 0 | -100,00 | ||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 797.191 | 1.878.242 | 73,74 | 17,00 | 13.552.247 | 31.930.114 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 87.809 | 170.778 | 105,83 | 17,00 | 1.492.753 | 2.903.226 | |
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 1.081.051 | 1.081.051 | |||||
| 2017-10-06 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
C - Conversion | 82.969 | 82.969 | |||||
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.045 | 154.498 | 6,22 | 2,28 | 20.623 | 352.255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.045 | 154.498 | 6,22 | 2,28 | 20.623 | 352.255 | |
| 2017-10-04 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 9.045 | 154.498 | 6,22 | 2,28 | 20.623 | 352.255 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330.113 | 0,19 | 32,09 | 19.960 | 10.593.326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330.113 | 0,19 | 32,09 | 19.960 | 10.593.326 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1.373.495 | 0,05 | 32,09 | 19.960 | 44.075.455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1.373.495 | 0,05 | 32,09 | 19.960 | 44.075.455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 1.373.495 | 0,05 | 32,09 | 19.960 | 44.075.455 | |
| 2017-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 622 | 330.113 | 0,19 | 32,09 | 19.960 | 10.593.326 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789.578 | 0,02 | 116,74 | 18.912 | 92.175.336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789.578 | 0,02 | 116,74 | 18.912 | 92.175.336 | |
| 2017-10-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 162 | 789.578 | 0,02 | 116,74 | 18.912 | 92.175.336 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.029 | 789.416 | 0,26 | 132,00 | 267.828 | 104.202.912 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 85.402 | 29.247.347 | 0,29 | 132,00 | 11.273.064 | 3.860.649.804 | |
| 2017-09-08 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12.569 | 4.386.818 | 0,29 | 132,00 | 1.659.108 | 579.059.976 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 158.279 | 3.476.256 | 4,77 | 71,00 | 11.237.809 | 246.814.176 | |
| 2017-08-14 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 17.777 | 372.975 | 5,00 | 71,00 | 1.262.167 | 26.481.225 | |
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 3.109.063 | 3.109.063 | 8,50 | 26.427.036 | 26.427.036 | ||
| 2017-08-02 |
|
4 | NVTA |
Invitae Corp
Series A Convertible Preferred |
P - Purchase | 349.760 | 349.760 | 8,50 | 2.972.960 | 2.972.960 | ||
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11.787 | 145.453 | 8,82 | 1,75 | 20.627 | 254.543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11.787 | 145.453 | 8,82 | 1,75 | 20.627 | 254.543 | |
| 2017-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 11.787 | 145.453 | 8,82 | 1,75 | 20.627 | 254.543 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 1.372.873 | 0,04 | 32,55 | 19.986 | 44.687.016 | |
| 2017-07-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 614 | 329.491 | 0,19 | 32,55 | 19.986 | 10.724.932 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1.246.660 | 0,01 | 125,91 | 18.886 | 156.966.961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 1.246.660 | 0,01 | 125,91 | 18.886 | 156.966.961 | |
| 2017-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 150 | 787.387 | 0,02 | 125,91 | 18.886 | 99.139.897 | |
| 2017-06-20 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22.560 | 7.317.906 | 0,31 | 117,95 | 2.660.914 | 863.134.572 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.564 | 647.367 | 0,40 | 117,95 | 302.419 | 76.355.837 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 197.126 | 7.295.346 | 2,78 | 117,51 | 23.163.488 | 857.246.927 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 22.399 | 644.803 | 3,60 | 117,51 | 2.632.017 | 75.768.221 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32.172 | 7.098.220 | 0,46 | 117,22 | 3.771.228 | 832.059.027 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.656 | 622.404 | 0,59 | 117,22 | 428.559 | 72.958.695 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 65.264 | 7.066.048 | 0,93 | 117,01 | 7.636.802 | 826.826.541 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.416 | 618.748 | 1,21 | 117,01 | 867.776 | 72.402.178 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 898 | 7.000.784 | 0,01 | 116,96 | 105.030 | 818.811.697 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 102 | 611.332 | 0,02 | 116,96 | 11.930 | 71.501.391 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 31.974 | 6.999.886 | 0,46 | 116,71 | 3.731.542 | 816.925.196 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.634 | 611.230 | 0,60 | 116,71 | 424.108 | 71.333.903 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 12.726 | 6.967.912 | 0,18 | 116,37 | 1.480.897 | 810.840.590 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.446 | 607.596 | 0,24 | 116,37 | 168.268 | 70.704.610 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 385.774 | 6.955.186 | 5,87 | 116,37 | 44.891.517 | 809.356.911 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43.835 | 606.150 | 7,80 | 116,37 | 5.100.965 | 70.536.100 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.976 | 6.569.412 | 0,03 | 116,18 | 229.562 | 763.202.753 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 224 | 562.315 | 0,04 | 116,18 | 26.023 | 65.327.058 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 169.897 | 6.567.436 | 2,66 | 115,77 | 19.668.568 | 760.296.304 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19.305 | 562.091 | 3,56 | 115,77 | 2.234.894 | 65.071.926 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 207.814 | 6.397.539 | 3,36 | 115,71 | 24.046.636 | 740.273.952 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 23.614 | 542.786 | 4,55 | 115,71 | 2.732.430 | 62.807.016 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 18.678 | 6.189.725 | 0,30 | 115,06 | 2.149.048 | 712.175.522 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.122 | 519.172 | 0,41 | 115,06 | 244.152 | 59.734.736 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 64.455 | 6.171.047 | 1,06 | 114,33 | 7.369.301 | 705.551.231 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 7.324 | 517.050 | 1,44 | 114,33 | 837.371 | 59.115.619 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 160.000 | 980.146 | 19,51 | 117,71 | 18.832.960 | 115.369.065 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103.200 | 820.146 | 14,39 | 117,63 | 12.139.416 | 96.473.774 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 32.008 | 716.946 | 4,67 | 117,60 | 3.764.067 | 84.311.201 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 300 | 684.938 | 0,04 | 116,75 | 35.025 | 79.966.512 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.747 | 7.645.906 | 0,05 | 116,75 | 437.462 | 892.659.526 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 426 | 684.638 | 0,06 | 116,75 | 49.736 | 79.931.486 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 44.898 | 7.642.159 | 0,59 | 117,50 | 5.275.484 | 897.948.333 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.102 | 684.212 | 0,75 | 117,50 | 599.481 | 80.394.431 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.373 | 7.597.261 | 0,07 | 117,21 | 629.790 | 890.504.591 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 611 | 679.110 | 0,09 | 117,21 | 71.618 | 79.601.132 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 217.305 | 7.591.888 | 2,95 | 117,05 | 25.434.638 | 888.598.604 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.692 | 678.499 | 3,78 | 117,05 | 2.890.095 | 79.415.458 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8.950 | 7.374.583 | 0,12 | 116,95 | 1.046.720 | 862.471.494 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.017 | 653.807 | 0,16 | 116,95 | 118.940 | 76.463.971 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 39.473 | 7.365.633 | 0,54 | 116,65 | 4.604.506 | 859.197.407 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.485 | 652.790 | 0,69 | 116,65 | 523.173 | 76.147.627 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.310 | 7.326.160 | 0,06 | 116,54 | 502.277 | 853.773.836 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 490 | 648.305 | 0,08 | 116,54 | 57.103 | 75.551.974 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.944 | 7.321.850 | 0,05 | 118,00 | 465.392 | 863.978.300 | |
| 2017-06-16 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
P - Purchase | 448 | 647.815 | 0,07 | 118,00 | 52.864 | 76.442.170 | |
| 2017-06-14 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 30.000 | 30.000 | |||||
| 2017-06-09 |
|
4/A | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100.000 | 100.000 | |||||
| 2017-06-08 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 100.000 | 100.000 | |||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 328.877 | 2,57 | 18,13 | 149.572 | 5.962.540 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 1.372.259 | 0,60 | 18,13 | 149.572 | 24.879.056 | |
| 2017-06-01 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 328.877 | 2,57 | 18,13 | 149.572 | 5.962.540 | |
| 2017-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 40.898.792 | 0,01 | 66,60 | 246.420 | 2.723.859.547 | |
| 2017-05-23 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 40.898.792 | 0,01 | 66,60 | 246.420 | 2.723.859.547 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 40.895.092 | 0,02 | 10,20 | 102.000 | 417.129.938 | |
| 2017-05-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 40.895.092 | 0,02 | 10,20 | 102.000 | 417.129.938 | |
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.030 | 6.559.338 | 0,03 | ||||
| 2017-05-12 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 2.030 | 6.106.592 | 0,03 | ||||
| 2017-05-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Non-Qualified Stock Option (right to buy) |
A - Award | 36.000 | 36.000 | |||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 787.237 | 2,61 | 7,26 | 145.200 | 5.715.341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 787.237 | 2,61 | 7,26 | 145.200 | 5.715.341 | |
| 2017-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 787.237 | 2,61 | 7,26 | 145.200 | 5.715.341 | |
| 2017-04-21 |
|
4 | BGNE |
BeiGene, Ltd.
Share Option (right to buy) |
A - Award | 399.984 | 399.984 | |||||
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.487 | 133.666 | 6,78 | 2,43 | 20.623 | 324.808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.487 | 133.666 | 6,78 | 2,43 | 20.623 | 324.808 | |
| 2017-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.487 | 133.666 | 6,78 | 2,43 | 20.623 | 324.808 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767.237 | 0,02 | 133,67 | 18.981 | 102.556.570 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 1.226.510 | 0,01 | 133,67 | 18.981 | 163.947.592 | |
| 2017-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 142 | 767.237 | 0,02 | 133,67 | 18.981 | 102.556.570 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320.627 | 0,20 | 31,49 | 19.965 | 10.096.544 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 1.364.009 | 0,05 | 31,49 | 19.965 | 42.952.643 | |
| 2017-04-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 634 | 320.627 | 0,20 | 31,49 | 19.965 | 10.096.544 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 151.177 | 4.527.089 | 3,45 | 12,00 | 1.814.124 | 54.325.068 | |
| 2017-03-28 |
|
4 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15.489 | 434.760 | 3,69 | 12,00 | 185.868 | 5.217.120 | |
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -6.050.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -5.674.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -243.450.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -228.326.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
D - Sale to Issuer | -25.000.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
D - Sale to Issuer | -25.000.000 | 0 | -100,00 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 121.672 | 767.095 | 18,85 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 111.514 | 645.423 | 20,89 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4.896.067 | 29.141.653 | 20,19 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 4.487.412 | 24.245.586 | 22,71 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 502.779 | 4.353.957 | 13,06 | ||||
| 2017-02-22 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 491.338 | 3.851.178 | 14,62 | ||||
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 32.051 | 9.764.459 | 0,33 | 17,76 | 569.226 | 173.416.792 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.389 | 1.169.695 | 0,29 | 17,76 | 60.189 | 20.773.783 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 235.169 | 9.732.408 | 2,48 | 17,60 | 4.138.880 | 171.286.488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 24.871 | 1.166.306 | 2,18 | 17,60 | 437.720 | 20.526.519 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 35.360 | 9.497.239 | 0,37 | 16,31 | 576.555 | 154.855.331 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.739 | 1.141.435 | 0,33 | 16,31 | 60.966 | 18.611.440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.006 | 9.461.879 | 0,05 | 15,62 | 78.207 | 147.819.151 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 529 | 1.137.696 | 0,05 | 15,62 | 8.264 | 17.773.770 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 15.148 | 9.456.873 | 0,16 | 15,13 | 229.189 | 143.082.488 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.602 | 1.137.167 | 0,14 | 15,13 | 24.238 | 17.205.337 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9.143 | 9.441.725 | 0,10 | 16,20 | 148.089 | 152.927.620 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 967 | 1.135.565 | 0,09 | 16,20 | 15.662 | 18.392.746 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 8.671 | 9.432.582 | 0,09 | 15,35 | 133.078 | 144.766.552 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 917 | 1.134.598 | 0,08 | 15,35 | 14.074 | 17.413.243 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.442 | 9.423.911 | 0,03 | 16,85 | 41.156 | 158.823.999 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 258 | 1.133.681 | 0,02 | 16,85 | 4.348 | 19.106.266 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11.305 | 9.421.469 | 0,12 | 15,32 | 173.204 | 144.346.327 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.195 | 1.133.423 | 0,11 | 15,32 | 18.309 | 17.365.174 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.697 | 9.410.164 | 0,06 | 16,74 | 95.365 | 157.521.440 | |
| 2017-01-09 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 603 | 1.132.228 | 0,05 | 16,74 | 10.094 | 18.952.931 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14.169 | 125.179 | 12,76 | 1,50 | 21.254 | 187.768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14.169 | 125.179 | 12,76 | 1,50 | 21.254 | 187.768 | |
| 2017-01-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 14.169 | 125.179 | 12,76 | 1,50 | 21.254 | 187.768 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993.182 | 0,02 | 100,27 | 18.951 | 99.586.359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 993.182 | 0,02 | 100,27 | 18.951 | 99.586.359 | |
| 2017-01-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 189 | 533.909 | 0,04 | 100,27 | 18.951 | 53.535.055 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 14.045.614 | 0,00 | 29,39 | 19.985 | 412.800.595 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 1.363.375 | 0,05 | 29,39 | 19.985 | 40.069.591 | |
| 2017-01-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 680 | 319.993 | 0,21 | 29,39 | 19.985 | 9.404.594 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1.594.671 | 3.317.977 | 92,54 | 32,00 | 51.029.472 | 106.175.264 | |
| 2016-11-21 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 165.824 | 355.198 | 87,56 | 32,00 | 5.306.368 | 11.366.336 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 664.259 | 6.480.668 | 11,42 | 6,00 | 3.985.554 | 38.884.008 | |
| 2016-11-18 |
|
4 | NVTA |
Invitae Corp
Common Stock |
P - Purchase | 69.074 | 734.261 | 10,38 | 6,00 | 414.444 | 4.405.566 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 294.178 | 40.885.092 | 0,72 | 59,46 | 17.493.177 | 2.431.215.642 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.122 | 4.874.864 | 0,66 | 59,46 | 1.910.122 | 289.881.838 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50.667 | 40.590.914 | 0,12 | 58,74 | 2.976.321 | 2.384.423.943 | |
| 2016-11-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.533 | 4.842.742 | 0,11 | 58,74 | 325.024 | 284.476.225 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.616 | 40.540.247 | 0,05 | 55,99 | 1.042.351 | 2.269.937.618 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.039 | 4.837.209 | 0,04 | 55,99 | 114.168 | 270.845.974 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.854 | 40.521.631 | 0,04 | 56,42 | 950.861 | 2.286.129.117 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.846 | 4.835.170 | 0,04 | 56,42 | 104.147 | 272.788.203 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 143.016 | 40.504.777 | 0,35 | 56,48 | 8.078.001 | 2.287.839.420 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15.662 | 4.833.324 | 0,33 | 56,48 | 884.640 | 273.001.606 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 361 | 40.361.761 | 0,00 | 56,49 | 20.393 | 2.280.035.879 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39 | 4.817.662 | 0,00 | 56,49 | 2.203 | 272.149.726 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456 | 40.361.400 | 0,00 | 56,55 | 25.788 | 2.282.558.254 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50 | 4.817.623 | 0,00 | 56,55 | 2.828 | 272.451.034 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 341.438 | 40.360.944 | 0,85 | 56,91 | 19.430.383 | 2.296.840.421 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 37.392 | 4.817.573 | 0,78 | 56,91 | 2.127.885 | 274.156.035 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95.280 | 40.019.506 | 0,24 | 55,84 | 5.320.673 | 2.234.789.264 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.434 | 4.780.181 | 0,22 | 55,84 | 582.661 | 266.937.257 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.335 | 39.924.226 | 0,01 | 55,87 | 186.336 | 2.230.686.279 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 365 | 4.769.747 | 0,01 | 55,87 | 20.394 | 266.500.074 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.289 | 39.920.891 | 0,02 | 56,12 | 352.915 | 2.240.208.704 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 689 | 4.769.382 | 0,01 | 56,12 | 38.664 | 267.639.594 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 26.381 | 39.914.602 | 0,07 | 56,13 | 1.480.758 | 2.240.394.636 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.889 | 4.768.693 | 0,06 | 56,13 | 162.159 | 267.665.307 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 289.278 | 39.888.221 | 0,73 | 56,26 | 16.274.202 | 2.244.031.537 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.679 | 4.765.804 | 0,67 | 56,26 | 1.782.197 | 268.114.601 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.884 | 39.598.943 | 0,01 | 51,83 | 149.479 | 2.052.425.095 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 316 | 4.734.125 | 0,01 | 51,83 | 16.378 | 245.371.119 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.434 | 39.596.059 | 0,01 | 53,33 | 129.815 | 2.111.812.251 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 266 | 4.733.809 | 0,01 | 53,33 | 14.187 | 252.472.496 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.717 | 39.593.625 | 0,08 | 53,66 | 1.755.578 | 2.124.574.121 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.583 | 4.733.543 | 0,08 | 53,66 | 192.262 | 253.999.551 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.332 | 39.560.908 | 0,10 | 54,37 | 2.192.976 | 2.151.049.207 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.417 | 4.729.960 | 0,09 | 54,37 | 240.166 | 257.182.588 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 924 | 39.520.576 | 0,00 | 54,51 | 50.365 | 2.154.183.605 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4.725.543 | 0,00 | 54,51 | 5.505 | 257.579.425 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.803 | 39.519.652 | 0,00 | 54,61 | 98.455 | 2.158.021.973 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 197 | 4.725.442 | 0,00 | 54,61 | 10.757 | 258.038.903 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 85.353 | 39.517.849 | 0,22 | 54,93 | 4.688.039 | 2.170.529.712 | |
| 2016-11-03 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.347 | 4.725.245 | 0,20 | 54,93 | 513.387 | 259.535.499 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 2.928.596 | 9.309.333 | 45,90 | 2,00 | 5.857.192 | 18.618.666 | |
| 2016-10-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 321.404 | 1.003.781 | 47,10 | 2,00 | 642.808 | 2.007.562 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.299 | 111.010 | 8,08 | 2,56 | 21.245 | 284.186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.299 | 111.010 | 8,08 | 2,56 | 21.245 | 284.186 | |
| 2016-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.299 | 111.010 | 8,08 | 2,56 | 21.245 | 284.186 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992.993 | 0,02 | 94,29 | 18.952 | 93.629.310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 992.993 | 0,02 | 94,29 | 18.952 | 93.629.310 | |
| 2016-10-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 201 | 533.720 | 0,04 | 94,29 | 18.952 | 50.324.459 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 1.362.695 | 0,05 | 28,92 | 19.955 | 39.409.139 | |
| 2016-10-04 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 690 | 319.313 | 0,22 | 28,92 | 19.955 | 9.234.532 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12.550 | 1.131.625 | 1,12 | 13,15 | 165.029 | 14.880.529 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.476.348 | 9.404.467 | 35,74 | 12,25 | 30.335.263 | 115.204.721 | |
| 2016-09-21 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 294.707 | 1.119.075 | 35,75 | 12,25 | 3.610.161 | 13.708.669 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.339 | 39.432.496 | 0,06 | 51,55 | 1.254.571 | 2.032.575.609 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.730 | 4.715.898 | 0,06 | 51,55 | 140.720 | 243.084.264 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 58.541 | 39.408.157 | 0,15 | 51,41 | 3.009.341 | 2.025.803.896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.565 | 4.713.168 | 0,14 | 51,41 | 337.478 | 242.283.700 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39.349.616 | 0,00 | 50,64 | 45.523 | 1.992.546.505 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4.706.603 | 0,00 | 50,64 | 5.114 | 238.328.256 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.804 | 39.348.717 | 0,06 | 50,42 | 1.099.388 | 1.984.017.399 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.445 | 4.706.502 | 0,05 | 50,42 | 123.280 | 237.308.420 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.290 | 39.326.913 | 0,05 | 50,41 | 1.073.191 | 1.982.398.896 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.388 | 4.704.057 | 0,05 | 50,41 | 120.375 | 237.123.046 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90 | 39.305.623 | 0,00 | 50,00 | 4.500 | 1.965.281.150 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10 | 4.701.669 | 0,00 | 50,00 | 500 | 235.083.450 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 899 | 39.305.533 | 0,00 | 49,84 | 44.802 | 1.958.791.237 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101 | 4.701.659 | 0,00 | 49,84 | 5.033 | 234.307.176 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.380 | 39.304.634 | 0,02 | 50,99 | 427.266 | 2.004.001.791 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4.701.558 | 0,02 | 50,99 | 47.927 | 239.715.517 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.338 | 39.296.254 | 0,01 | 50,48 | 118.029 | 1.983.788.861 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 262 | 4.700.618 | 0,01 | 50,48 | 13.227 | 237.300.828 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.241 | 39.293.916 | 0,08 | 51,25 | 1.703.751 | 2.013.990.018 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.728 | 4.700.356 | 0,08 | 51,25 | 191.077 | 240.914.397 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.440 | 39.260.675 | 0,06 | 50,33 | 1.179.656 | 1.975.856.286 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.637 | 4.696.628 | 0,06 | 50,33 | 132.711 | 236.365.319 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170.652 | 39.237.235 | 0,44 | 50,38 | 8.597.226 | 1.976.720.891 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.201 | 4.693.991 | 0,41 | 50,38 | 967.321 | 236.477.164 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.944 | 39.066.583 | 0,02 | 51,05 | 405.541 | 1.994.349.062 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 894 | 4.674.790 | 0,02 | 51,05 | 45.639 | 238.648.030 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 28.271 | 39.058.639 | 0,07 | 50,55 | 1.428.963 | 1.974.226.720 | |
| 2016-09-13 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.181 | 4.673.896 | 0,07 | 50,55 | 160.784 | 236.243.008 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.893 | 39.030.368 | 0,09 | 50,48 | 1.710.844 | 1.970.167.110 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.813 | 4.670.715 | 0,08 | 50,48 | 192.472 | 235.767.418 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48.036 | 38.996.475 | 0,12 | 50,10 | 2.406.829 | 1.953.906.681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.405 | 4.666.902 | 0,12 | 50,10 | 270.816 | 233.833.725 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 101.290 | 38.948.439 | 0,26 | 50,05 | 5.069.433 | 1.949.318.739 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.397 | 4.661.497 | 0,25 | 50,05 | 570.405 | 233.301.865 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.581 | 38.847.149 | 0,01 | 49,46 | 276.030 | 1.921.337.258 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 628 | 4.650.100 | 0,01 | 49,46 | 31.060 | 229.988.831 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 944 | 38.841.568 | 0,00 | 49,18 | 46.427 | 1.910.267.156 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106 | 4.649.472 | 0,00 | 49,18 | 5.213 | 228.665.682 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.825 | 38.840.624 | 0,04 | 48,61 | 672.033 | 1.888.042.733 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.556 | 4.649.366 | 0,03 | 48,61 | 75.637 | 226.005.681 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 12.955 | 38.826.799 | 0,03 | 48,95 | 634.191 | 1.900.703.822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.457 | 4.647.810 | 0,03 | 48,95 | 71.325 | 227.526.102 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 548 | 38.813.844 | 0,00 | 47,27 | 25.904 | 1.834.718.762 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62 | 4.646.353 | 0,00 | 47,27 | 2.931 | 219.631.712 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.681 | 38.813.296 | 0,03 | 48,16 | 562.550 | 1.869.225.047 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.314 | 4.646.291 | 0,03 | 48,16 | 63.281 | 223.762.587 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.598 | 38.801.615 | 0,02 | 48,44 | 416.460 | 1.879.426.065 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 967 | 4.644.977 | 0,02 | 48,44 | 46.838 | 224.987.822 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.930 | 38.793.017 | 0,02 | 48,29 | 286.332 | 1.873.132.464 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 667 | 4.644.010 | 0,01 | 48,29 | 32.206 | 224.237.416 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 84.331 | 4.643.343 | 1,85 | 46,17 | 3.893.638 | 214.387.325 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.600 | 4.559.012 | 0,08 | 45,10 | 162.369 | 205.623.295 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 35.263 | 4.555.412 | 0,78 | 45,39 | 1.600.457 | 206.753.296 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.360 | 4.520.149 | 0,19 | 46,10 | 385.414 | 208.388.813 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.735 | 4.511.789 | 0,06 | 44,98 | 123.025 | 202.948.842 | |
| 2016-09-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.074 | 4.509.054 | 0,20 | 45,80 | 415.623 | 206.531.357 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -850 | 9.418.390 | -0,01 | 4,29 | -3.645 | 40.392.649 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -140 | 1.551.387 | -0,01 | 4,29 | -600 | 6.653.433 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -343.583 | 9.419.240 | -3,52 | 4,83 | -1.658.681 | 45.472.323 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -56.417 | 1.551.527 | -3,51 | 4,83 | -272.359 | 7.490.152 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -296.856 | 9.762.823 | -2,95 | 5,25 | -1.559.711 | 51.294.848 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -48.744 | 1.607.944 | -2,94 | 5,25 | -256.106 | 8.448.299 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -2.834.561 | 10.059.679 | -21,98 | 5,00 | -14.172.805 | 50.298.395 | |
| 2016-08-16 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
S - Sale | -465.439 | 1.656.688 | -21,93 | 5,00 | -2.327.195 | 8.283.440 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 89.896 | 11.348.958 | 0,80 | 27,02 | 2.428.621 | 306.602.314 | |
| 2016-08-15 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10.104 | 1.758.289 | 0,58 | 27,02 | 272.969 | 47.501.760 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.169.877 | 22.337.275 | 5,53 | 33,00 | 38.605.941 | 737.130.075 | |
| 2016-08-12 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 133.153 | 3.029.953 | 4,60 | 33,00 | 4.394.049 | 99.988.449 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.038 | 102.711 | 14,54 | 1,63 | 21.252 | 167.419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.038 | 102.711 | 14,54 | 1,63 | 21.252 | 167.419 | |
| 2016-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 13.038 | 102.711 | 14,54 | 1,63 | 21.252 | 167.419 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13.937.394 | 0,01 | 26,74 | 19.948 | 372.685.916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 13.937.394 | 0,01 | 26,74 | 19.948 | 372.685.916 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1.362.005 | 0,05 | 26,74 | 19.948 | 36.420.014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 1.362.005 | 0,05 | 26,74 | 19.948 | 36.420.014 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318.623 | 0,23 | 26,74 | 19.948 | 8.519.979 | |
| 2016-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 746 | 318.623 | 0,23 | 26,74 | 19.948 | 8.519.979 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 23.803.844 | 0,00 | 79,98 | 18.955 | 1.903.831.443 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533.519 | 0,04 | 79,98 | 18.955 | 42.670.850 | |
| 2016-07-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 237 | 533.519 | 0,04 | 79,98 | 18.955 | 42.670.850 | |
| 2016-06-15 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70.000 | 70.000 | |||||
| 2016-06-13 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 26.500 | 26.500 | |||||
| 2016-06-13 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2.318 | 30.003 | -7,17 | 9,56 | -22.157 | 286.787 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -158.684 | 2.122.417 | -6,96 | 9,56 | -1.516.797 | 20.287.335 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -9.056 | 116.778 | -7,20 | 9,56 | -86.563 | 1.116.234 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -5.111 | 32.321 | -13,65 | 9,40 | -48.043 | 303.817 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -349.919 | 2.281.101 | -13,30 | 9,40 | -3.289.239 | 21.442.349 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -19.970 | 125.834 | -13,70 | 9,40 | -187.718 | 1.182.840 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -2.154 | 37.432 | -5,44 | 9,21 | -19.844 | 344.839 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -147.529 | 2.631.020 | -5,31 | 9,21 | -1.359.096 | 24.238.009 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -8.417 | 145.804 | -5,46 | 9,21 | -77.541 | 1.343.205 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -4.201 | 39.586 | -9,59 | 9,44 | -39.648 | 373.605 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -275.506 | 2.778.549 | -9,02 | 9,44 | -2.600.171 | 26.223.390 | |
| 2016-06-09 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
S - Sale | -16.493 | 154.221 | -9,66 | 9,44 | -155.658 | 1.455.507 | |
| 2016-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 38.787.087 | 0,01 | 38,82 | 143.634 | 1.505.714.717 | |
| 2016-05-24 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 38.787.087 | 0,01 | 38,82 | 143.634 | 1.505.714.717 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 13.932.918 | 0,06 | 10,73 | 88.522 | 149.500.210 | |
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
M - Exercise | -8.250 | 0 | -100,00 | ||||
| 2016-05-19 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
M - Exercise | 8.250 | 317.877 | 2,66 | 10,73 | 88.522 | 3.410.820 | |
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2.294 | 2.294 | |||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6.104.562 | 0,01 | ||||
| 2016-05-13 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 835 | 6.104.562 | 0,01 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -1.232.130 | 0 | -100,00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Series B Preferred Stock |
C - Conversion | -101.204 | 0 | -100,00 | ||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 179.531 | 976.214 | 22,53 | 18,00 | 3.231.558 | 17.571.852 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
P - Purchase | 20.469 | 85.906 | 31,28 | 18,00 | 368.442 | 1.546.308 | |
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 796.683 | 796.683 | |||||
| 2016-05-11 |
|
4 | NTLA |
Intellia Therapeutics, Inc.
Common Stock |
C - Conversion | 65.437 | 65.437 | |||||
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10.788 | 7.110.113 | 0,15 | 1,97 | 21.252 | 14.006.923 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10.788 | 89.673 | 13,68 | 1,97 | 21.252 | 176.656 | |
| 2016-04-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 10.788 | 89.673 | 13,68 | 1,97 | 21.252 | 176.656 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 13.883.418 | 0,01 | 25,48 | 19.976 | 353.749.491 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309.627 | 0,25 | 25,48 | 19.976 | 7.889.296 | |
| 2016-04-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 784 | 309.627 | 0,25 | 25,48 | 19.976 | 7.889.296 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533.282 | 0,05 | 72,47 | 18.987 | 38.646.947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533.282 | 0,05 | 72,47 | 18.987 | 38.646.947 | |
| 2016-04-04 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 262 | 533.282 | 0,05 | 72,47 | 18.987 | 38.646.947 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 3.268.830 | 0,00 | 6,74 | 923 | 22.031.914 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -3.479 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -310.003 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
X - Other | -137 | 0 | -100,00 | ||||
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 3.479 | 43.787 | 8,63 | 6,74 | 23.448 | 295.124 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 310.003 | 3.054.055 | 11,30 | 6,74 | 2.089.420 | 20.584.331 | |
| 2016-04-01 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
X - Other | 137 | 137 | 6,74 | 923 | 923 | ||
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 262.253 | 21.167.398 | 1,25 | 28,55 | 7.486.904 | 604.295.345 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28.647 | 2.896.800 | 1,00 | 28,55 | 817.826 | 82.699.005 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 10.818 | 20.905.145 | 0,05 | 27,82 | 300.959 | 581.585.315 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.182 | 2.868.153 | 0,04 | 27,82 | 32.883 | 79.792.590 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 318.969 | 20.894.327 | 1,55 | 27,72 | 8.840.959 | 579.134.330 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 34.844 | 2.866.971 | 1,23 | 27,72 | 965.782 | 79.464.695 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 60.587 | 20.575.358 | 0,30 | 27,56 | 1.669.705 | 567.032.176 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 6.618 | 2.832.127 | 0,23 | 27,56 | 182.384 | 78.050.022 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 28.433 | 20.514.771 | 0,14 | 26,55 | 755.024 | 544.759.487 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.106 | 2.825.509 | 0,11 | 26,55 | 82.478 | 75.029.979 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 180.122 | 20.486.338 | 0,89 | 26,49 | 4.772.224 | 542.773.234 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 19.676 | 2.822.403 | 0,70 | 26,49 | 521.304 | 74.777.874 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13.433 | 20.306.216 | 0,07 | 26,28 | 353.086 | 533.748.888 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.467 | 2.802.727 | 0,05 | 26,28 | 38.560 | 73.669.679 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 14.775 | 20.292.783 | 0,07 | 25,61 | 378.343 | 519.637.294 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.614 | 2.801.260 | 0,06 | 25,61 | 41.330 | 71.731.865 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 16.057 | 2.799.646 | 0,58 | 26,35 | 423.057 | 73.762.833 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 37.882 | 2.783.589 | 1,38 | 25,98 | 983.985 | 72.303.724 | |
| 2016-04-01 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 408.607 | 2.745.707 | 17,48 | 25,92 | 10.593.014 | 71.181.630 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 92.140 | 38.783.387 | 0,24 | 31,73 | 2.923.547 | 1.230.573.599 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.034 | 4.496.280 | 0,22 | 31,73 | 318.373 | 142.664.267 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.741 | 38.691.247 | 0,05 | 32,41 | 639.713 | 1.253.801.466 | |
| 2016-03-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.150 | 4.486.246 | 0,05 | 32,41 | 69.671 | 145.378.148 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 206.421.153 | 0,01 | 3,86 | 77.200 | 796.785.651 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 90.179 | 19.757.285 | 0,46 | 62,59 | 5.644.024 | 1.236.547.221 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 9.821 | 3.358.951 | 0,29 | 62,59 | 614.666 | 210.226.330 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 127.964 | 19.667.106 | 0,65 | 61,38 | 7.854.149 | 1.207.123.699 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13.936 | 3.349.130 | 0,42 | 61,38 | 855.361 | 205.562.231 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 24.431 | 19.539.142 | 0,13 | 61,03 | 1.490.975 | 1.192.434.758 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.660 | 3.335.194 | 0,08 | 61,03 | 162.334 | 203.540.219 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20.659 | 19.514.711 | 0,11 | 60,95 | 1.259.178 | 1.189.433.344 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.250 | 3.332.534 | 0,07 | 60,95 | 137.139 | 203.119.947 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 97.484 | 19.494.052 | 0,50 | 60,85 | 5.931.960 | 1.186.224.761 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 10.616 | 3.330.284 | 0,32 | 60,85 | 645.990 | 202.649.780 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 533.020 | 3,90 | 3,86 | 77.200 | 2.057.457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 533.020 | 3,90 | 3,86 | 77.200 | 2.057.457 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.182 | 19.376.568 | 0,01 | 65,29 | 77.176 | 1.265.142.628 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 129 | 3.299.668 | 0,00 | 65,29 | 8.423 | 215.443.243 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 179.176 | 19.375.386 | 0,93 | 65,80 | 11.789.387 | 1.274.857.773 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19.513 | 3.299.539 | 0,59 | 65,80 | 1.283.912 | 217.102.407 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 180.358 | 19.196.210 | 0,95 | 67,15 | 12.110.607 | 1.288.979.431 | |
| 2016-03-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19.642 | 3.280.026 | 0,60 | 67,15 | 1.318.913 | 220.245.874 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198.484 | 38.671.506 | 0,52 | 31,60 | 6.272.531 | 1.222.104.667 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.616 | 4.484.096 | 0,48 | 31,60 | 683.113 | 141.707.299 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.810 | 38.473.022 | 0,09 | 31,86 | 1.045.205 | 1.225.608.131 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.573 | 4.462.480 | 0,08 | 31,86 | 113.823 | 142.158.102 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.627 | 38.440.212 | 0,02 | 31,50 | 271.712 | 1.210.693.697 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 940 | 4.458.907 | 0,02 | 31,50 | 29.606 | 140.435.505 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 273.381 | 38.431.585 | 0,72 | 31,89 | 8.719.077 | 1.225.717.756 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.772 | 4.457.967 | 0,67 | 31,89 | 949.533 | 142.180.171 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 145.272 | 38.158.204 | 0,38 | 31,74 | 4.611.296 | 1.211.236.790 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15.821 | 4.428.195 | 0,36 | 31,74 | 502.198 | 140.561.980 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63.560 | 38.012.932 | 0,17 | 31,50 | 2.002.401 | 1.197.563.211 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.922 | 4.412.374 | 0,16 | 31,50 | 218.071 | 139.007.872 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 387.336 | 37.949.372 | 1,03 | 32,31 | 12.514.051 | 1.226.068.311 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42.182 | 4.405.452 | 0,97 | 32,31 | 1.362.816 | 142.331.343 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 107.260 | 37.562.036 | 0,29 | 33,77 | 3.622.063 | 1.268.432.394 | |
| 2016-03-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.681 | 4.363.270 | 0,27 | 33,77 | 394.456 | 147.343.265 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 128.975 | 6.928.119 | 1,90 | 8,16 | 1.051.920 | 56.505.739 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14.046 | 824.368 | 1,73 | 8,16 | 114.559 | 6.723.545 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 185.413 | 6.799.144 | 2,80 | 7,91 | 1.466.320 | 53.770.350 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20.192 | 810.322 | 2,56 | 7,91 | 159.686 | 6.408.351 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 11.840 | 6.613.731 | 0,18 | 7,70 | 91.160 | 50.921.099 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.289 | 790.130 | 0,16 | 7,70 | 9.924 | 6.083.448 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 68.132 | 6.601.891 | 1,04 | 8,03 | 546.807 | 52.984.797 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7.420 | 788.841 | 0,95 | 8,03 | 59.551 | 6.331.001 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 30.986 | 6.533.759 | 0,48 | 7,88 | 244.126 | 51.476.874 | |
| 2016-03-16 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.374 | 781.421 | 0,43 | 7,88 | 26.582 | 6.156.503 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.874 | 37.454.776 | 0,01 | 32,34 | 157.646 | 1.211.448.511 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 547 | 4.351.589 | 0,01 | 32,34 | 17.692 | 140.749.100 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 147.831 | 37.449.902 | 0,40 | 33,15 | 4.900.997 | 1.241.565.366 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.608 | 4.351.042 | 0,38 | 33,15 | 550.600 | 144.248.790 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.289 | 37.302.071 | 0,06 | 32,96 | 767.582 | 1.229.438.958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.616 | 4.334.434 | 0,06 | 32,96 | 86.221 | 142.858.610 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 95.682 | 37.278.782 | 0,26 | 32,41 | 3.100.652 | 1.208.048.754 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.749 | 4.331.818 | 0,25 | 32,41 | 348.330 | 140.376.028 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 165.237 | 37.183.100 | 0,45 | 32,30 | 5.337.915 | 1.201.185.172 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.563 | 4.321.069 | 0,43 | 32,30 | 599.670 | 139.590.406 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 36.589 | 37.017.863 | 0,10 | 31,15 | 1.139.842 | 1.153.202.679 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.111 | 4.302.506 | 0,10 | 31,15 | 128.068 | 134.034.248 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97.272 | 36.981.274 | 0,26 | 32,12 | 3.124.484 | 1.187.879.200 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.927 | 4.298.395 | 0,25 | 32,12 | 350.987 | 138.069.176 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 53.734 | 36.884.002 | 0,15 | 32,47 | 1.744.598 | 1.197.523.958 | |
| 2016-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.037 | 4.287.468 | 0,14 | 32,47 | 196.005 | 139.202.510 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 286.671.473 | 0,00 | 4,18 | 41.800 | 1.198.286.757 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88.732 | 36.830.268 | 0,24 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.968 | 4.281.431 | 0,23 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 48.996 | 36.741.536 | 0,13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.504 | 4.271.463 | 0,13 | ||||
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 36.692.540 | 0,03 | 4,18 | 41.800 | 153.374.817 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.157 | 36.682.540 | 0,04 | 33,72 | 477.445 | 1.237.118.662 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.590 | 4.255.959 | 0,04 | 33,72 | 53.623 | 143.532.217 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.921 | 36.668.383 | 0,11 | 33,68 | 1.378.043 | 1.234.833.465 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.597 | 4.254.369 | 0,11 | 33,68 | 154.807 | 143.268.854 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218.550 | 36.627.462 | 0,60 | 32,49 | 7.101.280 | 1.190.125.135 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.908 | 4.249.772 | 0,57 | 32,49 | 776.835 | 138.086.567 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 41.104 | 36.408.912 | 0,11 | 31,68 | 1.302.257 | 1.153.507.150 | |
| 2016-03-08 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.496 | 4.225.864 | 0,11 | 31,68 | 142.442 | 133.883.823 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59.492 | 36.367.808 | 0,16 | 32,24 | 1.918.022 | 1.172.498.130 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.508 | 4.221.368 | 0,15 | 32,24 | 209.818 | 136.096.904 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 301.066 | 36.308.316 | 0,84 | 32,76 | 9.862.139 | 1.189.366.031 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 32.934 | 4.214.860 | 0,79 | 32,76 | 1.078.832 | 138.067.855 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.814 | 36.007.250 | 0,06 | 31,24 | 681.563 | 1.125.021.321 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.386 | 4.181.926 | 0,06 | 31,24 | 74.549 | 130.661.351 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 172.462 | 35.985.436 | 0,48 | 30,34 | 5.232.928 | 1.091.888.092 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.866 | 4.179.540 | 0,45 | 30,34 | 572.442 | 126.817.692 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 54.439 | 35.812.974 | 0,15 | 30,55 | 1.663.024 | 1.094.029.055 | |
| 2016-03-02 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.955 | 4.160.674 | 0,14 | 30,55 | 181.916 | 127.101.934 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.022 | 19.015.852 | 0,03 | 74,00 | 445.628 | 1.407.173.048 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 678 | 3.260.384 | 0,02 | 74,00 | 50.172 | 241.268.416 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 20.492 | 19.009.830 | 0,11 | 69,70 | 1.428.282 | 1.324.975.646 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.308 | 3.259.706 | 0,07 | 69,70 | 160.866 | 227.199.878 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 23.157 | 18.989.338 | 0,12 | 70,50 | 1.632.684 | 1.338.843.276 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.608 | 3.257.398 | 0,08 | 70,50 | 183.877 | 229.662.846 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8.111 | 18.966.181 | 0,04 | 71,96 | 583.702 | 1.364.886.043 | |
| 2016-02-26 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 914 | 3.254.790 | 0,03 | 71,96 | 65.775 | 234.228.359 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39.815 | 35.758.535 | 0,11 | 30,13 | 1.199.793 | 1.077.554.845 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.485 | 4.154.719 | 0,11 | 30,13 | 135.152 | 125.199.133 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 128.255 | 35.718.720 | 0,36 | 29,86 | 3.830.118 | 1.066.678.851 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.447 | 4.150.234 | 0,35 | 29,86 | 431.435 | 123.939.683 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 67.407 | 35.590.465 | 0,19 | 28,52 | 1.922.670 | 1.015.157.510 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.593 | 4.135.787 | 0,18 | 28,52 | 216.577 | 117.966.293 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.134 | 35.523.058 | 0,01 | 28,46 | 117.674 | 1.011.163.846 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 466 | 4.128.194 | 0,01 | 28,46 | 13.265 | 117.509.042 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.056 | 35.518.924 | 0,12 | 29,77 | 1.281.975 | 1.057.561.755 | |
| 2016-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.850 | 4.127.728 | 0,12 | 29,77 | 144.407 | 122.901.450 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 218.768 | 35.475.868 | 0,62 | 30,21 | 6.610.053 | 1.071.899.804 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.643 | 4.122.878 | 0,60 | 30,21 | 744.586 | 124.572.346 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 456.849 | 35.257.100 | 1,31 | 29,20 | 13.339.991 | 1.029.507.320 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.677 | 4.098.235 | 1,23 | 29,20 | 1.450.568 | 119.668.462 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 226.865 | 34.800.251 | 0,66 | 29,94 | 6.791.816 | 1.041.839.474 | |
| 2016-02-22 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.669 | 4.048.558 | 0,61 | 29,94 | 738.533 | 121.204.515 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 726.291 | 34.573.386 | 2,15 | 31,25 | 22.694.197 | 1.080.304.220 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78.976 | 4.023.889 | 2,00 | 31,25 | 2.467.739 | 125.733.252 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 902 | 33.847.095 | 0,00 | 29,50 | 26.609 | 998.489.302 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98 | 3.944.913 | 0,00 | 29,50 | 2.891 | 116.374.934 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 106.444 | 33.846.193 | 0,32 | 29,19 | 3.107.590 | 988.126.066 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.575 | 3.944.815 | 0,29 | 29,19 | 337.927 | 115.167.296 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151.144 | 33.739.749 | 0,45 | 30,27 | 4.574.645 | 1.021.194.235 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.435 | 3.933.240 | 0,42 | 30,27 | 497.435 | 119.046.588 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 631 | 33.588.605 | 0,00 | 27,93 | 17.626 | 938.227.145 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69 | 3.916.805 | 0,00 | 27,93 | 1.927 | 109.407.722 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.073 | 33.587.974 | 0,22 | 27,28 | 1.966.043 | 916.229.549 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.909 | 3.916.736 | 0,20 | 27,28 | 215.746 | 106.842.683 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 87.049 | 33.515.901 | 0,26 | 28,07 | 2.443.831 | 940.932.108 | |
| 2016-02-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.551 | 3.908.827 | 0,24 | 28,07 | 268.137 | 109.737.191 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15.187 | 18.958.070 | 0,08 | 69,45 | 1.054.742 | 1.316.643.649 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.651 | 3.253.876 | 0,05 | 69,45 | 114.662 | 225.982.664 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 8.250 | 18.942.883 | 0,04 | 70,86 | 584.597 | 1.342.296.478 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 897 | 3.252.225 | 0,03 | 70,86 | 63.562 | 230.453.314 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 67.373 | 18.934.633 | 0,36 | 69,54 | 4.684.923 | 1.316.659.468 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.326 | 3.251.328 | 0,23 | 69,54 | 509.429 | 226.087.920 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 124.057 | 18.867.260 | 0,66 | 70,21 | 8.710.228 | 1.324.698.625 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 13.490 | 3.244.002 | 0,42 | 70,21 | 947.153 | 227.766.246 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 397.079 | 18.743.203 | 2,16 | 71,10 | 28.233.945 | 1.332.718.580 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 43.178 | 3.230.512 | 1,35 | 71,10 | 3.070.133 | 229.702.648 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 149.927 | 18.346.124 | 0,82 | 67,94 | 10.186.595 | 1.246.503.545 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 16.450 | 3.187.334 | 0,52 | 67,94 | 1.117.674 | 216.559.265 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 38.117 | 18.196.197 | 0,21 | 63,98 | 2.438.547 | 1.164.107.162 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 4.183 | 3.170.884 | 0,13 | 63,98 | 267.609 | 202.858.255 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 168.055 | 18.158.080 | 0,93 | 64,87 | 10.902.350 | 1.177.981.834 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 18.441 | 3.166.701 | 0,59 | 64,87 | 1.196.336 | 205.435.611 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 541.340 | 17.990.025 | 3,10 | 65,80 | 35.621.958 | 1.183.803.012 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 59.401 | 3.148.260 | 1,92 | 65,80 | 3.908.782 | 207.165.897 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 49.021 | 17.448.685 | 0,28 | 66,68 | 3.268.823 | 1.163.514.958 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5.379 | 3.088.859 | 0,17 | 66,68 | 358.683 | 205.971.605 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72.894 | 17.399.664 | 0,42 | 67,68 | 4.933.706 | 1.177.666.678 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.999 | 3.083.480 | 0,26 | 67,68 | 541.399 | 208.700.102 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.939 | 17.326.770 | 0,04 | 60,85 | 422.220 | 1.054.288.905 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 761 | 3.075.481 | 0,02 | 60,85 | 46.305 | 187.135.023 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 57.865 | 17.319.831 | 0,34 | 61,73 | 3.572.047 | 1.069.165.292 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 6.349 | 3.074.720 | 0,21 | 61,73 | 391.928 | 189.804.618 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 136.793 | 17.261.966 | 0,80 | 58,13 | 7.952.133 | 1.003.482.965 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 15.010 | 3.068.371 | 0,49 | 58,13 | 872.570 | 178.372.384 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 114.908 | 17.125.173 | 0,68 | 59,01 | 6.780.526 | 1.010.527.346 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12.609 | 3.053.361 | 0,41 | 59,01 | 744.036 | 180.173.642 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 65.309 | 17.010.265 | 0,39 | 60,40 | 3.944.513 | 1.027.380.882 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 7.166 | 3.040.752 | 0,24 | 60,40 | 432.810 | 183.654.427 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 113.546 | 16.944.956 | 0,67 | 61,40 | 6.971.475 | 1.040.383.019 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 12.459 | 3.033.586 | 0,41 | 61,40 | 764.955 | 186.255.507 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 289.755 | 16.831.410 | 1,75 | 62,56 | 18.126.986 | 1.052.967.960 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 31.795 | 3.021.127 | 1,06 | 62,56 | 1.989.086 | 189.000.799 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 176.647 | 16.541.655 | 1,08 | 63,37 | 11.194.368 | 1.048.267.836 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 19.383 | 2.989.332 | 0,65 | 63,37 | 1.228.328 | 189.438.154 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 235.734 | 16.365.008 | 1,46 | 64,46 | 15.195.814 | 1.054.916.236 | |
| 2016-02-16 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 25.869 | 2.969.949 | 0,88 | 64,46 | 1.667.560 | 191.447.961 | |
| 2016-02-09 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 45.000 | 12.894.240 | 0,35 | 6,33 | 284.656 | 81.565.094 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -56.853 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -2.296.890 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary stock warrant (right to buy) |
X - Other | -238.850 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -26.292.961 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A-2 Preferred shares |
C - Conversion | -1.912.167 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -582.747 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -44.572.171 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Series A Preferred shares |
C - Conversion | -4.382.118 | 0 | -100,00 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 1.723.306 | 1.723.306 | 24,00 | 41.359.344 | 41.359.344 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
American Depositary Shares |
P - Purchase | 189.374 | 189.374 | 24,00 | 4.544.976 | 4.544.976 | ||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 56.853 | 639.600 | 9,76 | 0,68 | 38.376 | 431.730 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 2.296.890 | 73.162.022 | 3,24 | 0,68 | 1.550.401 | 49.384.365 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
X - Other | 238.850 | 6.533.135 | 3,79 | 0,68 | 161.224 | 4.409.866 | |
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 26.292.961 | 70.865.132 | 58,99 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 1.912.167 | 6.294.285 | 43,64 | ||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 582.747 | 582.747 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 44.572.171 | 44.572.171 | |||||
| 2016-02-09 |
|
4 | BGNE |
BeiGene, Ltd.
Ordinary shares |
C - Conversion | 4.382.118 | 4.382.118 | |||||
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.800 | 12.849.240 | 0,19 | 6,65 | 164.915 | 85.444.876 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91.187 | 12.824.440 | 0,72 | 6,29 | 573.311 | 80.629.819 | |
| 2016-02-04 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 91.728 | 12.733.253 | 0,73 | 6,52 | 598.360 | 83.061.556 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25.000 | 12.641.525 | 0,20 | 6,88 | 172.015 | 86.981.277 | |
| 2016-01-29 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 63.345 | 12.616.525 | 0,50 | 6,98 | 441.971 | 88.028.018 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.581 | 6.502.773 | 0,06 | 11,00 | 39.377 | 71.504.492 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 395 | 778.047 | 0,05 | 11,00 | 4.343 | 8.555.405 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 66.345 | 6.499.192 | 1,03 | 10,80 | 716.745 | 70.212.721 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 7.318 | 777.652 | 0,95 | 10,80 | 79.059 | 8.401.208 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.522 | 6.432.847 | 0,04 | 11,20 | 28.257 | 72.075.548 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 278 | 770.334 | 0,04 | 11,20 | 3.115 | 8.631.053 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4.503 | 6.430.325 | 0,07 | 10,98 | 49.423 | 70.576.032 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 497 | 770.056 | 0,06 | 10,98 | 5.455 | 8.451.750 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.833 | 6.425.822 | 0,04 | 11,23 | 31.822 | 72.178.688 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 312 | 769.559 | 0,04 | 11,23 | 3.505 | 8.644.148 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 25.650 | 6.422.989 | 0,40 | 10,69 | 274.219 | 68.666.891 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.810 | 769.247 | 0,37 | 10,69 | 30.041 | 8.223.866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 156 | 6.397.339 | 0,00 | 10,60 | 1.654 | 67.811.793 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17 | 766.437 | 0,00 | 10,60 | 180 | 8.124.232 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4.021 | 6.397.183 | 0,06 | 10,69 | 42.999 | 68.409.556 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 440 | 766.420 | 0,06 | 10,69 | 4.705 | 8.195.866 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 17.221 | 6.393.162 | 0,27 | 10,78 | 185.666 | 68.927.237 | |
| 2016-01-26 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.887 | 765.980 | 0,25 | 10,78 | 20.345 | 8.258.337 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 3.200 | 12.553.180 | 0,03 | 7,00 | 22.389 | 87.829.579 | |
| 2016-01-25 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 103.600 | 12.549.980 | 0,83 | 7,29 | 755.368 | 91.504.414 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.734 | 6.375.941 | 0,03 | 8,90 | 15.433 | 56.745.875 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 190 | 764.093 | 0,02 | 8,90 | 1.691 | 6.800.428 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 27.996 | 6.374.207 | 0,44 | 8,96 | 250.766 | 57.095.047 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.067 | 763.903 | 0,40 | 8,96 | 27.472 | 6.842.432 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 13.789 | 6.346.211 | 0,22 | 8,96 | 123.493 | 56.836.031 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.511 | 760.836 | 0,20 | 8,96 | 13.532 | 6.813.971 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 57.453 | 6.332.422 | 0,92 | 9,89 | 567.934 | 62.597.258 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 6.294 | 759.325 | 0,84 | 9,89 | 62.217 | 7.506.079 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 14.313 | 6.274.969 | 0,23 | 9,15 | 131.017 | 57.439.184 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.568 | 753.031 | 0,21 | 9,15 | 14.353 | 6.893.020 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 10.123 | 6.260.656 | 0,16 | 9,21 | 93.282 | 57.691.319 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.109 | 751.463 | 0,15 | 9,21 | 10.219 | 6.924.656 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 45.903 | 6.250.533 | 0,74 | 9,08 | 416.602 | 56.727.962 | |
| 2016-01-20 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.029 | 750.354 | 0,67 | 9,08 | 45.642 | 6.809.988 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 1.325 | 12.446.380 | 0,01 | 6,94 | 9.197 | 86.396.547 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Comon Stock |
P - Purchase | 51.370 | 12.445.055 | 0,41 | 6,87 | 352.974 | 85.512.462 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 92.200 | 12.393.685 | 0,75 | 7,12 | 656.750 | 88.281.458 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25.000 | 12.301.485 | 0,20 | 7,49 | 187.332 | 92.178.718 | |
| 2016-01-20 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 175.000 | 12.276.485 | 1,45 | 7,45 | 1.303.890 | 91.469.634 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47.193 | 6.204.630 | 0,77 | 8,56 | 403.930 | 53.106.049 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.196 | 745.325 | 0,70 | 8,56 | 44.473 | 6.379.311 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4.949 | 6.157.437 | 0,08 | 8,95 | 44.308 | 55.126.918 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740.129 | 0,07 | 8,95 | 4.879 | 6.626.301 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.279 | 6.152.488 | 0,05 | 8,82 | 28.937 | 54.295.091 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739.584 | 0,05 | 8,82 | 3.186 | 6.526.755 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20.851 | 6.149.209 | 0,34 | 8,10 | 168.891 | 49.807.978 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.296 | 739.223 | 0,31 | 8,10 | 18.597 | 5.987.632 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.998 | 6.128.358 | 0,05 | 8,08 | 24.213 | 49.495.071 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736.927 | 0,04 | 8,08 | 2.665 | 5.951.717 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12.706 | 6.125.360 | 0,21 | 7,91 | 100.517 | 48.457.723 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.399 | 736.597 | 0,19 | 7,91 | 11.067 | 5.827.219 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90.550 | 6.112.654 | 1,50 | 8,17 | 739.947 | 49.950.775 | |
| 2016-01-15 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9.970 | 735.198 | 1,37 | 8,17 | 81.472 | 6.007.817 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 47.193 | 6.204.630 | 0,77 | 8,56 | 403.930 | 53.106.049 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 5.196 | 745.325 | 0,70 | 8,56 | 44.473 | 6.379.311 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 4.949 | 6.157.437 | 0,08 | 8,95 | 44.308 | 55.126.918 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 545 | 740.129 | 0,07 | 8,95 | 4.879 | 6.626.301 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 3.279 | 6.152.488 | 0,05 | 8,82 | 28.937 | 54.295.091 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 361 | 739.584 | 0,05 | 8,82 | 3.186 | 6.526.755 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 20.851 | 6.149.209 | 0,34 | 8,10 | 168.891 | 49.807.978 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.296 | 739.223 | 0,31 | 8,10 | 18.597 | 5.987.632 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.998 | 6.128.358 | 0,05 | 8,08 | 24.213 | 49.495.071 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 330 | 736.927 | 0,04 | 8,08 | 2.665 | 5.951.717 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 12.706 | 6.125.360 | 0,21 | 7,91 | 100.517 | 48.457.723 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 1.399 | 736.597 | 0,19 | 7,91 | 11.067 | 5.827.219 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 90.550 | 6.112.654 | 1,50 | 8,17 | 739.947 | 49.950.775 | |
| 2016-01-15 |
|
4/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 9.970 | 735.198 | 1,37 | 8,17 | 81.472 | 6.007.817 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.801.161 | 20.278.008 | 9,75 | 29,00 | 52.233.669 | 588.062.232 | |
| 2016-01-08 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785.045 | 2.337.100 | 50,58 | 29,00 | 22.766.305 | 67.775.900 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.801.161 | 20.278.008 | 9,75 | 29,00 | 52.233.669 | 588.062.232 | |
| 2016-01-08 |
|
4/A | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 785.045 | 2.337.100 | 50,58 | 29,00 | 22.766.305 | 67.775.900 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7.082 | 78.885 | 9,86 | 3,00 | 21.246 | 236.655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7.082 | 78.885 | 9,86 | 3,00 | 21.246 | 236.655 | |
| 2016-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 7.082 | 6.348.612 | 0,11 | 3,00 | 21.246 | 19.045.836 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513.020 | 0,03 | 108,45 | 18.979 | 55.637.019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 513.020 | 0,03 | 108,45 | 18.979 | 55.637.019 | |
| 2016-01-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 175 | 666.111 | 0,03 | 108,45 | 18.979 | 72.239.738 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308.843 | 0,18 | 35,20 | 19.994 | 10.871.274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 308.843 | 0,18 | 35,20 | 19.994 | 10.871.274 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 482.740 | 0,12 | 35,20 | 19.994 | 16.992.448 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 11.423.179 | 0,00 | 35,20 | 19.994 | 402.095.901 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 196.132 | 0,29 | 35,20 | 19.994 | 6.903.846 | |
| 2016-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 568 | 356.791 | 0,16 | 35,20 | 19.994 | 12.559.043 | |
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5.284.918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9.241.559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4.936.111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5.284.918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9.241.559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4.936.111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5.284.918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9.241.559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4.936.111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5.284.918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9.241.559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4.936.111 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
5.284.918 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
9.241.559 | ||||||||
| 2015-12-24 | 3 | BLCM |
BELLICUM PHARMACEUTICALS, INC
Common Stock |
4.936.111 | ||||||||
| 2015-12-15 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150.000 | 33.428.852 | 0,45 | 44,00 | 6.600.000 | 1.470.869.488 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.647 | 33.278.852 | 0,10 | 43,87 | 1.388.259 | 1.459.843.401 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57.461 | 33.247.205 | 0,17 | 43,93 | 2.524.015 | 1.460.406.753 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 75.612 | 33.189.744 | 0,23 | 43,93 | 3.321.363 | 1.457.905.971 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.000 | 33.114.132 | 0,01 | 43,00 | 172.000 | 1.423.907.676 | |
| 2015-11-20 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.638 | 33.110.132 | 0,03 | 43,84 | 466.321 | 1.451.395.880 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.400 | 33.099.494 | 0,03 | 44,00 | 413.600 | 1.456.377.736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 800 | 33.090.094 | 0,00 | 43,00 | 34.400 | 1.422.874.042 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 407.800 | 33.089.294 | 1,25 | 43,71 | 17.823.388 | 1.446.207.301 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98.700 | 32.681.494 | 0,30 | 44,00 | 4.342.800 | 1.437.985.736 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 196.490 | 32.582.794 | 0,61 | 41,31 | 8.117.179 | 1.346.024.545 | |
| 2015-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 221.434 | 32.386.304 | 0,69 | 42,51 | 9.412.318 | 1.376.618.715 | |
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16.392.657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26.372.015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16.392.657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26.372.015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16.392.657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26.372.015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16.392.657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26.372.015 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
14.293.989 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
16.392.657 | ||||||||
| 2015-11-06 | 3 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
26.372.015 | ||||||||
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.945 | 71.803 | 10,71 | 3,06 | 21.252 | 219.717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.945 | 71.803 | 10,71 | 3,06 | 21.252 | 219.717 | |
| 2015-10-05 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.945 | 71.803 | 10,71 | 3,06 | 21.252 | 219.717 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 512.845 | 0,03 | 110,33 | 18.977 | 56.582.189 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 972.118 | 0,02 | 110,33 | 18.977 | 107.253.779 | |
| 2015-10-05 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 172 | 16.282.190 | 0,00 | 110,33 | 18.977 | 1.796.414.023 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308.275 | 0,30 | 21,34 | 19.974 | 6.578.588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 308.275 | 0,30 | 21,34 | 19.974 | 6.578.588 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 11.422.611 | 0,01 | 21,34 | 19.974 | 243.758.519 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 1.911.734 | 0,05 | 21,34 | 19.974 | 40.796.404 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 195.564 | 0,48 | 21,34 | 19.974 | 4.173.336 | |
| 2015-10-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 936 | 356.223 | 0,26 | 21,34 | 19.974 | 7.601.799 | |
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -892.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -31.967.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -7.587.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -65.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Notes due 2015 |
M - Exercise | -64.000 | 0 | -100,00 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 101.652 | 512.673 | 24,73 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 3.642.962 | 16.128.927 | 29,18 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 864.614 | 2.943.733 | 41,59 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7.406 | 61.049 | 13,81 | ||||
| 2015-09-18 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 7.292 | 58.632 | 14,20 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | 137 | 137 | |||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock Warrants (right to buy) |
J - Other | -274 | 0 | -100,00 | ||||
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 139.220 | 2.744.052 | 5,34 | 45,00 | 6.264.900 | 123.482.340 | |
| 2015-09-16 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 10.780 | 170.714 | 6,74 | 45,00 | 485.100 | 7.682.130 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 346.000 | 32.164.870 | 1,09 | 48,44 | 16.761.728 | 1.558.204.612 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 50.000 | 31.818.870 | 0,16 | 47,40 | 2.370.000 | 1.508.214.438 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 160.453 | 31.768.870 | 0,51 | 48,60 | 7.798.690 | 1.544.100.511 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.320 | 31.608.417 | 0,11 | 47,98 | 1.598.614 | 1.516.495.987 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.386 | 31.575.097 | 0,05 | 47,54 | 683.847 | 1.500.941.181 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.600 | 31.560.711 | 0,01 | 47,24 | 75.577 | 1.490.798.589 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20.500 | 31.559.111 | 0,06 | 46,31 | 949.351 | 1.461.496.119 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.950 | 31.538.611 | 0,01 | 44,68 | 87.130 | 1.409.201.909 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89.843 | 31.536.661 | 0,29 | 45,28 | 4.067.696 | 1.427.841.249 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 212.983 | 31.446.818 | 0,68 | 46,81 | 9.969.500 | 1.471.990.959 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.818 | 31.233.835 | 0,03 | 46,74 | 458.905 | 1.459.906.929 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.331 | 31.224.017 | 0,01 | 45,63 | 106.368 | 1.424.814.344 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.513 | 31.221.686 | 0,01 | 45,43 | 159.601 | 1.418.448.028 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.897 | 31.218.173 | 0,04 | 45,00 | 625.359 | 1.404.805.298 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.649 | 31.204.276 | 0,13 | 42,14 | 1.713.148 | 1.315.101.092 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.063 | 31.163.627 | 0,03 | 44,40 | 357.971 | 1.383.565.315 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 15.391 | 31.155.564 | 0,05 | 40,67 | 625.950 | 1.267.093.672 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 191.321 | 31.140.173 | 0,62 | 41,06 | 7.856.214 | 1.278.708.924 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 88.640 | 30.948.852 | 0,29 | 42,44 | 3.761.802 | 1.313.441.425 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 183.073 | 30.860.212 | 0,60 | 43,28 | 7.923.253 | 1.335.605.287 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 274.814 | 30.677.139 | 0,90 | 44,63 | 12.265.553 | 1.369.188.203 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.100 | 30.402.325 | 0,01 | 40,55 | 125.706 | 1.232.823.399 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.300 | 30.399.225 | 0,04 | 41,13 | 464.823 | 1.250.466.041 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.612 | 30.387.925 | 0,14 | 43,60 | 1.901.322 | 1.324.801.095 | |
| 2015-09-15 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.338.927 | 30.344.313 | 12,36 | 41,00 | 136.896.007 | 1.244.116.833 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 2.213.469 | 6.022.104 | 58,12 | 15,50 | 34.308.770 | 93.342.612 | |
| 2015-09-11 |
|
4 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
P - Purchase | 266.563 | 725.228 | 58,12 | 15,50 | 4.131.726 | 11.241.034 | |
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7.220.154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12.371.376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6.628.338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7.220.154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12.371.376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6.628.338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7.220.154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12.371.376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6.628.338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7.220.154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12.371.376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6.628.338 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
7.220.154 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
12.371.376 | ||||||||
| 2015-08-27 | 3 | NVTA |
Invitae Corp
Common Stock |
6.628.338 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
4.725.965 | ||||||||
| 2015-08-10 | 3 | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
8.075.935 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2.260 | ||||||||
| 2015-08-10 | 3/A | AQXP |
AQUINOX PHARMACEUTICALS, INC
Common Stock |
2.260 | ||||||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 2.329 | 2.329 | |||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6.103.727 | 0,01 | ||||
| 2015-07-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 696 | 6.103.727 | 0,01 | ||||
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -229.436 | 90.538 | -71,70 | 1,09 | -250.659 | 98.913 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9.411.311 | 3.153.539 | -74,90 | 1,09 | -10.281.857 | 3.445.241 | |
| 2015-07-23 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1.359.253 | 467.436 | -74,41 | 1,09 | -1.484.984 | 510.674 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 307.339 | 0,24 | 27,34 | 19.958 | 8.402.648 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 1.350.721 | 0,05 | 27,34 | 19.958 | 36.928.712 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 481.236 | 0,15 | 27,34 | 19.958 | 13.156.992 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 11.421.675 | 0,01 | 27,34 | 19.958 | 312.268.594 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 194.628 | 0,38 | 27,34 | 19.958 | 5.321.130 | |
| 2015-07-06 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 730 | 355.287 | 0,21 | 27,34 | 19.958 | 9.713.547 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 826.200 | 0,02 | 104,21 | 18.966 | 86.098.302 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 411.021 | 0,04 | 104,21 | 18.966 | 42.832.498 | |
| 2015-07-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
A - Award | 182 | 549.414 | 0,03 | 104,21 | 18.966 | 57.254.433 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.260 | 64.858 | 8,83 | 3,66 | 19.252 | 237.380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.260 | 64.858 | 8,83 | 3,66 | 19.252 | 237.380 | |
| 2015-07-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.260 | 64.858 | 8,83 | 3,66 | 19.252 | 237.380 | |
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 6.103.033 | 6.103.033 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 506.166 | 506.166 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 94.412 | 94.412 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 66.154 | 66.154 | |||||
| 2015-06-24 |
|
4 | ALXN |
ALEXION PHARMACEUTICALS INC
Common Stock |
A - Award | 65.811 | 65.811 | |||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3.000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -3.000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15.000 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -2.750 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -9.184.771 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -12.250 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -680.187 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -143.462 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Comon Stock |
D - Sale to Issuer | -200.526 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -7.500 | 0 | -100,00 | ||||
| 2015-06-23 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
D - Sale to Issuer | -15.000 | 0 | -100,00 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 21.196 | 100.523 | 26,72 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -211.614 | 12.250 | -94,53 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 497 | 79.327 | 0,63 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -100.490 | 12.250 | -89,13 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 40.449 | 78.830 | 105,39 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -1.068.128 | 680.187 | -61,09 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 5.543 | 38.381 | 16,88 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -55.479 | 12.250 | -81,91 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 12.500 | 32.838 | 61,46 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -165.213 | 12.250 | -93,10 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | 19.318 | 20.338 | 1.893,92 | ||||
| 2015-06-22 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
J - Other | -206.800 | 12.250 | -94,41 | ||||
| 2015-06-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2015-06-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2015-06-10 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70.000 | 70.000 | |||||
| 2015-05-27 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 198.802 | 27.005.386 | 0,74 | 43,27 | 8.602.242 | 1.168.533.854 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 57.202 | 26.816.266 | 0,21 | 43,29 | 2.476.343 | 1.160.908.335 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 16.300 | 26.759.064 | 0,06 | 43,67 | 711.775 | 1.168.493.400 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90.155 | 26.742.764 | 0,34 | 43,62 | 3.932.723 | 1.166.567.503 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 150.000 | 26.652.609 | 0,57 | 42,93 | 6.439.500 | 1.144.196.504 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 9.200 | 26.492.927 | 0,03 | 40,95 | 376.718 | 1.084.821.778 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 52.381 | 26.483.727 | 0,20 | 41,54 | 2.176.038 | 1.100.200.229 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 139.683 | 26.431.346 | 0,53 | 42,68 | 5.961.908 | 1.128.134.781 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 13.352 | 26.291.663 | 0,05 | 42,97 | 573.749 | 1.129.779.051 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 2.300 | 26.278.311 | 0,01 | 42,15 | 96.949 | 1.107.675.482 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7.382 | 26.276.011 | 0,03 | 41,24 | 304.410 | 1.083.538.610 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.500 | 26.268.629 | 0,02 | 41,07 | 184.815 | 1.078.852.593 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 89.100 | 26.264.129 | 0,34 | 40,57 | 3.614.475 | 1.065.443.789 | |
| 2015-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 120.529 | 26.175.029 | 0,46 | 41,09 | 4.951.958 | 1.075.406.301 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 9.260 | 9.260 | |||||
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 26.054.500 | 0,01 | 39,94 | 147.778 | 1.040.616.730 | |
| 2015-05-18 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.700 | 26.054.500 | 0,01 | 39,94 | 147.778 | 1.040.616.730 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -20.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 410.839 | 5,12 | 7,68 | 153.600 | 3.155.244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 410.839 | 5,12 | 7,68 | 153.600 | 3.155.244 | |
| 2015-05-12 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 20.000 | 410.839 | 5,12 | 7,68 | 153.600 | 3.155.244 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 26.050.800 | 0,04 | 5,11 | 51.100 | 133.119.588 | |
| 2015-05-12 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 26.050.800 | 0,04 | 5,11 | 51.100 | 133.119.588 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.100 | 26.040.800 | 0,00 | 37,07 | 40.777 | 965.332.456 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46.617 | 26.039.700 | 0,18 | 37,15 | 1.732.013 | 967.481.618 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 8.334 | 25.993.083 | 0,03 | 35,85 | 298.745 | 931.761.050 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 129.118 | 25.984.749 | 0,50 | 36,40 | 4.700.515 | 945.969.590 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 137.800 | 25.855.631 | 0,54 | 36,25 | 4.995.250 | 937.266.624 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 155.731 | 25.717.831 | 0,61 | 36,67 | 5.710.048 | 942.972.563 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 23.012 | 25.562.100 | 0,09 | 35,91 | 826.437 | 918.019.366 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stoc |
P - Purchase | 354.300 | 25.539.088 | 1,41 | 34,76 | 12.315.078 | 887.710.606 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59.973 | 25.184.788 | 0,24 | 34,61 | 2.075.833 | 871.716.030 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.330 | 25.124.815 | 0,02 | 33,99 | 147.177 | 853.992.462 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 90.397 | 25.120.485 | 0,36 | 34,56 | 3.123.949 | 868.116.233 | |
| 2015-05-07 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.952 | 25.030.088 | 0,09 | 34,52 | 757.888 | 864.158.782 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.470 | 59.598 | 10,11 | 3,52 | 19.254 | 209.785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.470 | 59.598 | 10,11 | 3,52 | 19.254 | 209.785 | |
| 2015-04-02 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 5.470 | 59.598 | 10,11 | 3,52 | 19.254 | 209.785 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306.609 | 0,21 | 30,43 | 19.962 | 9.330.112 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 1.349.991 | 0,05 | 30,43 | 19.962 | 41.080.226 | |
| 2015-04-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 656 | 306.609 | 0,21 | 30,43 | 19.962 | 9.330.112 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.880 | 25.008.136 | 0,01 | 34,72 | 99.986 | 868.217.461 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.439 | 25.005.256 | 0,03 | 34,47 | 221.935 | 861.863.660 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 158.771 | 24.998.817 | 0,64 | 34,69 | 5.507.401 | 867.151.464 | |
| 2015-03-11 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 116.946 | 24.840.046 | 0,47 | 34,62 | 4.049.208 | 860.076.657 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.600 | 24.723.100 | 0,08 | 34,82 | 682.537 | 860.939.928 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.021 | 24.703.500 | 0,02 | 34,79 | 139.882 | 859.380.417 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 213.820 | 24.699.479 | 0,87 | 34,76 | 7.432.169 | 858.529.191 | |
| 2015-03-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 211.400 | 24.485.659 | 0,87 | 34,92 | 7.382.532 | 855.090.632 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.000 | 24.274.259 | 0,00 | 35,60 | 35.595 | 864.042.249 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 62.650 | 24.273.259 | 0,26 | 34,46 | 2.159.163 | 836.551.171 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 163.054 | 24.210.609 | 0,68 | 33,80 | 5.510.818 | 818.258.058 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.995 | 24.047.555 | 0,02 | 33,60 | 167.830 | 807.985.824 | |
| 2015-02-26 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.416 | 24.042.560 | 0,21 | 33,65 | 1.662.843 | 809.029.740 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 4.898.409 | 6.323.855 | 343,64 | 3,75 | 18.369.034 | 23.714.456 | |
| 2015-02-17 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
P - Purchase | 434.924 | 625.495 | 228,22 | 3,75 | 1.630.965 | 2.345.606 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 390.935 | 2.604.832 | 17,66 | 20,00 | 7.818.700 | 52.096.640 | |
| 2015-02-02 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 34.065 | 159.934 | 27,06 | 20,00 | 681.300 | 3.198.680 | |
| 2015-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1.000.000 | 9.184.771 | 12,22 | 94,19 | 94.190.000 | 865.113.580 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21.441 | 345.074 | -5,85 | 3,86 | -82.762 | 1.331.986 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -859.988 | 12.589.950 | -6,39 | 3,86 | -3.319.554 | 48.597.207 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118.571 | 1.851.789 | -6,02 | 3,86 | -457.684 | 7.147.906 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -21.548 | 366.515 | -5,55 | 3,81 | -82.130 | 1.396.972 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -863.100 | 13.449.938 | -6,03 | 3,81 | -3.289.706 | 51.264.439 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -118.652 | 1.970.360 | -5,68 | 3,81 | -452.242 | 7.510.027 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4.554 | 388.063 | -1,16 | 3,55 | -16.184 | 1.379.059 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -182.454 | 14.313.038 | -1,26 | 3,55 | -648.387 | 50.864.243 | |
| 2015-01-06 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -25.092 | 2.089.012 | -1,19 | 3,55 | -89.169 | 7.423.722 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.927 | 54.128 | 7,82 | 4,90 | 19.242 | 265.227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.927 | 54.128 | 7,82 | 4,90 | 19.242 | 265.227 | |
| 2015-01-06 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 3.927 | 1.425.446 | 0,28 | 4,90 | 19.242 | 6.984.685 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 305.953 | 0,20 | 31,97 | 19.949 | 9.781.317 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1.349.335 | 0,05 | 31,97 | 19.949 | 43.138.240 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 11.420.289 | 0,01 | 31,97 | 19.949 | 365.106.639 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 1.909.412 | 0,03 | 31,97 | 19.949 | 61.043.902 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 193.242 | 0,32 | 31,97 | 19.949 | 6.177.947 | |
| 2015-01-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 624 | 353.901 | 0,18 | 31,97 | 19.949 | 11.314.215 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8.415 | 392.617 | -2,10 | 3,65 | -30.711 | 1.432.856 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337.123 | 14.495.492 | -2,27 | 3,65 | -1.230.330 | 52.901.298 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46.362 | 2.114.104 | -2,15 | 3,65 | -169.198 | 7.715.423 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -4.746 | 401.032 | -1,17 | 3,68 | -17.447 | 1.474.274 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -190.117 | 14.832.615 | -1,27 | 3,68 | -698.908 | 54.527.659 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -26.137 | 2.160.466 | -1,20 | 3,68 | -96.085 | 7.942.305 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -2.825 | 405.778 | -0,69 | 3,71 | -10.482 | 1.505.680 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -112.855 | 15.022.732 | -0,75 | 3,71 | -418.760 | 55.743.349 | |
| 2014-12-30 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -15.420 | 2.186.603 | -0,70 | 3,71 | -57.217 | 8.113.609 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -16.182 | 408.603 | -3,81 | 4,21 | -68.102 | 1.719.606 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -647.781 | 15.135.587 | -4,10 | 4,21 | -2.726.186 | 63.698.118 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -88.937 | 2.202.023 | -3,88 | 4,21 | -374.291 | 9.267.214 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -3.558 | 424.785 | -0,83 | 4,29 | -15.260 | 1.821.903 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -142.543 | 15.783.368 | -0,90 | 4,29 | -611.367 | 67.694.865 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -19.599 | 2.290.960 | -0,85 | 4,29 | -84.060 | 9.825.927 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -14.753 | 428.343 | -3,33 | 4,31 | -63.571 | 1.845.730 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -590.638 | 15.925.911 | -3,58 | 4,31 | -2.545.059 | 68.624.750 | |
| 2014-12-19 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -81.109 | 2.310.559 | -3,39 | 4,31 | -349.499 | 9.956.199 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.900 | 23.993.144 | 0,02 | 31,97 | 124.679 | 767.036.821 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 500 | 23.989.244 | 0,00 | 30,80 | 15.400 | 738.868.715 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.685 | 23.988.744 | 0,21 | 31,82 | 1.581.096 | 763.379.407 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.855.894 | 23.939.059 | 8,40 | 31,94 | 59.276.698 | 764.606.363 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 597.000 | 22.083.165 | 2,78 | 31,75 | 18.954.631 | 701.136.072 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 305.532 | 21.486.165 | 1,44 | 31,68 | 9.680.415 | 680.763.355 | |
| 2014-12-17 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 70.867 | 21.180.633 | 0,34 | 31,41 | 2.226.244 | 665.376.877 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -6.874 | 443.096 | -1,53 | 4,27 | -29.358 | 1.892.419 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -274.734 | 16.516.549 | -1,64 | 4,27 | -1.173.361 | 70.540.529 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -37.592 | 2.391.668 | -1,55 | 4,27 | -160.552 | 10.214.575 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -9.908 | 449.970 | -2,15 | 4,45 | -44.093 | 2.002.456 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -396.496 | 16.791.283 | -2,31 | 4,45 | -1.764.486 | 74.724.568 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -54.396 | 2.429.260 | -2,19 | 4,45 | -242.073 | 10.810.693 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -5.457 | 459.878 | -1,17 | 4,71 | -25.724 | 2.167.865 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -218.383 | 17.187.779 | -1,25 | 4,71 | -1.029.457 | 81.023.190 | |
| 2014-12-16 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -29.960 | 2.483.656 | -1,19 | 4,71 | -141.231 | 11.707.954 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -8.429 | 465.335 | -1,78 | 4,62 | -38.907 | 2.147.940 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -337.541 | 17.406.162 | -1,90 | 4,62 | -1.558.056 | 80.345.103 | |
| 2014-12-10 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -46.383 | 2.513.616 | -1,81 | 4,62 | -214.099 | 11.602.600 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100.000 | 21.109.766 | 0,48 | 34,95 | 3.495.000 | 737.786.322 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 354.000 | 21.009.766 | 1,71 | 34,27 | 12.131.651 | 720.008.883 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 14.772 | 20.655.766 | 0,07 | 34,53 | 510.114 | 713.295.239 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185.378 | 20.640.994 | 0,91 | 34,33 | 6.364.935 | 708.706.465 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30.507 | 107.504 | 39,62 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 30.507 | 3.993.087 | 0,77 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -399.208 | 0 | -100,00 | ||||
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.500 | 20.455.616 | 0,03 | 33,90 | 186.438 | 693.400.380 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 80.430 | 20.450.116 | 0,39 | 34,64 | 2.786.393 | 708.467.684 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42.500 | 20.369.686 | 0,21 | 33,28 | 1.414.515 | 677.958.148 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 185.528 | 20.327.186 | 0,92 | 33,31 | 6.180.420 | 677.151.416 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 216.284 | 20.141.658 | 1,09 | 32,56 | 7.043.267 | 655.911.079 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38.614 | 19.925.374 | 0,19 | 33,00 | 1.274.254 | 657.533.357 | |
| 2014-12-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 24.890 | 19.886.760 | 0,13 | 33,06 | 822.744 | 657.360.829 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -28.086 | 473.764 | -5,60 | 4,55 | -127.671 | 2.153.589 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -1.122.584 | 17.743.703 | -5,95 | 4,55 | -5.102.930 | 80.657.551 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -153.618 | 2.559.999 | -5,66 | 4,55 | -698.301 | 11.636.987 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -11.965 | 501.850 | -2,33 | 4,84 | -57.913 | 2.429.054 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -486.800 | 18.866.287 | -2,52 | 4,84 | -2.356.209 | 91.316.602 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -69.153 | 2.713.617 | -2,49 | 4,84 | -334.714 | 13.134.449 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -10.534 | 513.815 | -2,01 | 5,36 | -56.453 | 2.753.586 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -428.583 | 19.353.087 | -2,17 | 5,36 | -2.296.819 | 103.715.129 | |
| 2014-12-04 |
|
4 | XOMA |
XOMA Corp
Common Stock |
S - Sale | -60.883 | 2.782.770 | -2,14 | 5,36 | -326.278 | 14.913.143 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 98.076 | 19.861.870 | 0,50 | 36,57 | 3.586.737 | 726.368.448 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.639 | 19.763.794 | 0,05 | 36,75 | 390.999 | 726.349.075 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 69.397 | 19.753.155 | 0,35 | 35,88 | 2.490.291 | 708.836.041 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 63.137 | 19.683.758 | 0,32 | 36,74 | 2.319.502 | 723.134.028 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.505 | 19.620.621 | 0,13 | 35,91 | 915.851 | 704.550.993 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22.839 | 19.595.116 | 0,12 | 35,55 | 811.963 | 696.637.726 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.116 | 19.572.277 | 0,07 | 35,56 | 466.413 | 696.001.913 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 17.098 | 19.559.161 | 0,09 | 34,91 | 596.816 | 682.724.250 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 104.140 | 19.542.063 | 0,54 | 35,98 | 3.746.947 | 703.121.473 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.006 | 19.437.923 | 0,15 | 35,28 | 1.023.471 | 685.863.225 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.500 | 19.408.917 | 0,07 | 34,26 | 462.530 | 664.978.610 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.769 | 19.395.417 | 0,13 | 34,58 | 890.989 | 670.615.938 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 866.669 | 19.369.648 | 4,68 | 33,79 | 29.287.172 | 654.554.641 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 4.394 | 18.502.979 | 0,02 | 33,71 | 148.139 | 623.807.584 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 38.166 | 18.498.585 | 0,21 | 34,83 | 1.329.390 | 644.339.013 | |
| 2014-11-10 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 252.474 | 18.460.419 | 1,39 | 34,41 | 8.686.949 | 635.173.175 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.914 | 50.201 | 21,59 | 2,16 | 19.254 | 108.434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.914 | 50.201 | 21,59 | 2,16 | 19.254 | 108.434 | |
| 2014-10-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 8.914 | 1.421.519 | 0,63 | 2,16 | 19.254 | 3.070.481 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305.329 | 0,23 | 28,54 | 19.978 | 8.714.090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 305.329 | 0,23 | 28,54 | 19.978 | 8.714.090 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 1.348.711 | 0,05 | 28,54 | 19.978 | 38.492.212 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 11.419.665 | 0,01 | 28,54 | 19.978 | 325.917.239 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 192.618 | 0,36 | 28,54 | 19.978 | 5.497.318 | |
| 2014-10-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 700 | 353.277 | 0,20 | 28,54 | 19.978 | 10.082.526 | |
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 7.000 | 7.000 | |||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5.500 | 524.349 | 1,06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5.500 | 524.349 | 1,06 | ||||
| 2014-09-16 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 5.500 | 524.349 | 1,06 | ||||
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.182 | 41.287 | 17,61 | 2,83 | 17.495 | 116.842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.182 | 41.287 | 17,61 | 2,83 | 17.495 | 116.842 | |
| 2014-07-03 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Common Stock |
A - Award | 6.182 | 1.412.605 | 0,44 | 2,83 | 17.495 | 3.997.672 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 304.629 | 0,24 | 27,86 | 19.948 | 8.486.964 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1.348.011 | 0,05 | 27,86 | 19.948 | 37.555.586 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 11.418.965 | 0,01 | 27,86 | 19.948 | 318.132.365 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 1.908.088 | 0,04 | 27,86 | 19.948 | 53.159.332 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 191.918 | 0,37 | 27,86 | 19.948 | 5.346.835 | |
| 2014-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 716 | 352.577 | 0,20 | 27,86 | 19.948 | 9.822.795 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -4.250 | 0 | -100,00 | ||||
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 223.864 | 1,94 | 60,45 | 256.912 | 13.532.579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 223.864 | 1,94 | 60,45 | 256.912 | 13.532.579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 223.864 | 1,94 | 60,45 | 256.912 | 13.532.579 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 257.722 | 1,68 | 60,45 | 256.912 | 15.579.295 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 1.893.297 | 0,22 | 60,45 | 256.912 | 114.449.804 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 212.711 | 2,04 | 60,45 | 256.912 | 12.858.380 | |
| 2014-06-24 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 4.250 | 322.445 | 1,34 | 60,45 | 256.912 | 19.491.800 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 670 | 416.208 | 0,16 | 39,80 | 26.668 | 16.566.494 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 27.046 | 18.207.945 | 0,15 | 39,80 | 1.076.523 | 724.738.118 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.471 | 415.538 | 0,36 | 39,93 | 58.731 | 16.590.770 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 59.400 | 18.180.899 | 0,33 | 39,93 | 2.371.604 | 725.890.573 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.938 | 414.067 | 0,47 | 39,99 | 77.503 | 16.559.036 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 78.262 | 18.121.499 | 0,43 | 39,99 | 3.129.791 | 724.700.491 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.155 | 412.129 | 0,28 | 39,84 | 46.021 | 16.421.239 | |
| 2014-06-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46.653 | 18.043.237 | 0,26 | 39,84 | 1.858.884 | 718.930.974 | |
| 2014-06-11 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 70.000 | 70.000 | |||||
| 2014-06-10 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2014-06-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.534 | 410.974 | 1,36 | 38,96 | 215.578 | 16.009.574 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 223.466 | 17.996.584 | 1,26 | 38,96 | 8.705.163 | 701.060.529 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 534 | 405.440 | 0,13 | 38,56 | 20.591 | 15.633.847 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 21.559 | 17.773.118 | 0,12 | 38,56 | 831.319 | 685.334.985 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 477 | 404.906 | 0,12 | 37,52 | 17.895 | 15.190.413 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.223 | 17.751.559 | 0,11 | 37,52 | 721.168 | 665.965.712 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.757 | 404.429 | 0,94 | 37,40 | 140.504 | 15.124.795 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 151.530 | 17.732.336 | 0,86 | 37,40 | 5.666.904 | 663.152.128 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.411 | 400.672 | 0,61 | 37,67 | 90.826 | 15.093.995 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 97.254 | 17.580.806 | 0,56 | 37,67 | 3.663.724 | 662.298.849 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 496 | 398.261 | 0,12 | 37,63 | 18.667 | 14.988.274 | |
| 2014-06-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20.011 | 17.483.552 | 0,11 | 37,63 | 753.100 | 657.981.241 | |
| 2014-06-06 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.534 | 397.765 | 0,39 | 36,04 | 55.281 | 14.334.377 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61.878 | 17.463.541 | 0,36 | 36,04 | 2.229.916 | 629.338.866 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 572 | 396.231 | 0,14 | 36,39 | 20.817 | 14.419.995 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 23.058 | 17.401.663 | 0,13 | 36,39 | 839.147 | 633.296.981 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19 | 395.659 | 0,00 | 35,27 | 670 | 13.956.001 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 781 | 17.378.605 | 0,00 | 35,27 | 27.548 | 612.992.058 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.137 | 395.640 | 0,54 | 34,38 | 73.479 | 13.603.725 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 86.201 | 17.377.824 | 0,50 | 34,38 | 2.963.944 | 597.520.838 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 270 | 393.503 | 0,07 | 35,11 | 9.481 | 13.817.386 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 10.896 | 17.291.623 | 0,06 | 35,11 | 382.600 | 607.174.592 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.809 | 393.233 | 0,46 | 34,05 | 61.604 | 13.391.196 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.980 | 17.280.727 | 0,42 | 34,05 | 2.485.268 | 588.479.605 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 480 | 391.424 | 0,12 | 34,21 | 16.421 | 13.391.046 | |
| 2014-06-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 19.348 | 17.207.747 | 0,11 | 34,21 | 661.916 | 588.695.953 | |
| 2014-05-29 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 518.849 | 1,65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 518.849 | 1,65 | ||||
| 2014-05-27 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 518.849 | 1,65 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 390.839 | 2,63 | 7,02 | 70.200 | 2.743.690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 390.839 | 2,63 | 7,02 | 70.200 | 2.743.690 | |
| 2014-05-23 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 390.839 | 2,63 | 7,02 | 70.200 | 2.743.690 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.151 | 390.944 | 0,30 | 34,08 | 39.232 | 13.325.287 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 46.460 | 17.188.399 | 0,27 | 34,08 | 1.583.584 | 585.864.861 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.921 | 389.793 | 0,76 | 34,03 | 99.415 | 13.266.449 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 117.879 | 17.141.939 | 0,69 | 34,03 | 4.011.965 | 583.419.037 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 386.872 | 0,91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 386.872 | 0,91 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 17.178.061 | 0,02 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 505 | 383.372 | 0,13 | 34,26 | 17.304 | 13.136.012 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 20.395 | 17.020.560 | 0,12 | 34,26 | 698.822 | 583.199.276 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 7 | 382.867 | 0,00 | 34,10 | 239 | 13.055.765 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 293 | 17.000.165 | 0,00 | 34,10 | 9.991 | 579.705.626 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | ||||
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 382.860 | 2,68 | 7,26 | 72.600 | 2.779.564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 382.860 | 2,68 | 7,26 | 72.600 | 2.779.564 | |
| 2014-05-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
M - Exercise | 10.000 | 382.860 | 2,68 | 7,26 | 72.600 | 2.779.564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372.860 | 0,20 | 34,60 | 25.815 | 12.902.522 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30.122 | 16.989.872 | 0,18 | 34,60 | 1.042.348 | 587.920.929 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372.114 | 0,20 | 33,73 | 24.964 | 12.553.191 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.865 | 16.959.750 | 0,18 | 33,73 | 1.007.490 | 572.133.774 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.069 | 371.374 | 0,29 | 34,31 | 36.673 | 12.740.319 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.131 | 16.929.885 | 0,26 | 34,31 | 1.479.648 | 580.794.942 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370.305 | 0,21 | 33,92 | 26.559 | 12.560.486 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.617 | 16.886.754 | 0,19 | 33,92 | 1.072.427 | 572.786.875 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369.522 | 0,09 | 34,74 | 11.430 | 12.837.564 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.271 | 16.855.137 | 0,08 | 34,74 | 461.048 | 585.564.315 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.933 | 369.193 | 0,80 | 33,77 | 99.060 | 12.469.235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118.389 | 16.841.866 | 0,71 | 33,77 | 3.998.506 | 568.822.235 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366.260 | 0,23 | 33,72 | 28.295 | 12.352.009 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.868 | 16.723.477 | 0,20 | 34,72 | 1.176.056 | 580.717.722 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.534 | 365.421 | 0,42 | 33,98 | 52.118 | 12.415.252 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61.892 | 16.689.609 | 0,37 | 33,98 | 2.102.793 | 567.032.804 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363.887 | 0,17 | 34,01 | 21.190 | 12.376.779 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.156 | 16.627.717 | 0,15 | 34,01 | 855.623 | 565.553.550 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.228 | 363.264 | 0,34 | 33,40 | 41.020 | 12.134.580 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.553 | 16.602.561 | 0,30 | 33,40 | 1.655.283 | 554.596.928 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362.036 | 0,27 | 33,54 | 33.007 | 12.143.991 | |
| 2014-05-16 |
|
4/A | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39.710 | 16.553.008 | 0,24 | 33,54 | 1.332.016 | 555.247.479 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 746 | 372.860 | 0,20 | 34,60 | 25.815 | 12.902.522 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 30.122 | 16.989.872 | 0,18 | 34,60 | 1.042.348 | 587.920.929 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 740 | 372.114 | 0,20 | 33,73 | 24.964 | 12.553.191 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 29.865 | 16.959.750 | 0,18 | 33,73 | 1.007.490 | 572.133.774 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.069 | 371.374 | 0,29 | 34,31 | 36.673 | 12.740.319 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 43.131 | 16.929.885 | 0,26 | 34,31 | 1.479.648 | 580.794.942 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 783 | 370.305 | 0,21 | 33,92 | 26.559 | 12.560.486 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 31.617 | 16.886.754 | 0,19 | 33,92 | 1.072.427 | 572.786.875 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 329 | 369.522 | 0,09 | 34,74 | 11.430 | 12.837.564 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.271 | 16.855.137 | 0,08 | 34,74 | 461.048 | 585.564.315 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.933 | 369.193 | 0,80 | 33,77 | 99.060 | 12.469.235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 118.389 | 16.841.866 | 0,71 | 33,77 | 3.998.506 | 568.822.235 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 839 | 366.260 | 0,23 | 33,72 | 28.295 | 12.352.009 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 33.868 | 16.723.477 | 0,20 | 34,72 | 1.176.056 | 580.717.722 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.534 | 365.421 | 0,42 | 33,98 | 52.118 | 12.415.252 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 61.892 | 16.689.609 | 0,37 | 33,98 | 2.102.793 | 567.032.804 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 623 | 363.887 | 0,17 | 34,01 | 21.190 | 12.376.779 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.156 | 16.627.717 | 0,15 | 34,01 | 855.623 | 565.553.550 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.228 | 363.264 | 0,34 | 33,40 | 41.020 | 12.134.580 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 49.553 | 16.602.561 | 0,30 | 33,40 | 1.655.283 | 554.596.928 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 984 | 362.036 | 0,27 | 33,54 | 33.007 | 12.143.991 | |
| 2014-05-09 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 39.710 | 16.553.008 | 0,24 | 33,54 | 1.332.016 | 555.247.479 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | 8.000 | 0 | -100,00 | 65,10 | 520.800 | ||
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 219.614 | 3,78 | 65,10 | 520.800 | 14.296.871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 219.614 | 3,78 | 65,10 | 520.800 | 14.296.871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 219.614 | 3,78 | 65,10 | 520.800 | 14.296.871 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 253.472 | 3,26 | 65,10 | 520.800 | 16.501.027 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 1.889.047 | 0,43 | 65,10 | 520.800 | 122.976.960 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 208.461 | 3,99 | 65,10 | 520.800 | 13.570.811 | |
| 2014-04-25 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
M - Exercise | 8.000 | 318.195 | 2,58 | 65,10 | 520.800 | 20.714.494 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303.913 | 0,25 | 26,57 | 19.981 | 8.074.968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 303.913 | 0,25 | 26,57 | 19.981 | 8.074.968 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1.347.295 | 0,06 | 26,57 | 19.981 | 35.797.628 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 11.418.249 | 0,01 | 26,57 | 19.981 | 303.382.876 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 1.907.372 | 0,04 | 26,57 | 19.981 | 50.678.874 | |
| 2014-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 752 | 191.202 | 0,39 | 26,57 | 19.981 | 5.080.237 | |
| 2014-03-19 |
|
4 | IDRA |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 80.000 | 80.000 | |||||
| 2014-03-12 |
|
4 | IDP |
IDERA PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) |
A - Award | 60.000 | 60.000 | |||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.784.624 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
3.019.499 | ||||||||
| 2014-03-12 | 3 | IDP |
IDERA PHARMACEUTICALS, INC.
Common Stock |
1.648.181 | ||||||||
| 2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 9.031 | 211.614 | 4,46 | 105,75 | 955.028 | 22.378.180 | |
| 2014-03-07 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 365.969 | 8.172.521 | 4,69 | 105,75 | 38.701.222 | 864.244.096 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.738 | 452.540 | 2,66 | 28,50 | 334.533 | 12.897.390 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 475.644 | 18.476.847 | 2,64 | 28,50 | 13.555.854 | 526.590.140 | |
| 2014-03-07 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 38.934 | 1.552.055 | 2,57 | 28,50 | 1.109.619 | 44.233.568 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303.161 | 0,23 | 29,27 | 19.962 | 8.873.522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 303.161 | 0,23 | 29,27 | 19.962 | 8.873.522 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 11.243.600 | 0,01 | 29,27 | 19.962 | 329.100.172 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 1.732.723 | 0,04 | 29,27 | 19.962 | 50.716.802 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 16.553 | 4,30 | 29,27 | 19.962 | 484.506 | |
| 2014-01-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 682 | 177.212 | 0,39 | 29,27 | 19.962 | 5.186.995 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 639 | 361.052 | 0,18 | 39,91 | 25.504 | 14.410.344 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 25.596 | 16.513.298 | 0,16 | 39,91 | 1.021.590 | 659.080.401 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.280 | 360.413 | 0,36 | 39,92 | 51.100 | 14.388.372 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 51.244 | 16.487.702 | 0,31 | 39,92 | 2.045.758 | 658.220.390 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.063 | 359.133 | 0,30 | 39,65 | 42.153 | 14.241.383 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 42.646 | 16.436.458 | 0,26 | 39,65 | 1.691.123 | 651.786.098 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.486 | 358.070 | 0,70 | 39,70 | 98.694 | 14.215.379 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 99.775 | 16.393.812 | 0,61 | 39,70 | 3.961.068 | 650.834.336 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.377 | 355.584 | 0,39 | 39,54 | 54.442 | 14.058.725 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 55.256 | 16.294.037 | 0,34 | 39,54 | 2.184.656 | 644.217.341 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.056 | 354.207 | 0,87 | 39,53 | 120.798 | 14.001.201 | |
| 2013-12-16 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 122.660 | 16.238.781 | 0,76 | 39,53 | 4.848.541 | 641.891.407 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 5.492 | 351.151 | 1,59 | 43,98 | 241.512 | 15.441.935 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 219.958 | 16.116.121 | 1,38 | 43,98 | 9.672.697 | 708.709.644 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 553 | 345.659 | 0,16 | 44,00 | 24.332 | 15.208.823 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 22.147 | 15.896.163 | 0,14 | 44,00 | 974.457 | 699.423.224 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.863 | 345.106 | 0,84 | 44,05 | 126.102 | 15.200.366 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 114.663 | 15.874.016 | 0,73 | 44,05 | 5.050.389 | 699.178.972 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 170 | 342.243 | 0,05 | 43,42 | 7.382 | 14.861.800 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 6.814 | 15.759.353 | 0,04 | 43,42 | 295.896 | 684.345.176 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.512 | 342.073 | 0,74 | 42,95 | 107.883 | 14.691.043 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 100.626 | 15.752.539 | 0,64 | 42,95 | 4.321.595 | 676.525.868 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 340 | 339.561 | 0,10 | 43,72 | 14.864 | 14.845.233 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 13.632 | 15.651.913 | 0,09 | 43,72 | 595.976 | 684.284.419 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.011 | 339.221 | 0,30 | 43,01 | 43.479 | 14.588.403 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 40.471 | 15.638.281 | 0,26 | 43,01 | 1.740.480 | 672.533.657 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 1.818 | 338.210 | 0,54 | 43,20 | 78.547 | 14.612.329 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 72.807 | 15.597.810 | 0,47 | 43,20 | 3.145.619 | 673.901.821 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 455 | 336.392 | 0,14 | 43,64 | 19.858 | 14.681.829 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 18.232 | 15.525.003 | 0,12 | 43,64 | 795.736 | 677.588.756 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 290 | 335.937 | 0,09 | 42,65 | 12.369 | 14.328.721 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 11.617 | 15.506.771 | 0,07 | 42,65 | 495.500 | 661.410.303 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 3.551 | 335.647 | 1,07 | 42,56 | 151.129 | 14.284.968 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 142.220 | 15.495.154 | 0,93 | 42,56 | 6.052.812 | 659.466.007 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.632 | 332.096 | 0,80 | 42,41 | 111.631 | 14.085.188 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 105.414 | 15.352.934 | 0,69 | 42,41 | 4.470.924 | 651.163.990 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 2.816 | 329.464 | 0,86 | 42,31 | 119.144 | 13.939.556 | |
| 2013-12-05 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
P - Purchase | 112.797 | 15.247.520 | 0,75 | 42,31 | 4.772.419 | 645.119.522 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -127.000 | 892.000 | -12,46 | 432,60 | -54.940.390 | 385.880.538 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -4.567.000 | 31.967.000 | -12,50 | 432,60 | -1.975.691.050 | 13.828.972.150 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -1.084.000 | 7.587.000 | -12,50 | 432,60 | -468.940.026 | 3.282.147.580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -2.459.000 | 1.019.000 | -70,70 | 425,88 | -1.047.233.756 | 433.969.580 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -88.153.000 | 36.534.000 | -70,70 | 425,88 | -37.542.414.519 | 15.559.023.199 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
4.75% Convertible Senior Note due 2015 |
D - Sale to Issuer | -20.922.000 | 8.671.000 | -70,70 | 425,88 | -8.910.217.424 | 3.692.787.271 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 170.000 | 6.050.000 | 2,89 | 104,52 | 17.768.043 | 632.333.295 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 6.830.000 | 243.450.000 | 2,89 | 104,52 | 713.857.257 | 25.444.882.755 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 242.000 | 5.880.000 | 4,29 | 104,25 | 25.228.500 | 612.990.000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 9.758.000 | 236.620.000 | 4,30 | 104,25 | 1.017.271.500 | 24.667.635.000 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 61.000 | 5.638.000 | 1,09 | 103,75 | 6.328.750 | 584.942.500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 2.439.000 | 226.862.000 | 1,09 | 103,75 | 253.046.250 | 23.536.932.500 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 121.000 | 5.577.000 | 2,22 | 104,75 | 12.674.750 | 584.190.750 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 4.879.000 | 224.423.000 | 2,22 | 104,75 | 511.075.250 | 23.508.309.250 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5.456.000 | 5.456.000 | 100,00 | 545.600.000 | 545.600.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 5.456.000 | 5.456.000 | 100,00 | 545.600.000 | 545.600.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 219.544.000 | 219.544.000 | 100,00 | 21.954.400.000 | 21.954.400.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 219.544.000 | 219.544.000 | 100,00 | 21.954.400.000 | 21.954.400.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 25.000.000 | 25.000.000 | 100,00 | 2.500.000.000 | 2.500.000.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
1.25% Convertible Senior Note due 2020 |
P - Purchase | 25.000.000 | 25.000.000 | 100,00 | 2.500.000.000 | 2.500.000.000 | ||
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 133.000 | 5.674.000 | 2,40 | 104,09 | 13.844.090 | 590.611.767 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 5.367.000 | 228.326.000 | 2,41 | 104,09 | 558.655.860 | 23.766.658.833 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 85.000 | 5.541.000 | 1,56 | 104,12 | 8.850.625 | 576.956.625 | |
| 2013-11-13 |
|
4 | INCY |
INCYTE CORP
0.375% Convertible Senior Note due 2018 |
P - Purchase | 3.415.000 | 222.959.000 | 1,56 | 104,12 | 355.586.875 | 23.215.605.875 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 8.721 | 40.308 | 27,61 | 17,50 | 152.618 | 705.390 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 346.965 | 2.213.897 | 18,58 | 17,50 | 6.071.888 | 38.743.198 | |
| 2013-10-28 |
|
4 | MRTX |
Mirati Therapeutics, Inc.
Common Stock |
P - Purchase | 44.314 | 125.869 | 54,34 | 17,50 | 775.495 | 2.202.708 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 302.479 | 0,22 | 30,33 | 19.957 | 9.174.188 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 11.242.918 | 0,01 | 30,33 | 19.957 | 340.997.703 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 1.732.041 | 0,04 | 30,33 | 19.957 | 52.532.804 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 15.871 | 4,33 | 30,33 | 19.957 | 481.367 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 176.530 | 0,37 | 30,33 | 19.957 | 5.354.155 | |
| 2013-10-02 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 658 | 196.794 | 0,34 | 30,33 | 19.957 | 5.968.762 | |
| 2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 25.663 | 202.583 | 14,51 | 56,63 | 1.453.296 | 11.472.275 | |
| 2013-09-27 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 1.024.337 | 7.806.552 | 15,10 | 56,63 | 58.008.204 | 442.085.040 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 21.410 | 510.449 | 4,38 | 3,62 | 77.504 | 1.847.825 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 1.854.058 | 19.767.770 | 10,35 | 3,62 | 6.711.690 | 71.559.327 | |
| 2013-08-21 |
|
4 | XOMA |
XOMA Corp
Common Stock |
A - Award | 882.323 | 2.829.753 | 45,31 | 3,62 | 3.194.009 | 10.243.706 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 21.410 | 510.449 | 4,38 | 3,62 | 77.504 | 1.847.825 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 1.854.058 | 19.767.770 | 10,35 | 3,62 | 6.711.690 | 71.559.327 | |
| 2013-08-21 |
|
4/A | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 882.323 | 2.829.753 | 45,31 | 3,62 | 3.194.009 | 10.243.706 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 24.705 | 145.533 | 20,45 | 4,40 | 108.702 | 640.345 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 991.161 | 4.832.285 | 25,80 | 4,40 | 4.361.108 | 21.262.054 | |
| 2013-08-02 |
|
4 | BCRX |
BIOCRYST PHARMACEUTICALS INC
Common Stock |
P - Purchase | 120.498 | 1.642.513 | 7,92 | 4,40 | 530.191 | 7.227.057 | |
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 3.030 | 3.030 | |||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
81.555 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
1.866.932 | ||||||||
| 2013-07-11 | 3 | MYG |
Mirati Therapeutics, Inc.
Common Stock |
31.587 | ||||||||
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301.821 | 0,20 | 32,85 | 19.907 | 9.914.820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301.821 | 0,20 | 32,85 | 19.907 | 9.914.820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 301.821 | 0,20 | 32,85 | 19.907 | 9.914.820 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 1.731.383 | 0,04 | 32,85 | 19.907 | 56.875.932 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 15.213 | 4,15 | 32,85 | 19.907 | 499.747 | |
| 2013-07-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 606 | 175.872 | 0,35 | 32,85 | 19.907 | 5.777.395 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 10.000 | -50,00 | 4,44 | -44.400 | 44.400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 10.000 | -50,00 | 4,44 | -44.400 | 44.400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 10.000 | -50,00 | 4,44 | -44.400 | 44.400 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 380.839 | 2,70 | 4,44 | 44.400 | 1.690.925 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 380.839 | 2,70 | 4,44 | 44.400 | 1.690.925 | |
| 2013-06-13 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 12.455.783 | 0,08 | 4,44 | 44.400 | 55.303.677 | |
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Non-Qualified Stock Option (right to buy) |
A - Award | 16.500 | 16.500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2013-06-11 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 12.500 | 12.500 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-10 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Non-Qualified Stock Option (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5.437 | 440.802 | 1,25 | 14,46 | 78.641 | 6.375.804 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217.986 | 18.001.203 | 1,23 | 14,46 | 3.152.971 | 260.371.200 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26.577 | 1.513.121 | 1,79 | 14,46 | 384.412 | 21.885.933 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 3.790 | 435.365 | 0,88 | 14,55 | 55.145 | 6.334.648 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 151.980 | 17.783.217 | 0,86 | 14,55 | 2.211.339 | 258.749.364 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 18.530 | 1.486.544 | 1,26 | 14,55 | 269.615 | 21.629.513 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 4.312 | 431.575 | 1,01 | 14,58 | 62.885 | 6.294.003 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 172.893 | 17.631.237 | 0,99 | 14,58 | 2.521.437 | 257.130.434 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 21.080 | 1.468.014 | 1,46 | 14,58 | 307.427 | 21.409.223 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 5.437 | 427.263 | 1,29 | 14,46 | 78.600 | 6.176.728 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 217.986 | 17.458.344 | 1,26 | 14,46 | 3.151.315 | 252.386.550 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stoc |
P - Purchase | 26.577 | 1.446.934 | 1,87 | 14,46 | 384.210 | 20.917.601 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 2.775 | 421.826 | 0,66 | 14,42 | 40.004 | 6.081.001 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 111.266 | 17.240.358 | 0,65 | 14,42 | 1.604.000 | 248.535.277 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 13.566 | 1.420.357 | 0,96 | 14,42 | 195.566 | 20.475.724 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.552 | 419.051 | 2,83 | 14,45 | 166.955 | 6.056.335 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 463.197 | 17.129.092 | 2,78 | 14,45 | 6.694.355 | 247.558.202 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56.475 | 1.406.791 | 4,18 | 14,45 | 816.205 | 20.331.647 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 890 | 407.499 | 0,22 | 14,50 | 12.903 | 5.907.798 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 35.702 | 16.665.895 | 0,21 | 14,50 | 517.597 | 241.617.146 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 4.353 | 1.350.316 | 0,32 | 14,50 | 63.108 | 19.576.476 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 5.189 | 406.609 | 1,29 | 14,00 | 72.641 | 5.692.119 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 208.063 | 16.630.193 | 1,27 | 14,00 | 2.912.674 | 232.806.072 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 25.368 | 1.345.963 | 1,92 | 14,00 | 355.127 | 18.842.136 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 11.511 | 401.420 | 2,95 | 14,08 | 162.100 | 5.652.877 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 461.548 | 16.422.130 | 2,89 | 14,08 | 6.499.611 | 231.259.719 | |
| 2013-06-05 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 56.274 | 1.320.595 | 4,45 | 14,08 | 792.462 | 18.596.883 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.735 | 301.215 | 1,60 | 35,82 | 169.584 | 10.788.015 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 189.886 | 11.241.654 | 1,72 | 35,82 | 6.800.767 | 402.619.838 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23.152 | 1.730.777 | 1,36 | 35,82 | 829.189 | 61.987.778 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.558 | 296.480 | 1,21 | 36,62 | 130.294 | 10.857.098 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 142.702 | 11.051.768 | 1,31 | 36,62 | 5.225.747 | 404.715.744 | |
| 2013-06-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17.399 | 1.707.625 | 1,03 | 36,62 | 637.151 | 62.533.228 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.790 | 292.922 | 0,96 | 36,69 | 102.356 | 10.746.400 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 111.907 | 10.909.066 | 1,04 | 36,69 | 4.105.521 | 400.219.813 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13.644 | 1.690.226 | 0,81 | 36,69 | 500.556 | 62.009.152 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.114 | 290.132 | 0,39 | 36,75 | 40.942 | 10.662.989 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44.627 | 10.797.159 | 0,42 | 36,75 | 1.640.140 | 396.819.347 | |
| 2013-06-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.501 | 1.676.582 | 0,33 | 36,75 | 202.174 | 61.618.077 | |
| 2013-05-31 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.021 | 289.018 | 0,35 | 36,82 | 37.595 | 10.642.105 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40.933 | 10.752.532 | 0,38 | 36,82 | 1.507.219 | 395.925.432 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.046 | 1.671.081 | 0,30 | 36,82 | 185.802 | 61.531.876 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.613 | 287.997 | 0,56 | 36,93 | 59.574 | 10.636.852 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 64.679 | 10.711.599 | 0,61 | 36,93 | 2.388.848 | 395.621.126 | |
| 2013-05-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.974 | 1.666.035 | 0,48 | 36,93 | 294.511 | 61.533.170 | |
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Non-Qualified Stock Option (right to buy) |
A - Award | 11.600 | 11.600 | |||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 489.039 | 1,75 | ||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 489.039 | 1,75 | ||||
| 2013-05-24 |
|
4 | XOMA |
XOMA Corp
Common Shares |
A - Award | 8.400 | 1.947.430 | 0,43 | ||||
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.358 | 286.384 | 0,48 | 36,93 | 50.154 | 10.576.877 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 54.399 | 10.646.920 | 0,51 | 36,93 | 2.009.091 | 393.217.373 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6.760 | 1.658.061 | 0,41 | 36,93 | 249.664 | 61.236.338 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 332 | 285.026 | 0,12 | 36,99 | 12.280 | 10.542.371 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13.313 | 10.592.521 | 0,13 | 36,99 | 492.413 | 391.789.811 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.655 | 1.651.301 | 0,10 | 36,99 | 61.214 | 61.077.331 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35 | 284.694 | 0,01 | 36,18 | 1.266 | 10.300.969 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.392 | 10.579.208 | 0,01 | 36,18 | 50.366 | 382.783.251 | |
| 2013-05-24 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 173 | 1.649.646 | 0,01 | 36,18 | 6.260 | 59.688.481 | |
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy) |
A - Award | 8.750 | 8.750 | |||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 326.648 | 1,08 | ||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 326.648 | 1,08 | ||||
| 2013-05-21 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
A - Award | 3.500 | 326.648 | 1,08 | ||||
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 43.184 | 389.909 | 12,45 | 12,50 | 539.800 | 4.873.862 | |
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 1.730.970 | 15.960.582 | 12,16 | 12,50 | 21.637.125 | 199.507.275 | |
| 2013-05-17 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 218.846 | 1.264.321 | 20,93 | 12,50 | 2.735.575 | 15.804.012 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 418 | 284.659 | 0,15 | 36,54 | 15.273 | 10.401.212 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16.768 | 10.577.816 | 0,16 | 36,54 | 612.689 | 386.504.934 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.120 | 1.649.473 | 0,13 | 36,54 | 77.463 | 60.270.424 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.129 | 284.241 | 0,40 | 36,41 | 41.111 | 10.350.295 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 45.279 | 10.561.048 | 0,43 | 36,41 | 1.648.780 | 384.567.890 | |
| 2013-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.725 | 1.647.353 | 0,35 | 36,41 | 208.469 | 59.986.383 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 589 | 283.112 | 0,21 | 35,53 | 20.928 | 10.059.507 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23.610 | 10.515.769 | 0,23 | 35,53 | 838.908 | 373.645.253 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.985 | 1.641.628 | 0,18 | 35,53 | 106.063 | 58.330.162 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.516 | 282.523 | 1,26 | 34,02 | 119.609 | 9.610.980 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 140.962 | 10.492.159 | 1,36 | 34,02 | 4.795.302 | 356.926.462 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17.822 | 1.638.643 | 1,10 | 34,02 | 606.276 | 55.744.013 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.104 | 279.007 | 0,40 | 34,74 | 38.358 | 9.694.098 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 44.244 | 10.351.197 | 0,43 | 34,74 | 1.537.258 | 359.652.340 | |
| 2013-05-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.594 | 1.620.821 | 0,35 | 34,74 | 194.364 | 56.315.426 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277.903 | 0,26 | 27,99 | 19.985 | 7.778.505 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 277.903 | 0,26 | 27,99 | 19.985 | 7.778.505 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 10.306.953 | 0,01 | 27,99 | 19.985 | 288.491.614 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 1.615.227 | 0,04 | 27,99 | 19.985 | 45.210.204 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 14.607 | 5,14 | 27,99 | 19.985 | 408.850 | |
| 2013-04-03 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
A - Award | 714 | 175.266 | 0,41 | 27,99 | 19.985 | 4.905.695 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 612 | 277.189 | 0,22 | 27,63 | 16.912 | 7.659.813 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24.508 | 10.306.239 | 0,24 | 27,64 | 677.325 | 284.832.497 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.080 | 1.614.513 | 0,19 | 27,64 | 85.122 | 44.620.134 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 453 | 276.577 | 0,16 | 27,97 | 12.672 | 7.736.744 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 18.151 | 10.281.731 | 0,18 | 27,97 | 507.742 | 287.612.918 | |
| 2013-02-21 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.281 | 1.611.433 | 0,14 | 27,97 | 63.807 | 45.076.938 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 758 | 276.124 | 0,28 | 28,43 | 21.551 | 7.850.509 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 30.102 | 10.263.580 | 0,29 | 28,43 | 855.833 | 291.804.869 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.940 | 1.609.152 | 0,25 | 28,43 | 112.019 | 45.749.961 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 375 | 275.366 | 0,14 | 28,58 | 10.718 | 7.870.098 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14.878 | 10.233.478 | 0,15 | 28,58 | 425.221 | 292.477.918 | |
| 2013-02-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.947 | 1.605.212 | 0,12 | 28,58 | 55.646 | 45.877.762 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.742 | 274.991 | 0,64 | 28,23 | 49.180 | 7.763.463 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 69.187 | 10.218.600 | 0,68 | 28,23 | 1.953.267 | 288.488.450 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9.055 | 1.603.265 | 0,57 | 28,23 | 255.638 | 45.262.897 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 788 | 273.249 | 0,29 | 27,96 | 22.033 | 7.640.288 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31.584 | 10.149.413 | 0,31 | 27,96 | 883.117 | 283.786.722 | |
| 2013-02-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.004 | 1.594.210 | 0,25 | 27,96 | 111.955 | 44.575.546 | |
| 2013-01-23 |
|
4 | ACAD |
ACADIA PHARMACEUTICALS INC
Stock Options (right to buy) |
A - Award | 15.000 | 15.000 | |||||
| 2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 20.099 | 176.920 | 12,82 | 47,53 | 955.305 | 8.409.008 | |
| 2013-01-08 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 839.621 | 6.782.215 | 14,13 | 47,53 | 39.907.186 | 322.358.679 | |
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
1.045.475 | ||||||||
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
14.229.612 | ||||||||
| 2012-12-21 | 3 | ACAD |
ACADIA PHARMACEUTICALS INC
Common Stock |
346.725 | ||||||||
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6 | 271.806 | 0,00 | 27,54 | 165 | 7.485.537 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 268 | 10.117.174 | 0,00 | 27,54 | 7.381 | 278.626.972 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26 | 1.589.551 | 0,00 | 27,54 | 716 | 43.776.235 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.859 | 271.800 | 1,82 | 26,83 | 130.352 | 7.291.551 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 202.311 | 10.116.906 | 2,04 | 26,83 | 5.427.377 | 271.405.226 | |
| 2012-11-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 21.830 | 1.589.525 | 1,39 | 26,83 | 585.631 | 42.642.028 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.223 | 266.941 | 0,84 | 27,32 | 60.725 | 7.291.894 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92.592 | 9.914.595 | 0,94 | 27,32 | 2.529.289 | 270.832.034 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8.352 | 1.567.695 | 0,54 | 27,32 | 228.147 | 42.823.940 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.231 | 264.718 | 0,85 | 27,99 | 62.450 | 7.409.960 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 92.917 | 9.822.003 | 0,96 | 27,99 | 2.600.923 | 274.936.526 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8.691 | 1.559.343 | 0,56 | 27,99 | 243.278 | 43.648.973 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.298 | 262.487 | 1,66 | 27,94 | 120.075 | 7.333.204 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 178.978 | 9.729.086 | 1,87 | 27,94 | 5.000.180 | 271.805.367 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16.724 | 1.550.652 | 1,09 | 27,94 | 467.225 | 43.321.185 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143 | 258.189 | 0,06 | 27,86 | 3.983 | 7.192.010 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24 | 258.046 | 0,01 | 26,68 | 640 | 6.884.693 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 79 | 258.022 | 0,03 | 27,16 | 2.146 | 7.008.187 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9.905 | 257.943 | 3,99 | 27,84 | 275.793 | 7.182.113 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 651 | 248.038 | 0,26 | 26,91 | 17.516 | 6.673.735 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 324 | 247.387 | 0,13 | 25,83 | 8.367 | 6.388.868 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.972 | 9.550.108 | 0,06 | 27,86 | 166.354 | 266.023.988 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 980 | 9.544.136 | 0,01 | 26,68 | 26.146 | 254.638.503 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.298 | 9.543.156 | 0,03 | 27,16 | 89.578 | 259.203.569 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 412.596 | 9.539.858 | 4,52 | 27,84 | 11.488.241 | 265.625.898 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 27.125 | 9.127.262 | 0,30 | 26,91 | 729.828 | 245.579.024 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 13.447 | 9.100.137 | 0,15 | 25,83 | 347.274 | 235.014.678 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 585 | 1.533.928 | 0,04 | 27,86 | 16.296 | 42.728.485 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 96 | 1.533.343 | 0,01 | 26,68 | 2.561 | 40.909.745 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 323 | 1.533.247 | 0,02 | 27,16 | 8.773 | 41.644.828 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40.412 | 1.532.924 | 2,71 | 27,84 | 1.125.224 | 42.682.429 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.657 | 1.492.512 | 0,18 | 26,91 | 71.490 | 40.157.677 | |
| 2012-11-14 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.316 | 1.489.855 | 0,09 | 25,83 | 33.986 | 38.476.101 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 103.608 | 463.839 | 28,76 | 3,00 | 310.824 | 1.391.517 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 4.282.419 | 17.888.512 | 31,47 | 3,00 | 12.847.257 | 53.665.536 | |
| 2012-10-31 |
|
4 | XOMA |
XOMA Corp
Common Stock |
P - Purchase | 336.639 | 1.922.230 | 21,23 | 3,00 | 1.009.917 | 5.766.690 | |
| 2012-08-03 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -10.000 | 0 | -100,00 | 5,67 | -56.700 | ||
| 2012-08-03 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 10.000 | 66.340 | 17,75 | 5,67 | 56.700 | 376.148 | |
| 2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 21.082 | 156.821 | 15,53 | 41,20 | 868.578 | 6.461.025 | |
| 2012-07-13 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
P - Purchase | 864.918 | 5.942.594 | 17,03 | 41,20 | 35.634.622 | 244.834.873 | |
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -12.500 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -12.500 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Stock Option (Right to Buy) |
D - Sale to Issuer | -25.000 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -4.023 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -147.292 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -46.195 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -998 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Warrants |
D - Sale to Issuer | -205 | 0 | -100,00 | ||||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -116.454 | 0 | -100,00 | 32,00 | -3.726.528 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -4.922.226 | 0 | -100,00 | 32,00 | -157.511.232 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -1.646.964 | 0 | -100,00 | 32,00 | -52.702.848 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -99.636 | 0 | -100,00 | 32,00 | -3.188.352 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -65.882 | 0 | -100,00 | 32,00 | -2.108.224 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -60.827 | 0 | -100,00 | 32,00 | -1.946.464 | ||
| 2012-06-21 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
D - Sale to Issuer | -2.302 | 0 | -100,00 | 32,00 | -73.664 | ||
| 2012-06-12 |
|
4 | GHDX |
GENOMIC HEALTH INC
Director Stock Option (right to buy) |
A - Award | 8.250 | 8.250 | |||||
| 2012-06-06 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
M - Exercise | -5.000 | 0 | -100,00 | 6,66 | -33.300 | ||
| 2012-06-06 |
|
4 | INCY |
INCYTE CORP
Common Stock |
M - Exercise | 5.000 | 5.000 | 6,66 | 33.300 | 33.300 | ||
| 2012-06-01 |
|
4 | INCY |
INCYTE CORP
Non-Qualified Stock Options (right to buy) |
A - Award | 20.000 | 20.000 | |||||
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 380 | 247.063 | 0,15 | 32,94 | 12.518 | 8.138.922 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17.026 | 9.086.690 | 0,19 | 32,94 | 560.882 | 299.340.103 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.732 | 246.683 | 1,12 | 32,21 | 87.992 | 7.945.166 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 546 | 243.951 | 0,22 | 32,04 | 17.493 | 7.815.922 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 122.268 | 9.069.664 | 1,37 | 32,21 | 3.938.008 | 292.115.738 | |
| 2012-05-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24.454 | 8.947.396 | 0,27 | 32,04 | 783.479 | 286.664.726 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 517 | 243.405 | 0,21 | 34,46 | 17.815 | 8.387.176 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 23.104 | 8.922.942 | 0,26 | 34,46 | 796.111 | 307.464.059 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.972 | 242.888 | 0,82 | 34,25 | 67.541 | 8.318.914 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 540 | 240.916 | 0,22 | 33,11 | 17.882 | 7.977.668 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 555 | 240.376 | 0,23 | 34,47 | 19.129 | 8.285.160 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 88.028 | 8.899.838 | 1,00 | 34,25 | 3.014.959 | 304.819.452 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24.136 | 8.811.810 | 0,27 | 33,11 | 799.237 | 291.793.395 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 24.769 | 8.787.674 | 0,28 | 34,47 | 853.726 | 302.889.154 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.212 | 239.821 | 1,36 | 33,92 | 108.951 | 8.134.728 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 897 | 236.609 | 0,38 | 33,67 | 30.198 | 7.965.513 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 370 | 235.712 | 0,16 | 32,59 | 12.058 | 7.681.501 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 175 | 235.342 | 0,07 | 31,53 | 5.517 | 7.419.863 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 143.388 | 8.762.905 | 1,66 | 33,92 | 4.863.721 | 297.237.738 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 40.073 | 8.619.517 | 0,47 | 33,67 | 1.349.070 | 290.178.626 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 16.526 | 8.579.444 | 0,19 | 32,59 | 538.558 | 279.591.211 | |
| 2012-05-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.797 | 8.562.918 | 0,09 | 31,53 | 245.824 | 269.971.679 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 627 | 235.167 | 0,27 | 30,22 | 18.946 | 7.105.877 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 26.033 | 8.555.121 | 0,31 | 30,22 | 786.621 | 258.504.103 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 214 | 234.540 | 0,09 | 29,98 | 6.415 | 7.030.829 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8.867 | 8.529.088 | 0,10 | 29,98 | 265.807 | 255.677.324 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.402 | 234.326 | 0,60 | 29,86 | 41.861 | 6.996.599 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 58.198 | 8.520.221 | 0,69 | 29,86 | 1.737.699 | 254.400.167 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 460 | 232.924 | 0,20 | 29,90 | 13.752 | 6.963.379 | |
| 2012-05-11 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19.087 | 8.462.023 | 0,23 | 29,90 | 570.615 | 252.976.409 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 116 | 232.464 | 0,05 | 28,50 | 3.306 | 6.624.620 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.737 | 232.348 | 0,75 | 28,90 | 50.196 | 6.714.416 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 172 | 230.611 | 0,07 | 28,41 | 4.886 | 6.550.529 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.811 | 8.442.936 | 0,06 | 28,50 | 137.101 | 240.601.724 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 72.073 | 8.438.125 | 0,86 | 28,90 | 2.082.773 | 243.845.780 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.124 | 8.366.052 | 0,09 | 28,41 | 202.358 | 237.638.544 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 536 | 230.439 | 0,23 | 28,28 | 15.159 | 6.517.184 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 754 | 229.903 | 0,33 | 28,25 | 21.300 | 6.494.530 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22.241 | 8.358.928 | 0,27 | 28,28 | 629.011 | 236.403.858 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 31.273 | 8.336.687 | 0,38 | 28,25 | 883.431 | 235.503.071 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 722 | 1.488.539 | 0,05 | 28,28 | 20.419 | 42.098.265 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.014 | 1.487.817 | 0,07 | 28,25 | 28.644 | 42.029.342 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5 | 229.149 | 0,00 | 28,00 | 140 | 6.416.172 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 369 | 229.144 | 0,16 | 27,99 | 10.330 | 6.414.863 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 935 | 228.775 | 0,41 | 28,03 | 26.208 | 6.412.540 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 188 | 8.305.414 | 0,00 | 28,00 | 5.264 | 232.551.592 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 14.078 | 8.305.226 | 0,17 | 27,99 | 394.112 | 232.503.971 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 35.727 | 8.291.148 | 0,43 | 28,03 | 1.001.424 | 232.400.049 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7 | 1.486.803 | 0,00 | 28,00 | 196 | 41.630.484 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 514 | 1.486.796 | 0,03 | 27,99 | 14.389 | 41.622.705 | |
| 2012-05-08 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.305 | 1.486.282 | 0,09 | 28,03 | 36.579 | 41.660.336 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 910 | 57.704 | 1,60 | 3,01 | 2.735 | 173.429 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1.482 | 56.794 | 2,68 | 2,99 | 4.430 | 169.763 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4.186 | 55.312 | 8,19 | 2,96 | 12.383 | 163.618 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 15.076 | 51.126 | 41,82 | 2,55 | 38.444 | 130.371 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 8.628 | 36.050 | 31,46 | 2,34 | 20.186 | 84.343 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1.170 | 27.422 | 4,46 | 1,87 | 2.188 | 51.279 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 430 | 26.252 | 1,67 | 1,89 | 811 | 49.506 | |
| 2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
25.822 | ||||||||
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 34.544 | 3.540.015 | 0,99 | 3,01 | 103.822 | 10.639.515 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 56.294 | 3.505.471 | 1,63 | 2,99 | 168.268 | 10.478.203 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 159.015 | 3.449.177 | 4,83 | 2,96 | 470.382 | 10.203.010 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 572.737 | 3.290.162 | 21,08 | 2,55 | 1.460.479 | 8.389.913 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 327.769 | 2.717.425 | 13,72 | 2,34 | 766.848 | 6.357.688 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 44.467 | 2.389.656 | 1,90 | 1,87 | 83.153 | 4.468.657 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 16.326 | 2.345.189 | 0,70 | 1,89 | 30.788 | 4.422.557 | |
| 2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
2.328.863 | ||||||||
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4.592 | 232.011 | 2,02 | 3,01 | 13.801 | 697.309 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 7.484 | 227.419 | 3,40 | 2,99 | 22.370 | 679.778 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 15.599 | 219.935 | 7,63 | 2,96 | 46.143 | 650.590 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 56.187 | 204.336 | 37,93 | 2,55 | 143.277 | 521.057 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 32.155 | 148.149 | 27,72 | 2,34 | 75.230 | 346.609 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 4.363 | 115.994 | 3,91 | 1,87 | 8.159 | 216.909 | |
| 2012-03-14 |
|
4 | TZYM |
TRANZYME INC
Common Stock |
P - Purchase | 1.601 | 111.631 | 1,46 | 1,89 | 3.019 | 210.514 | |
| 2012-03-14 | 3 | TZYM |
TRANZYME INC
Common Stock |
110.030 | ||||||||
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 516 | 227.840 | 0,23 | 30,36 | 15.668 | 6.918.088 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 583 | 227.324 | 0,26 | 29,88 | 17.420 | 6.792.259 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19.513 | 8.255.421 | 0,24 | 30,36 | 592.489 | 250.665.952 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22.071 | 8.235.908 | 0,27 | 29,88 | 659.464 | 246.082.342 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.162 | 1.484.977 | 0,15 | 30,36 | 65.647 | 45.089.545 | |
| 2012-03-09 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.346 | 1.482.815 | 0,16 | 29,88 | 70.097 | 44.305.326 | |
| 2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
360.231 | ||||||||
| 2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
1.585.591 | ||||||||
| 2012-03-08 | 3 | XOMA |
XOMA Corp
Common Stock |
13.606.093 | ||||||||
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.845 | 226.741 | 0,82 | 30,07 | 55.477 | 6.817.830 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.254 | 224.896 | 1,01 | 29,96 | 67.521 | 6.737.007 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.419 | 222.642 | 1,10 | 29,52 | 71.410 | 6.572.503 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 405 | 220.223 | 0,18 | 29,47 | 11.936 | 6.490.060 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 69.783 | 8.213.837 | 0,86 | 30,07 | 2.098.291 | 246.980.222 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 85.231 | 8.144.054 | 1,06 | 29,96 | 2.553.188 | 243.964.096 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 91.459 | 8.058.823 | 1,15 | 29,52 | 2.699.915 | 237.900.484 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 15.288 | 7.967.364 | 0,19 | 29,47 | 450.543 | 234.801.404 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 8.372 | 1.480.469 | 0,57 | 30,07 | 251.736 | 44.515.926 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10.225 | 1.472.097 | 0,70 | 29,96 | 306.301 | 44.098.285 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10.972 | 1.461.872 | 0,76 | 29,52 | 323.899 | 43.155.192 | |
| 2012-03-05 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.763 | 1.450.900 | 0,12 | 29,47 | 51.956 | 42.758.603 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.149 | 219.818 | 1,92 | 29,06 | 120.562 | 6.387.493 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.353 | 215.669 | 0,63 | 29,11 | 39.384 | 6.277.801 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 974 | 214.316 | 0,46 | 29,03 | 28.276 | 6.221.722 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 156.902 | 7.952.076 | 2,01 | 29,06 | 4.559.274 | 231.072.220 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 51.248 | 7.795.174 | 0,66 | 29,11 | 1.491.752 | 226.905.822 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 36.881 | 7.743.926 | 0,48 | 29,03 | 1.070.678 | 224.810.818 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 19.552 | 1.449.137 | 1,37 | 29,06 | 568.144 | 42.109.168 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.934 | 1.429.585 | 0,42 | 29,11 | 172.730 | 41.613.075 | |
| 2012-02-29 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.270 | 1.423.651 | 0,30 | 29,03 | 123.961 | 41.329.443 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.639 | 213.342 | 0,77 | 28,12 | 46.095 | 5.999.988 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 145 | 211.703 | 0,07 | 27,98 | 4.057 | 5.923.683 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.238 | 211.558 | 0,59 | 27,98 | 34.635 | 5.918.737 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 62.098 | 7.707.045 | 0,81 | 28,12 | 1.746.432 | 216.751.392 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.511 | 7.644.947 | 0,07 | 27,98 | 154.204 | 213.914.027 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 46.909 | 7.639.436 | 0,62 | 27,98 | 1.312.368 | 213.727.737 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.477 | 1.419.381 | 0,53 | 28,12 | 210.282 | 39.918.387 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 638 | 1.411.904 | 0,05 | 27,98 | 17.852 | 39.506.627 | |
| 2012-02-23 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 5.217 | 1.411.266 | 0,37 | 27,98 | 145.955 | 39.482.848 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.419 | 210.320 | 1,16 | 29,85 | 72.219 | 6.279.062 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.460 | 207.901 | 1,20 | 29,61 | 72.842 | 6.156.073 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10 | 205.441 | 0,00 | 28,96 | 290 | 5.950.085 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 849 | 205.431 | 0,41 | 28,88 | 24.517 | 5.932.272 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.475 | 204.582 | 0,73 | 28,44 | 41.945 | 5.817.698 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 91.543 | 7.592.527 | 1,22 | 29,85 | 2.732.998 | 226.673.375 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 93.088 | 7.500.984 | 1,26 | 29,61 | 2.756.392 | 222.108.637 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 349 | 7.407.896 | 0,00 | 28,96 | 10.108 | 214.551.188 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 32.125 | 7.407.547 | 0,44 | 28,88 | 927.680 | 213.909.216 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 55.804 | 7.375.422 | 0,76 | 28,44 | 1.586.898 | 209.734.875 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 10.838 | 1.406.049 | 0,78 | 29,85 | 323.566 | 41.977.312 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 11.021 | 1.395.211 | 0,80 | 29,61 | 326.338 | 41.313.035 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 41 | 1.384.190 | 0,00 | 28,96 | 1.187 | 40.089.603 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.944 | 1.384.149 | 0,29 | 28,88 | 113.892 | 39.970.348 | |
| 2012-02-16 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.341 | 1.380.205 | 0,53 | 28,44 | 208.756 | 39.248.890 | |
| 2012-02-14 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 150.000 | 557.211 | 36,84 | 20,85 | 3.128.040 | 11.619.855 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 753 | 203.107 | 0,37 | 26,52 | 19.967 | 5.385.666 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 492 | 202.354 | 0,24 | 26,62 | 13.098 | 5.387.048 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.980 | 201.862 | 1,50 | 26,60 | 79.278 | 5.370.195 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 102 | 198.882 | 0,05 | 26,24 | 2.676 | 5.217.868 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.312 | 198.780 | 0,66 | 26,33 | 34.540 | 5.233.162 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 64 | 197.468 | 0,03 | 26,27 | 1.681 | 5.187.208 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 1.594 | 197.404 | 0,81 | 26,26 | 41.851 | 5.182.921 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.585 | 195.810 | 1,87 | 26,18 | 93.840 | 5.125.464 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 161 | 192.225 | 0,08 | 26,17 | 4.213 | 5.029.586 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 28.469 | 7.319.618 | 0,39 | 26,52 | 754.895 | 194.089.919 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 18.628 | 7.291.149 | 0,26 | 26,62 | 495.913 | 194.104.240 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 112.735 | 7.272.521 | 1,57 | 26,60 | 2.999.123 | 193.473.058 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 3.883 | 7.159.786 | 0,05 | 26,24 | 101.874 | 187.844.145 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 49.670 | 7.155.903 | 0,70 | 26,33 | 1.307.632 | 188.389.165 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.441 | 7.106.233 | 0,03 | 26,27 | 64.122 | 186.670.792 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 60.315 | 7.103.792 | 0,86 | 26,26 | 1.583.594 | 186.512.900 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 135.681 | 7.043.477 | 1,96 | 26,18 | 3.551.545 | 184.367.941 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 6.093 | 6.907.796 | 0,09 | 26,17 | 159.424 | 180.743.173 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 4.378 | 1.372.864 | 0,32 | 26,52 | 116.089 | 36.403.411 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 2.865 | 1.368.486 | 0,21 | 26,62 | 76.272 | 36.431.697 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 17.339 | 1.365.621 | 1,29 | 26,60 | 461.275 | 36.330.025 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 615 | 1.348.282 | 0,05 | 26,24 | 16.135 | 35.373.527 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 7.858 | 1.347.667 | 0,59 | 26,33 | 206.873 | 35.479.221 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 387 | 1.339.809 | 0,03 | 26,27 | 10.166 | 35.194.907 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 9.891 | 1.339.422 | 0,74 | 26,26 | 259.692 | 35.167.060 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 22.251 | 1.329.531 | 1,70 | 26,18 | 582.436 | 34.801.405 | |
| 2012-02-10 |
|
4 | GHDX |
GENOMIC HEALTH INC
Common Stock |
P - Purchase | 999 | 1.307.280 | 0,08 | 26,17 | 26.139 | 34.205.112 | |
| 2012-02-03 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
P - Purchase | 23.172 | 116.454 | 24,84 | 17,00 | 393.924 | 1.979.718 | |
| 2012-02-03 |
|
4 | RDEA |
Ardea Biosciences, Inc./DE
Common Stock |
P - Purchase | 876.828 | 4.922.226 | 21,67 | 17,00 | 14.906.076 | 83.677.842 | |
| 2012-01-31 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -59.340 | 0 | -100,00 | 0,22 | -13.156 | ||
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12.907 | 407.211 | 3,27 | 17,89 | 230.942 | 7.286.145 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 28.966 | 394.304 | 7,93 | 17,95 | 519.960 | 7.078.033 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 3.018 | 365.338 | 0,83 | 18,43 | 55.629 | 6.734.093 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 18.547 | 362.320 | 5,40 | 18,55 | 343.997 | 6.720.058 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 14.629 | 343.773 | 4,44 | 18,01 | 263.424 | 6.190.320 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7.926 | 329.144 | 2,47 | 17,86 | 141.534 | 5.877.491 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.944 | 195.858 | 1,00 | 17,89 | 34.784 | 3.504.448 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 4.360 | 193.914 | 2,30 | 17,95 | 78.265 | 3.480.892 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 454 | 189.554 | 0,24 | 18,43 | 8.368 | 3.493.954 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2.792 | 189.100 | 1,50 | 18,55 | 51.784 | 3.507.294 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2.202 | 186.308 | 1,20 | 18,01 | 39.651 | 3.354.848 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.193 | 184.106 | 0,65 | 17,86 | 21.303 | 3.287.562 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 75.149 | 8.574.445 | 0,88 | 17,89 | 1.344.626 | 153.420.829 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 168.641 | 8.499.296 | 2,02 | 17,95 | 3.027.224 | 152.568.313 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 17.571 | 8.330.655 | 0,21 | 18,43 | 323.877 | 153.554.798 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 107.980 | 8.313.084 | 1,32 | 18,55 | 2.002.737 | 154.185.263 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 85.169 | 8.205.104 | 1,05 | 18,01 | 1.533.638 | 147.749.308 | |
| 2012-01-26 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 46.142 | 8.119.935 | 0,57 | 17,86 | 823.953 | 144.996.867 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7.925 | 321.218 | 2,53 | 16,84 | 133.456 | 5.409.279 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12.694 | 313.293 | 4,22 | 16,88 | 214.254 | 5.287.885 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 7.590 | 300.599 | 2,59 | 16,90 | 128.252 | 5.079.372 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -16 | 0 | -100,00 | 1,50 | -24 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -28 | 16 | -63,64 | 1,25 | -35 | 20 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 16 | 44 | 57,14 | 1,50 | 24 | 66 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 1.600 | 293.009 | 0,55 | 15,00 | 24.000 | 4.395.135 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 2.800 | 291.409 | 0,97 | 15,00 | 42.000 | 4.371.135 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 12.041 | 288.609 | 4,35 | 16,44 | 197.940 | 4.744.386 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 31.115 | 276.568 | 12,68 | 16,41 | 510.585 | 4.538.370 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 28 | 28 | 1,25 | 35 | 35 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 426 | 245.453 | 0,17 | 15,81 | 6.735 | 3.880.391 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.795 | 245.027 | 0,74 | 16,07 | 28.843 | 3.937.241 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 3.839 | 243.232 | 1,60 | 16,07 | 61.686 | 3.908.300 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.201 | 182.913 | 0,66 | 16,84 | 20.225 | 3.080.237 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.923 | 181.712 | 1,07 | 16,88 | 32.457 | 3.067.008 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.149 | 179.789 | 0,64 | 16,90 | 19.415 | 3.037.985 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -2 | 0 | -100,00 | 1,50 | -3 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -5 | 2 | -71,43 | 1,25 | -6 | 2 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 2 | 7 | 40,00 | 1,50 | 3 | 10 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 200 | 178.640 | 0,11 | 15,00 | 3.000 | 2.679.600 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 500 | 178.440 | 0,28 | 15,00 | 7.500 | 2.676.600 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 1.824 | 177.940 | 1,04 | 16,44 | 29.984 | 2.925.120 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 4.712 | 176.116 | 2,75 | 16,41 | 77.322 | 2.889.993 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 5 | 5 | 1,25 | 6 | 6 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 66 | 171.404 | 0,04 | 15,81 | 1.043 | 2.709.743 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 278 | 171.338 | 0,16 | 16,07 | 4.467 | 2.753.162 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 594 | 171.060 | 0,35 | 16,07 | 9.545 | 2.748.626 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 45.574 | 8.073.793 | 0,57 | 16,84 | 767.462 | 135.961.867 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 72.997 | 8.028.219 | 0,92 | 16,88 | 1.232.073 | 135.503.492 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 43.644 | 7.955.222 | 0,55 | 16,90 | 737.474 | 134.423.364 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -87 | 0 | -100,00 | 1,50 | -130 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
X - Other | -162 | 87 | -65,06 | 1,25 | -202 | 109 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 87 | 249 | 53,70 | 1,50 | 130 | 373 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 8.700 | 7.911.578 | 0,11 | 15,00 | 130.500 | 118.673.670 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
X - Other | 16.200 | 7.902.878 | 0,21 | 15,00 | 243.000 | 118.543.170 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 69.245 | 7.886.678 | 0,89 | 16,43 | 1.137.958 | 129.608.089 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 178.921 | 7.817.433 | 2,34 | 16,41 | 2.936.022 | 128.280.949 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Call Option |
P - Purchase | 162 | 162 | 1,25 | 202 | 202 | ||
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 2.449 | 7.638.512 | 0,03 | 15,81 | 38.716 | 120.758.000 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 10.327 | 7.636.063 | 0,14 | 16,07 | 165.940 | 122.700.842 | |
| 2012-01-23 |
|
4 | PCYC |
PHARMACYCLICS INC
Common Stock |
P - Purchase | 22.081 | 7.625.736 | 0,29 | 16,07 | 354.802 | 122.531.851 | |
| 2012-01-20 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -20.000 | 59.340 | -25,21 | 0,20 | -4.000 | 11.868 | |
| 2012-01-20 |
|
4 | DDXS |
diaDexus, Inc.
Common Stock |
S - Sale | -118.800 | 79.340 | -59,96 | 0,21 | -25.233 | 16.852 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.122 | 355.839 | 0,32 | 16,62 | 18.648 | 5.914.115 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 1.965 | 354.717 | 0,56 | 16,58 | 32.576 | 5.880.463 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.769 | 352.752 | 0,79 | 16,46 | 45.570 | 5.805.345 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 5.919 | 349.983 | 1,72 | 16,21 | 95.924 | 5.671.859 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 2.850 | 344.064 | 0,84 | 16,38 | 46.691 | 5.636.697 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 41.677 | 12.430.783 | 0,34 | 16,62 | 692.680 | 206.602.100 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 72.978 | 12.389.106 | 0,59 | 16,58 | 1.209.822 | 205.385.360 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 102.856 | 12.316.128 | 0,84 | 16,46 | 1.692.732 | 202.690.213 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 219.881 | 12.213.272 | 1,83 | 16,21 | 3.563.413 | 197.929.507 | |
| 2012-01-17 |
|
4 | INCY |
INCYTE CORP
Common Stock |
P - Purchase | 105.847 | 11.993.391 | 0,89 | 16,38 | 1.734.060 | 196.484.127 | |
| 2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 29.089 | 135.739 | 27,28 | 25,18 | 732.461 | 3.417.908 | |
| 2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 1.077.225 | 5.077.676 | 26,93 | 25,18 | 27.124.526 | 127.855.882 | |
| 2012-01-09 |
|
4 | GEVA |
SYNAGEVA BIOPHARMA CORP
Common Stock |
A - Award | 187.576 | 1.736.065 | 12,11 | 25,18 | 4.723.164 | 43.714.117 | |
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -355.143 | 0 | -100,00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 355.143 | 15.131.223 | 2,40 | 6,25 | 2.219.644 | 94.570.144 | |
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -49.563 | 0 | -100,00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 49.563 | 450.461 | 12,36 | 6,25 | 309.769 | 2.815.381 | |
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -68.006 | 0 | -100,00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 68.006 | 539.130 | 14,43 | 6,25 | 425.038 | 3.369.562 | |
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
X - Other | -339.788 | 0 | -100,00 | ||||
| 2012-01-04 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
X - Other | 339.788 | 4.966.001 | 7,34 | 6,25 | 2.123.675 | 31.037.506 | |
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -186.272 | 0 | -100,00 | 4,25 | -791.656 | ||
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -6.669.338 | 0 | -100,00 | 4,25 | -28.344.686 | ||
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -12.679 | 0 | -100,00 | 4,25 | -53.886 | ||
| 2012-01-03 |
|
4 | ADLR |
ADOLOR CORP
Common Stock |
U - Other | -79.054 | 0 | -100,00 | 4,25 | -335.980 | ||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | 284.115 | 284.115 | |||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | -34.385 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Series A Convertible Preferred Stock |
J - Other | -249.730 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | 355.143 | 355.143 | |||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | -42.981 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock Warrants (right to buy) |
J - Other | -312.162 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | 448.047 | 682.908 | 190,77 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -45.090 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -49.807 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | SGEN |
SEATTLE GENETICS INC /WA
Common Stock |
J - Other | -353.150 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | INCY |
INCYTE CORP
3.5% Convertible Subordinated Notes due 2011 |
J - Other | 8.167.000 | 10.864.000 | 302,82 | ||||
| 2006-04-28 |
|
4 | INCY |
INCYTE CORP
3.5% Convertible Subordinated Notes due 2011 |
J - Other | -516.000 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | INCY |
INCYTE CORP
3.5% Convertible Subordinated Notes due 2011 |
J - Other | -444.000 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | INCY |
INCYTE CORP
3.5% Convertible Subordinated Notes due 2011 |
J - Other | -7.207.000 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | 1.203.937 | 1.278.127 | 1.622,78 | ||||
| 2006-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -14.235 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -84.112 | 0 | -100,00 | ||||
| 2006-04-28 |
|
4 | INCY |
INCYTE CORP
Common Stock |
J - Other | -1.105.590 | 0 | -100,00 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
